Horizon Technology Finance (HRZN) 10-Q 29 Oct 24 2024 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Oct. 29, 2024
Document Information [Line Items]
Entity Central Index Key	0001487428
Entity Registrant Name	Horizon Technology Finance Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	814-00802
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-2114934
Entity Address, Address Line One	312 Farmington Avenue
Entity Address, City or Town	Farmington
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06032
City Area Code	860
Local Phone Number	676‑8654
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		38,062,377
The 6.25% Notes due 2027 [Member]
Document Information [Line Items]
Title of 12(b) Security	6.25% Notes due 2027
Trading Symbol	HTFC
Security Exchange Name	NYSE
The 4.875% Notes due 2026 [Member]
Document Information [Line Items]
Title of 12(b) Security	4.875% Notes due 2026
Trading Symbol	HTFB
Security Exchange Name	NYSE
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	HRZN
Security Exchange Name	NASDAQ

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Assets
Investments at fair value	$ 684,000	$ 709,085
Cash	52,302	46,630
Investments in money market funds	31,080	26,450
Restricted investments in money market funds	3,266	2,642
Interest receivable	15,789	13,926
Other assets	6,637	3,623
Total assets	793,074	802,356
Liabilities
Borrowings (Note 7)	433,969	462,235
Distributions payable	12,475	11,011
Base management fee payable (Note 3)	1,025	1,052
Other accrued expenses	3,072	4,077
Total liabilities	450,541	478,375
Commitments and contingencies (Notes 3 and 8)
Net assets
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of September 30, 2024 and December 31, 2023	0	0
Common stock, par value $0.001 per share, 100,000,000 shares authorized, 37,970,529 and 33,534,854 shares issued and 37,803,064 and 33,367,389 shares outstanding as of September 30, 2024 and December 31, 2023, respectively	42	36
Paid-in capital in excess of par	500,345	450,949
Distributable loss	(157,854)	(127,004)
Total net assets	342,533	323,981
Total liabilities and net assets	$ 793,074	$ 802,356
Net asset value per common share (in dollars per share)	$ 9.06	$ 9.71
Investment, Unaffiliated Issuer [Member]
Assets
Investments at fair value	$ 655,962	$ 693,730
Investment, Affiliated Issuer, Noncontrolled [Member]
Assets
Investments at fair value	8,307	1,132
Investment, Affiliated Issuer, Controlled [Member]
Assets
Investments at fair value	$ 19,731	$ 14,223

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Investments at cost	$ 733,232	$ 759,182
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares oustanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	37,970,529	33,534,854
Common stock, shares outstanding (in shares)	37,803,064	33,367,389
Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 680,401	$ 716,077
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	27,478	28,677
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	$ 25,353	$ 14,428

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investment income
Payment-in-kind interest income			$ 2,114	$ 6,088
Total investment income	$ 24,563	$ 29,138	76,370	85,292
Expenses
Interest expense	7,945	7,107	24,046	21,407
Base management fee (Note 3)	2,989	3,213	9,178	9,621
Performance based incentive fee (Note 3)	0	0	295	3,094
Administrative fee (Note 3)	400	441	1,259	1,249
Professional fees	587	452	1,707	1,558
General and administrative	432	392	1,419	1,384
Total expenses	12,353	11,605	37,904	38,313
Net investment income before excise tax	12,210	17,533	38,466	46,979
Provision for excise tax	373	179	1,109	542
Net investment income	11,837	17,354	37,357	46,437
Net realized and unrealized loss
Net realized gain (loss) on investments	(33,894)	(11,816)	(31,422)	(28,513)
Net unrealized appreciation (depreciation) on investments	29,335	(17,518)	864	(24,448)
Net realized and unrealized loss	(4,559)	(29,334)	(30,558)	(52,961)
Net increase (decrease) in net assets resulting from operations	$ 7,278	$ (11,980)	$ 6,799	$ (6,524)
Net investment income per common share (in dollars per share)	$ 0.32	$ 0.53	$ 1.06	$ 1.54
Net increase (decrease) in net assets resulting from operations per common share (in dollars per share)	0.2	(0.37)	0.19	(0.22)
Distributions declared per share (in dollars per share)	$ 0.33	$ 0.33	$ 1.04	$ 0.99
Weighted average shares outstanding (in shares)	36,571,000	32,451,900	35,200,189	30,155,287
Investment, Unaffiliated Issuer [Member]
Investment income
Interest income	$ 22,779	$ 23,825	$ 71,549	$ 75,695
Fee income	1,382	124	2,661	2,255
Payment-in-kind interest income	161	3,777	1,554	5,930
Net realized and unrealized loss
Net realized gain (loss) on investments	(33,894)	(11,816)	(31,459)	(28,513)
Net unrealized appreciation (depreciation) on investments	35,407	180	(2,094)	(7,656)
Investment, Affiliated Issuer, Noncontrolled [Member]
Investment income
Interest income	0	1,246	0	1,246
Net realized and unrealized loss
Net realized gain (loss) on investments	0	0	37	0
Net unrealized appreciation (depreciation) on investments	(6,237)	(19,055)	8,374	(18,149)
Investment, Affiliated Issuer, Controlled [Member]
Investment income
Interest income	25	8	46	8
Payment-in-kind interest income	216	158	560	158
Net realized and unrealized loss
Net realized gain (loss) on investments	0	0	0	0
Net unrealized appreciation (depreciation) on investments	$ 165	$ 1,357	$ (5,416)	$ 1,357

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Common Stock Outstanding [Member]
Balance (in shares)	36,043,815	32,096,259	33,367,389	27,753,373
Issuance of common stock, net of offering costs (in shares)	1,709,096	1,186,303	4,279,141	5,490,326
Issuance of common stock under dividend reinvestment plan (in shares)	50,153	24,396	156,534	63,259
Balance (in shares)	37,803,064	33,306,958	37,803,064	33,306,958
Common Stock [Member]
Balance	$ 40	$ 34	$ 36	$ 29
Issuance of common stock, net of offering costs	2	1	6	6
Net investment income, net of excise tax	0	0	0	0
Net realized gain (loss) on investments	0	0	0	0
Net unrealized appreciation (depreciation) on investments	0	0	0	0
Issuance of common stock under dividend reinvestment plan	0	0	0	0
Distributions declared	0	0	0	0
Balance	42	35	42	35
Additional Paid-in Capital [Member]
Balance	481,349	437,561	450,949	385,921
Issuance of common stock, net of offering costs	18,413	13,854	47,521	65,025
Net investment income, net of excise tax	0	0	0	0
Net realized gain (loss) on investments	0	0	0	0
Net unrealized appreciation (depreciation) on investments	0	0	0	0
Issuance of common stock under dividend reinvestment plan	583	307	1,875	776
Distributions declared	0	0	0	0
Balance	500,345	451,722	500,345	451,722
Retained Earnings [Member]
Balance	(152,611)	(82,176)	(127,004)	(67,502)
Issuance of common stock, net of offering costs	0	0	0	0
Net investment income, net of excise tax	11,837	17,354	37,357	46,437
Net realized gain (loss) on investments	(33,894)	(11,816)	(31,422)	(28,513)
Net unrealized appreciation (depreciation) on investments	29,335	(17,518)	864	(24,448)
Issuance of common stock under dividend reinvestment plan	0	0	0	0
Distributions declared	(12,521)	(11,026)	(37,649)	(31,156)
Balance	(157,854)	(105,182)	(157,854)	(105,182)
Balance	328,778	355,419	323,981	318,448
Issuance of common stock, net of offering costs	18,415	13,855	47,527	65,031
Net investment income, net of excise tax	11,837	17,354	37,357	46,437
Net realized gain (loss) on investments	(33,894)	(11,816)	(31,422)	(28,513)
Net unrealized appreciation (depreciation) on investments	29,335	(17,518)	864	(24,448)
Issuance of common stock under dividend reinvestment plan	583	307	1,875	776
Distributions declared	(12,521)	(11,026)	(37,649)	(31,156)
Balance	$ 342,533	$ 346,575	$ 342,533	$ 346,575

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 7,278	$ (11,980)	$ 6,799	$ (6,524)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Amortization of debt issuance costs	500	500	1,272	1,433
Net realized (gain) loss on investments			31,422	28,513
Net unrealized (appreciation) depreciation on investments	(29,335)	17,518	(864)	24,448
Purchase of investments			(121,211)	(154,488)
Principal payments received on investments			120,448	90,222
Payment-in-kind interest on investments			(2,114)	(6,088)
Proceeds from sale of investments			157	11,063
Equity received in settlement of fee income			0	(89)
Warrants received in settlement of fee income			(359)	(80)
Changes in assets and liabilities:
(Increase) decrease in interest receivable			(775)	1,491
Increase in end-of-term payments			(1,088)	(1,960)
Decrease in unearned income			(2,381)	(2,621)
Increase in other assets			(201)	(837)
(Decrease) increase in other accrued expenses			(1,005)	414
(Decrease) increase in base management fee payable			(27)	15
Decrease in incentive fee payable			0	(1,392)
Net cash provided by (used in) operating activities			30,073	(16,480)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs			47,527	65,031
Advances on Credit Facilities			50,000	59,250
Repayment of Credit Facilities			(70,000)	(35,000)
Debt issuance costs			(3,334)	(732)
Distributions paid			(34,310)	(28,548)
Net cash (used in) provided by financing activities			(19,147)	36,125
Net increase in cash, cash equivalents and restricted cash			10,926	19,645
Cash, cash equivalents and restricted cash:
Beginning of period			75,722	30,466
End of period	86,648	50,111	86,648	50,111
Supplemental disclosure of cash flow information:
Cash paid for interest			22,770	19,956
Supplemental non-cash investing and financing activities:
Refinanced debt investment balances			19,540	0
Warrant investments received and recorded as unearned income			1,269	1,870
Distributions payable	12,475	10,991	12,475	10,991
End-of-term payments receivable			12,905	11,743
Non-cash income			9,448	12,861
Cash	52,302	34,816	52,302	34,816
Investments in money market funds	31,080	12,457	31,080	12,457
Restricted investments in money market funds	3,266	2,838	3,266	2,838
Total cash, cash equivalents and restricted cash	$ 86,648	$ 50,111	86,648	50,111
Asset-backed Notes 2022 [Member]
Cash flows from financing activities:
Repayment of note			(9,030)	0
Asset-backed Notes 2019 [Member]
Cash flows from financing activities:
Repayment of note			$ 0	$ (23,876)

Consolidated Schedule of Invest

Consolidated Schedule of Investments (Unaudited)	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Schedule of Investments [Text Block]	September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 191.6 Non-Affiliate Debt Investments — 182.9 Non-Affiliate Debt Investments — Life Science — 76.0 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 3,958 $ 3,948 $ 3,948 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,958 3,948 3,948 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,375 2,368 2,368 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,958 3,948 3,948 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,958 3,949 3,949 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,375 2,369 2,369 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 12.72 % Prime 4.72 % 9.75 % — 5.00 % November 1, 2025 5,000 4,970 4,970 Term Loan 12.72 % Prime 4.72 % 9.75 % — 5.00 % May 1, 2026 5,000 4,975 4,975 Greenlight Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.75 % Prime 5.75 % 9.00 % — 3.00 % July 1, 2025 1,667 1,624 1,624 Term Loan 13.75 % Prime 5.75 % 9.00 % — 3.00 % July 1, 2025 833 812 812 KSQ Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.75 % Prime 4.75 % 8.50 % — 5.50 % May 1, 2027 6,250 6,215 6,215 Term Loan 12.75 % Prime 4.75 % 8.50 % — 5.50 % May 1, 2027 6,250 6,215 6,215 Native Microbials, Inc (2)(12) Biotechnology Term Loan 13.25 % Prime 5.25 % 8.50 % — 5.00 % November 1, 2026 3,250 3,234 3,234 Term Loan 13.25 % Prime 5.25 % 8.50 % — 5.00 % November 1, 2026 2,167 2,156 2,156 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Term Loan 13.75 % Prime 5.75 % 9.75 % — 3.75 % September 1, 2026 10,000 9,950 9,950 Term Loan 13.75 % Prime 5.75 % 9.75 % — 3.75 % September 1, 2026 3,750 3,731 3,731 Term Loan 13.75 % Prime 5.75 % 9.75 % — 3.75 % September 1, 2026 3,750 3,731 3,731 Provivi, Inc. (2)(12) Biotechnology Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.30 % January 1, 2027 3,482 3,410 3,218 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.30 % January 1, 2027 3,482 3,410 3,218 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,701 1,605 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,701 1,605 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,699 1,604 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,699 1,604 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % October 1, 2025 2,631 2,598 2,598 Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % October 1, 2025 1,315 1,299 1,299 Tallac Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.25 % Prime 4.25 % 12.25 % — 4.00 % August 1, 2027 2,500 2,468 2,468 Term Loan 12.25 % Prime 4.25 % 12.25 % — 4.00 % August 1, 2027 2,500 2,468 2,468 Aerobiotix, LLC (2)(12) Medical Device Term Loan 9.00 % Fixed — — — 18.00 % April 1, 2028 2,500 2,477 2,205 Term Loan 9.00 % Fixed — — — 18.00 % April 1, 2028 2,500 2,477 2,205 Term Loan 9.00 % Fixed — — — 18.00 % April 1, 2028 200 188 168 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Candesant Biomedical, Inc. (2)(12) Medical Device Term Loan 11.50 % Prime 3.50 % 11.50 % — 5.00 % September 1, 2027 5,000 4,777 4,777 Term Loan 11.50 % Prime 3.50 % 11.50 % — 5.00 % September 1, 2027 2,500 2,464 2,464 Term Loan 11.50 % Prime 3.50 % 11.50 % — 5.00 % September 1, 2027 2,500 2,464 2,464 Ceribell, Inc. (2)(12) Medical Device Term Loan 10.75 % Prime 2.75 % 9.25 % — 4.00 % March 1, 2029 5,000 4,817 4,817 Term Loan 10.75 % Prime 2.75 % 9.25 % — 4.00 % March 1, 2029 5,000 4,938 4,938 Term Loan 10.75 % Prime 2.75 % 9.25 % — 4.00 % March 1, 2029 4,000 3,950 3,950 Cognoa, Inc. (2)(12) Medical Device Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % August 1, 2026 3,611 3,584 3,356 Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % August 1, 2026 1,806 1,792 1,678 Conventus Orthopaedics, Inc. (2)(12) Medical Device Term Loan 12.82 % Prime 4.82 % 9.25 % — 10.36 % July 1, 2025 3,477 3,448 3,448 Term Loan 12.82 % Prime 4.82 % 9.25 % — 10.36 % July 1, 2025 3,477 3,448 3,448 Infobionic, Inc. (2)(12) Medical Device Term Loan 13.00 % Prime 4.50 % 12.00 % — 2.00 % September 1, 2029 5,000 4,916 4,916 Term Loan 13.00 % Prime 4.50 % 12.00 % — 2.00 % September 1, 2029 5,000 4,916 4,916 Term Loan 13.00 % Prime 4.50 % 12.00 % — 2.00 % September 1, 2029 5,000 4,916 4,916 MicroTransponder, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % — 3.50 % January 1, 2029 3,750 3,696 3,696 Term Loan 12.25 % Prime 3.75 % 12.25 % — 3.50 % January 1, 2029 3,750 3,696 3,696 Scientia Vascular, Inc. (2)(12) Medical Device Term Loan 13.25 % Prime 4.75 % 8.50 % — 5.00 % January 1, 2027 3,750 3,734 3,734 Term Loan 13.25 % Prime 4.75 % 8.50 % — 5.00 % January 1, 2027 3,750 3,733 3,733 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % January 1, 2027 5,000 4,959 4,959 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % January 1, 2027 5,000 4,927 4,927 Sonex Health, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 2,500 2,479 2,479 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 2,500 2,479 2,479 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 5,000 4,957 4,957 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 5,000 4,957 4,957 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Spineology, Inc. (2)(12) Medical Device Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 5,000 4,911 4,911 Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 4,250 4,174 4,174 Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 4,250 4,174 4,174 Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 2,500 2,455 2,455 Swift Health Systems Inc. (2)(12)(14) Medical Device Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,510 3,509 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,475 3,474 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,469 3,468 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,469 3,468 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Term Loan 13.75 % Prime 5.25 % 9.00 % — 100.00 % July 1, 2027 300 300 300 Term Loan 13.75 % Prime 5.25 % 9.00 % — 100.00 % July 1, 2027 150 150 150 Term Loan 13.75 % Prime 5.25 % 9.00 % — — July 1, 2027 200 200 200 Term Loan 13.25 % Prime 5.25 % 9.00 % — — July 1, 2027 350 350 350 Vero Biotech, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 15,000 14,719 14,117 Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 10,000 9,813 9,411 Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 5,000 4,907 4,706 Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 2,500 2,453 2,353 Total Non-Affiliate Debt Investments — Life Science 263,158 260,177 Non-Affiliate Debt Investments — Sustainability — 19.8 Pivot Bio, Inc.(2)(12) Energy Efficiency Term Loan 12.00 % Prime 4.00 % 12.00 % — 4.00 % February 1, 2029 5,000 4,739 4,739 Term Loan 12.00 % Prime 4.00 % 12.00 % — 4.00 % February 1, 2029 5,000 4,948 4,948 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Term Loan 14.75 % Prime 6.75 % 10.00 % — 4.33 % December 1, 2026 3,750 3,712 3,712 Term Loan 14.75 % Prime 6.75 % 10.00 % — 4.33 % December 1, 2026 3,750 3,712 3,712 Soli Organic, Inc. (2)(12) Other Sustainability Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % April 1, 2026 5,000 4,937 4,937 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % April 1, 2026 2,500 2,469 2,469 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % May 1, 2026 5,000 4,938 4,938 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % May 1, 2026 2,500 2,469 2,469 Term Loan 13.50 % Prime 5.50 % 11.75 % — 2.75 % December 1, 2026 5,000 4,946 4,946 Term Loan 13.50 % Prime 5.50 % 11.75 % — 2.75 % December 1, 2026 2,500 2,473 2,473 Temperpack Technologies, Inc. (2)(12) Other Sustainability Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,703 3,703 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,703 3,703 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 7,500 7,400 7,400 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 14.00 % Prime 6.00 % 10.00 % — 2.00 % January 1, 2029 4,500 4,452 4,452 Term Loan 14.00 % Prime 6.00 % 10.00 % — 2.00 % January 1, 2029 2,000 1,979 1,979 Total Non-Affiliate Debt Investments — Sustainability 67,980 67,980 Non-Affiliate Debt Investments — Technology — 56.7 Axiom Space, Inc. (2)(12) Communications Term Loan 14.50 % Prime 6.00 % 9.25 % — 2.50 % June 1, 2026 4,375 4,354 4,354 Term Loan 14.50 % Prime 6.00 % 9.25 % — 2.50 % June 1, 2026 4,375 4,353 4,353 Term Loan 14.50 % Prime 6.00 % 9.25 % — 2.50 % June 1, 2026 4,375 4,353 4,353 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Term Loan 15.25 % Prime 7.25 % 10.50 % — 3.00 % March 1, 2027 2,033 1,980 1,922 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Clara Foods Co. (2)(12) Consumer-related Technologies Term Loan 14.25 % Prime 5.75 % 9.00 % — 5.50 % August 1, 2025 833 828 828 Term Loan 14.25 % Prime 5.75 % 9.00 % — 5.50 % August 1, 2025 833 828 828 Havenly, Inc. (2)(12) Consumer-related Technologies Term Loan 13.00 % Prime 5.00 % 5.00 % — 10.40 % March 1, 2027 2,000 1,467 1,467 Term Loan 13.00 % Prime 5.00 % 5.00 % — 10.40 % March 1, 2027 3,000 2,441 2,441 Term Loan 11.50 % Prime 3.50 % 10.50 % — 7.78 % February 1, 2028 2,813 2,813 2,813 Term Loan 11.50 % Prime 3.50 % 10.50 % — 7.78 % February 1, 2028 2,813 2,813 2,813 Lyrical Foods, Inc. (2)(12) Consumer-related Technologies Term Loan 11.50 % (11) Prime 3.50 % 9.00 % — 5.00 % July 1, 2028 2,603 2,692 2,341 NextCar Holding Company, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 5,908 5,489 3,256 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,363 2,196 1,303 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 3,545 3,294 1,953 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 5,908 5,489 3,255 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Optoro, Inc. (2)(12) Consumer-related Technologies Term Loan 14.75 % Prime 6.25 % 9.50 % — 4.00 % August 1, 2027 2,500 2,440 2,440 Term Loan 14.75 % Prime 6.25 % 9.50 % — 4.00 % July 1, 2028 1,875 1,800 1,800 Standvast Holdings, LLC (2)(12) Consumer-related Technologies Term Loan 12.75 % Prime 4.25 % 12.75 % — 3.00 % June 1, 2028 2,500 2,245 2,245 Term Loan 12.75 % Prime 4.25 % 12.75 % — 3.00 % June 1, 2028 2,500 2,421 2,421 Unagi, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 15.75 % (11) Prime 7.75 % 11.00 % — — May 1, 2027 1,361 1,086 228 Term Loan 15.75 % (11) Prime 7.75 % 11.00 % — — May 1, 2027 680 543 114 Term Loan 15.75 % (11) Prime 7.75 % 11.00 % — — May 1, 2027 680 543 114 Fictiv, Inc. (2)(12) Networking Term Loan 11.25 % Prime 3.25 % 10.00 % — 4.00 % April 1, 2029 5,000 4,703 4,703 Term Loan 11.25 % Prime 3.25 % 10.00 % — 4.00 % April 1, 2029 5,000 4,938 4,938 BriteCore Holdings, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 5,000 4,905 4,905 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 2,500 2,471 2,471 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 2,500 2,471 2,471 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 2,500 2,471 2,471 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % April 1, 2029 2,500 2,467 2,467 Dropoff, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.50 % 9.75 % — 3.50 % June 1, 2026 6,804 6,729 6,337 Term Loan 14.50 % Prime 6.50 % 9.75 % — 3.50 % June 1, 2026 6,280 6,211 5,849 Term Loan 14.50 % Prime 6.50 % 9.75 % — 3.50 % June 1, 2026 2,617 2,590 2,439 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Kodiak Robotics, Inc. (2)(12) Software Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 10,000 9,946 9,946 Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 10,000 9,946 9,946 Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 5,000 4,973 4,973 Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 5,000 4,973 4,973 Lytics, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.00 % 14.25 % — 5.00 % November 1, 2026 2,500 2,479 2,479 Term Loan 14.50 % Prime 6.00 % 14.25 % — 5.00 % December 1, 2026 1,250 1,242 1,242 Term Loan 14.50 % Prime 6.00 % 14.25 % — 5.00 % April 1, 2027 1,000 996 996 Mirantis, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Noodle Partners, Inc. (2)(12) Software Term Loan 13.00 % Prime 5.00 % 12.00 % — 3.00 % March 1, 2027 10,000 9,916 9,916 Term Loan 13.00 % Prime 5.00 % 12.00 % — 3.00 % March 1, 2027 5,000 4,958 4,958 Term Loan 13.00 % Prime 5.00 % 12.00 % — 3.00 % March 1, 2027 5,000 4,958 4,958 Reputation Institute, Inc. (2)(12) Software Term Loan 15.75 % Prime 7.25 % 10.50 % — 3.00 % August 1, 2025 1,933 1,901 1,901 Supply Network Visibility Holdings LLC (2)(12) Software Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 2,500 2,476 2,476 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 3,500 3,491 3,491 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 2,500 2,493 2,493 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 1,500 1,496 1,496 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % July 1, 2029 5,000 4,983 4,983 Viken Detection Corporation (2)(12) Software Term Loan 12.00 % Prime 4.00 % 11.75 % — 3.50 % June 1, 2027 5,000 4,951 4,951 Term Loan 12.00 % Prime 4.00 % 11.75 % — 3.50 % June 1, 2027 2,500 2,476 2,476 Term Loan 12.00 % Prime 4.00 % 11.75 % — 3.50 % June 1, 2027 2,500 2,476 2,476 Total Non-Affiliate Debt Investments — Technology 208,250 194,051 Non-Affiliate Debt Investments — Healthcare information and services — 30.4 Hound Labs Inc. (12)(13) Diagnostics Term Loan 14.00 % Prime 6.00 % 9.25 % — 3.50 % June 1, 2026 1,607 1,577 1,034 Term Loan 14.00 % Prime 6.00 % 9.25 % — 3.50 % June 1, 2026 1,607 1,577 1,034 Term Loan 14.00 % Prime 6.00 % 9.25 % — 3.50 % June 1, 2026 3,214 3,151 2,068 Term Loan 14.00 % Fixed — — — 50.00 % March 1, 2025 300 300 197 Term Loan 14.00 % Fixed — — — 100.00 % March 1, 2025 250 250 164 Parse Biosciences, Inc. (2)(12) Diagnostics Term Loan 11.75 % Prime 3.25 % 11.50 % — 5.00 % January 1, 2028 5,000 4,652 4,652 Term Loan 11.75 % Prime 3.25 % 11.50 % — 5.00 % January 1, 2028 5,000 4,903 4,903 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) BrightInsight, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % August 1, 2027 7,000 6,814 6,814 Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % August 1, 2027 3,500 3,473 3,473 Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % August 1, 2027 3,500 3,473 3,473 Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % April 1, 2028 2,750 2,717 2,717 Elligo Health Research, Inc. (2)(12) Software Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 10,000 9,783 9,783 Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 5,000 4,940 4,940 Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 5,000 4,940 4,940 Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 5,000 4,940 4,940 SafelyYou, Inc. (2)(12) Software Term Loan 11.25 % Prime 3.25 % 11.00 % — 5.00 % June 1, 2027 5,000 4,791 4,791 Term Loan 11.25 % Prime 3.25 % 11.00 % — 5.00 % June 1, 2027 5,000 4,938 4,938 GT Medical Technologies, Inc. (2)(12) Other Healthcare Services Term Loan 11.25 % Prime 3.25 % 11.25 % — 4.00 % October 1, 2029 3,750 3,592 3,592 Term Loan 11.25 % Prime 3.25 % 11.25 % — 4.00 % October 1, 2029 3,750 3,692 3,692 Term Loan 11.25 % Prime 3.25 % 11.25 % — 4.00 % October 1, 2029 7,500 7,384 7,384 Hometeam Technologies, Inc. (2)(12) Other Healthcare Services Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,851 4,851 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Total Non-Affiliate Debt Investments — Healthcare information and services $ 106,542 $ 104,184 Total Non- Affiliate Debt Investments $ 645,930 $ 626,392 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrant Investments 5.5 Non-Affiliate Warrants Life Science 1.5 Avalo Therapeutics, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 117 $ 311 $ — Castle Creek Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 7,404 214 169 Emalex Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 110,402 176 127 Imunon, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 19,671 64 — KSQ Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 48,076 49 53 Mustang Bio, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 16,611 146 — Native Microbials, Inc (2)(12) Biotechnology Preferred Stock Warrant 103,679 64 58 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Common Stock Warrant 299,848 160 316 Provivi, Inc. (2)(12) Biotechnology Common Stock Warrant 175,098 278 — Provivi, Inc. (2)(12) Biotechnology Preferred Stock Warrant 709,981 312 222 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Common Stock Warrant 318,181 265 110 Tallac Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 1,600,002 195 167 Xeris Pharmaceuticals, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 126,000 73 64 AccuVein Inc. (2)(12) Medical Device Common Stock Warrant 271 7 — Aerin Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 1,818,183 66 1,048 Aerobiotix, LLC (2)(12) Medical Device Preferred Stock Warrant 8,800 48 9 Canary Medical Inc. (2)(12) Medical Device Preferred Stock Warrant 12,153 87 171 Candesant Biomedical, Inc. (2)(12) Medical Device Preferred Stock Warrant 93,336 152 131 Ceribell, Inc. (2)(12) Medical Device Preferred Stock Warrant 231,050 147 192 Cognoa, Inc. (2)(12) Medical Device Common Stock Warrant 30,585 — — Cognoa, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,635,992 162 13 Conventus Orthopaedics, Inc. (2)(12) Medical Device Preferred Stock Warrant 9,313,541 256 197 CSA Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,917,794 174 471 CVRx, Inc. (2)(5)(12) Medical Device Common Stock Warrant 47,410 76 50 Infobionic, Inc. (2)(12) Medical Device Preferred Stock Warrant 5,361,130 231 169 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Magnolia Medical Technologies, Inc. (2)(12) Medical Device Preferred Stock Warrant 809,931 194 304 Meditrina, Inc. (2)(12) Medical Device Preferred Stock Warrant 233,993 83 29 MicroTransponder, Inc. (2)(12) Medical Device Preferred Stock Warrant 103,172 48 48 Scientia Vascular, Inc (2)(12) Medical Device Preferred Stock Warrant 34,410 103 273 Sonex Health, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,637,133 275 262 VERO Biotech LLC (2)(12) Medical Device Preferred Stock Warrant 4,109 432 196 Spineology, Inc. (2)(12) Medical Device Common Stock Warrant 2,714,033 143 108 Spineology, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,255,155 16 27 Swift Health Systems Inc. (2)(12) Medical Device Preferred Stock Warrant 135,484 71 — Total Non-Affiliate Warrants — Life Science 5,078 4,984 Non-Affiliate Warrants — Sustainability — 0.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Preferred Stock Warrant 400,000 82 69 LiquiGlide, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 61,359 40 25 Soli Organic, Inc. (2)(12) Other Sustainability Common Stock Warrant 65 20 19 Soli Organic, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 1,103 382 489 Temperpack Technologies, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 49,693 178 91 Pivot Bio, Inc. (2)(12) Energy Efficiency Preferred Stock Warrant 210,418 14 14 Total Non-Affiliate Warrants — Sustainability 716 707 Non-Affiliate Warrants — Technology — 3.5 Axiom Space Holdings, Inc. (2)(12) Communications Common Stock Warrant 1,991 46 57 Intelepeer Holdings, Inc. (2)(12) Communications Preferred Stock Warrant 2,936,535 137 2,100 Alula Holdings, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 20,000 93 7 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 112,356 36 39 Clara Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 46,745 30 121 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 9,801 79 55 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 53,264 454 622 Havenly, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 1,446,429 3,178 2,489 MyForest Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 250 28 24 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 12,618 188 — NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 3,913,723 9 — Optoro, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 11,550 181 144 Primary Kids, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 553,778 57 587 Quip NYC Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 6,191 325 — Standvast Holdings, LLC (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,225,492 275 258 Unagi, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 171,081 29 — Updater, Inc.(2)(12) Consumer-related Technologies Preferred Stock Warrant 108,333 34 26 CPG Beyond, Inc. (2)(12) Data Storage Preferred Stock Warrant 500,000 242 290 Silk, Inc. (2)(12) Data Storage Preferred Stock Warrant 394,110 175 119 Global Worldwide LLC (2)(12) Internet and Media Preferred Stock Warrant 245,810 75 — Rocket Lawyer Incorporated (2)(12) Internet and Media Preferred Stock Warrant 261,721 92 313 Skillshare, Inc. (2)(12) Internet and Media Preferred Stock Warrant 139,074 162 671 Liqid, Inc. (2)(12) Networking Preferred Stock Warrant 344,102 364 103 Fictiv, Inc. (2)(12) Networking Common Stock Warrant 126,841 59 74 Halio, Inc. (2)(12) Power Management Common Stock Warrant 38,241,466 1,585 2,700 Avalanche Technology, Inc. (2)(12) Semiconductors Preferred Stock Warrant 5,938 45 — BriteCore Holdings, Inc. (2)(12) Software Preferred Stock Warrant 161,215 98 254 Dropoff, Inc. (2)(12) Software Common Stock Warrant 516,732 455 90 E La Carte, Inc. (2)(5)(12) Software Common Stock Warrant 147,361 60 — Everstream Holdings, LLC (2)(12) Software Preferred Stock Warrant 350,000 70 21 Kodiak Robotics, Inc. (2)(12) Software Preferred Stock Warrant 639,918 273 9 Lemongrass Holdings, Inc. (2)(12) Software Preferred Stock Warrant 101,308 34 83 Lotame Solutions, Inc. (2)(12) Software Preferred Stock Warrant 71,305 18 40 Lytics, Inc. (2)(12) Software Preferred Stock Warrant 85,543 43 — Mirantis, Inc. (2)(12) Software Common Stock Warrant 948,275 223 240 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Noodle Partners, Inc. (2)(12) Software Preferred Stock Warrant 84,037 116 — Reputation Institute, Inc. (2)(12) Software Preferred Stock Warrant 4,104 63 33 Revinate Holdings, Inc. (2)(12) Software Preferred Stock Warrant 682,034 44 90 SIGNiX, Inc. (12) Software Preferred Stock Warrant 186,235 225 — Slingshot Aerospace, Inc. (2)(12) Software Preferred Stock Warrant 309,208 123 79 Supply Network Visibility Holdings LLC (2)(12) Software Preferred Stock Warrant 682 65 75 Topia Mobility, Inc. (2)(12) Software Preferred Stock Warrant 3,049,607 137 — Viken Detection Corporation (2)(12) Software Preferred Stock Warrant 345,443 120 203 xAd, Inc. (2)(12) Software Preferred Stock Warrant 4,343,348 176 7 Total Non-Affiliate Warrants — Technology 10,321 12,023 Non-Affiliate Warrants — Healthcare information and services — 0.3 Hound Labs, Inc (12) Diagnostics Preferred Stock Warrant 451,796 45 — Parse Biosciences, Inc. (2)(12) Diagnostics Common Stock Warrant 32,244 71 15 Parse Biosciences, Inc. (2)(12) Diagnostics Preferred Stock Warrant 184,253 166 47 Kate Farms, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 82,965 103 777 GT Medical Technologies, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 255,871 85 86 BrightInsight, Inc. (2)(12) Software Preferred Stock Warrant 85,066 167 — Elligo Health Research, Inc. (2)(12) Software Preferred Stock Warrant 652,250 191 85 Medsphere Systems Corporation (2)(12) Software Preferred Stock Warrant 7,097,792 61 — SafelyYou, Inc. (2)(12) Software Preferred Stock Warrant 150,353 163 11 Total Non-Affiliate Warrants — Healthcare information and services 1,052 1,021 Total Non-Affiliate Warrants 17,167 18,735 Non-Affiliate Other Investments — Life Science — 1.5 Lumithera, Inc. (12) Medical Device Royalty Agreement 1,147 100 Robin Healthcare, Inc. (2)(12) Medical Device Royalty Agreement 7,271 3,247 ZetrOZ, Inc. (12) Medical Device Royalty Agreement — — Total Non-Affiliate Other Investments 8,418 3,347 Non-Affiliate Equity — 2.2 Cadrenal Therapeutics, Inc. (5) Biotechnology Common Stock 600,000 — 546 Castle Creek Biosciences, Inc. (12) Biotechnology Common Stock 1,162 250 250 Emalex Biosciences, Inc. (12) Biotechnology Common Stock 32,831 356 356 Axiom Space, Inc. (12) Communications Preferred Stock 1,810 261 306 PebblePost, Inc. (2)(12) Communications Preferred Stock 598,850 73 73 Caastle, Inc. (2)(12) Consumer-related Technologies Preferred Stock 242,180 2,681 2,687 Getaround, Inc. (2)(5) Consumer-related Technologies Common Stock 87,082 253 5 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock 2,688,971 89 — SnagAJob.com, Inc. (12) Consumer-related Technologies Common Stock 82,974 7 83 Lumithera, Inc. (12) Medical Device Common Stock 392,651 2,000 1,700 Tigo Energy, Inc. (5) Other Sustainability Common Stock 5,205 111 11 Decisyon, Inc. (12) Software Preferred Stock 280,000 2,800 1,281 Lotame, Inc. (12) Software Preferred Stock 66,127 5 190 Total Non-Affiliate Equity 8,886 7,488 Total Non-Affiliate Portfolio Investment Assets $680,401 $655,962 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) September 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Controlled Affiliate Investments — 2.4 Non-Controlled Affiliate Other Investments — 2.4 Evelo Holdings, Inc. (2)(5)(12)(17) Biotechnology Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 $ 5,770 $ 4,910 $ 1,825 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 8,656 7,621 2,832 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 3,462 2,947 1,095 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 3,462 2,947 1,095 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 2,308 1,964 730 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 2,308 1,964 730 Total Non-Controlled Affiliate Other Investments 22,353 8,307 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-controlled Affiliate Equity 0.0 Aulea Medical, Inc. (12) Medical Device Common Stock 660,537 $ — $ — Evelo Holdings, Inc. (2)(5)(12) Biotechnology Common Stock 2,164,502 5,000 — Total Non-Controlled Affiliate Equity 5,000 — Non-controlled Affiliate Warrants 0.0 Evelo Holdings, Inc. (2)(5)(12) Biotechnology Common Stock 23,196 125 — Total Non-Controlled Affiliate Warrants 125 — Total Non-Controlled Affiliate Portfolio Investment Assets $ 27,478 $ 8,307 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Controlled Affiliate Investments 5.7 Controlled Affiliate Debt Investments 2.0 Better Place Forests Co. (12) Consumer-related Technologies Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — 2.78 % August 1, 2029 $ 3,891 $ 3,935 $ 3,234 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — 2.78 % August 1, 2029 1,946 1,927 1,583 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — — August 1, 2025 521 521 489 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — — August 1, 2025 516 517 484 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — — August 1, 2025 506 507 474 Nexii, Inc. (12) Other Sustainability Term Loan 10.00 % Fixed — — — — July 1, 2027 790 790 628 Total Controlled Affiliate Debt Investments 8,197 6,892 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Controlled Affiliate Equity — 1.9 Better Place Forests Co. (12) Consumer-related Technologies Common Stock 2,278,272 2,060 — Better Place Forests Co. (12) Consumer-related Technologies Preferred Stock 5,350,142 2,500 — Nexii, Inc. (2)(12) Other Sustainability Common Stock 108,320 3,297 3,309 Nexii, Inc. (2)(12) Other Sustainability Preferred Stock 542 3,419 3,240 Total Controlled Affiliate Equity 11,276 6,549 Controlled Affiliate Other Investments — 1.8 HIMV LLC (12)(16) Biotechnology Other Investment 5,880 6,290 Total Controlled Affiliate Other 5,880 6,290 Total Controlled Affiliate Portfolio Investment Assets $ 25,353 $ 19,731 Total Portfolio Investment Assets — 199.7 $ 733,232 $ 684,000 Short Term Investments - Unrestricted Investments - 9.1 US Bank Money Market Deposit Account 31,080 31,080 Total Short Term Investments - Unrestricted Investments $ 31,080 $ 31,080 Short Term Investments - Restricted Investments - 1.0 US Bank Money Market Deposit Account 3,266 3,266 Total Short Term Investments - Restricted Invest

Note 1 - Organization

Note 1 - Organization	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Horizon Technology Finance Corporation (the “Company”) was organized as a Delaware corporation on March 16, 2010 1940 1986, not On October 28, 2010, Horizon Credit II LLC (“Credit II”) was formed as a Delaware limited liability company on June 28, 2011, not The Company formed Horizon Funding 2019‑1 “2019‑1 May 2, 2019 2019‑1 May 15, 2019 “2019‑1 2019‑1 “2019‑1 2019‑1 2019‑1 August 13, 2019 ( “2019 2019 1 February 27, 2024. Horizon Funding I, LLC (“HFI”) was formed as a Delaware limited liability company on May 9, 2018, not April 21, 2020, The Company formed Horizon Funding 2022‑1 “2022‑1 September 30, 2022 2022‑1 October 18, 2022 ( “2022‑1 2022‑1 “2022‑1 2022‑1 2022‑1 2022 2022 1 Horizon Funding II, LLC (“HFII”) was formed as a Delaware limited liability company o May 13, 20 24, not The Company has established wholly owned subsidiaries, which are structured as Delaware limited liability companies, either to hold assets of portfolio companies acquired in connection with a foreclosure or bankruptcy or to hold equity in portfolio companies which the Company may The Company, together with its co-lender to IMV, established HIMV LLC, a Delaware limited liability company to purchase and sell the assets of IMV, a past borrower of the Company. The assets of IMV were sold for (i) the right to receive certain payments, if any, in connection with the potential future development and licensing of the assets sold and (ii) equity in the buyer of such assets. HIMV LLC is 70% owned by the Company and 30% owned by a third The Company’s investment strategy is to maximize the investment portfolio’s return by generating current income from the debt investments the Company makes and capital appreciation from the warrants the Company receives when making such debt investments. The Company has entered into an investment management agreement with Horizon Technology Finance Management LLC (the “Advisor”) under which the Advisor manages the day-to-day operations of, and provides investment advisory services to, the Company.

Note 2 - Basis of Presentation

Note 2 - Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 2. The consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the requirements for reporting on Form 10‑Q 6 10 X X” 1933, not may December 31, 2023 Principles of consolidation As required under GAAP and Regulation S- X, Assets related to transactions that do not 860, Transfers and Servicing 2019‑1 2022 1 not Use of estimates In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments. Fair value The Company records all of its investments at fair value in accordance with relevant GAAP, which establishes a framework used to measure fair value and requires disclosures for fair value measurements. The Company has categorized its investments carried at fair value, based on the priority of the valuation technique, into a three 6. not The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3. See Note 6 Segments The Company has determined that it has a single reporting segment and operating unit structure. The Company lends to and invests in portfolio companies in various technology, life science, healthcare information and services and sustainability industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these debt investments and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment. Investments Investments are recorded at fair value. Pursuant to the amended SEC Rule 2a 5 1940 July 29, 2022, Interest on debt investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. Interest income is determined using a method that results in a level rate of return on principal amounts outstanding. Generally, when a debt investment becomes 90 not may may September 30, 2024 four December 31, 2023 four three nine September 30, 2024 three nine September 30, 2023 not The Company has a limited number of debt investments that contain a PIK provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. For the three September 30, 2024 2023, 13.5%, nine September 30, 2024 2023, 7.1%, not three September 30, 2024, no nine September 30, 2024 one nine September 30, 2024 three nine September 30, 2023, three three nine September 30, 2023, The Company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees, success fees and prepayment fees. In a limited number of cases, the Company may Certain debt investment agreements also require the borrower to make an ETP, that is accrued into interest receivable and taken into income over the life of the debt investment to the extent such amounts are expected to be collected. The Company will generally cease accruing the income if there is insufficient value to support the accrual or the Company does not not three September 30, 2024 2023 not nine September 30, 2024 2023 In connection with substantially all lending arrangements, the Company receives warrants to purchase shares of stock from the borrower. The warrants are recorded as assets at estimated fair value on the grant date using the Black-Scholes valuation model. The warrants are considered loan fees and are recorded as unearned income on the grant date. The unearned income is recognized as interest income over the contractual life of the related debt investment in accordance with the Company’s income recognition policy. Subsequent to debt investment origination, the fair value of the warrants is determined using the Black-Scholes valuation model. Any adjustment to fair value is recorded through earnings as net unrealized appreciation or depreciation on investments. Gains and losses from the disposition of the warrants or stock acquired from the exercise of warrants are recognized as realized gains and losses on investments. Realized gains or losses on the sale of investments, or upon the determination that an investment balance, or portion thereof, is not Debt issuance costs Debt issuance costs are fees and other direct incremental costs incurred by the Company in obtaining debt financing from its lenders and issuing debt securities. The unamortized balance of debt issuance costs as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 three September 30, 2024 2023 nine September 30, 2024 2023 Income taxes As a BDC, the Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC and to avoid the imposition of corporate-level income tax on the portion of its taxable income distributed to stockholders, among other things, the Company is required to meet certain source of income and asset diversification requirements and to timely distribute dividends out of assets legally available for distribution to its stockholders of an amount generally at least equal to 90% no 946, Financial Services Investment Companies no Depending on the level of taxable income earned in a tax year, the Company may three September 30, 2024 2023 nine September 30, 2024 2023 The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than- not” 740, Income Taxes 946. not not September 30, 2024 December 31, 2023 2024, 2023, 2022 2021 Distributions Distributions to common stockholders are recorded on the declaration date. The amount to be paid out as distributions is determined by the Board. Net realized capital gains, if any, may may The Company has adopted a dividend reinvestment plan that provides for reinvestment of cash distributions on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board declares a cash distribution, then stockholders who have not may Stockholders Equity On August 2, 2021, “2021 2021 may On September 22, 2023, 2021 “2023 2021 2023 may may 415 During the three September 30, 2024 2023 During the three September 30, 2023 2023 2021 During the nine September 30, 2024 2023 During the nine September 30, 2023 2023 2021 The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of September 30, 2024 2023 On June 2, 2023, Stock Repurchase Program On April 26, 2024, may, not 10b‑18 1934, 1940 June 30, 2025 $5.0 three nine September 30, 2024 2023 not September 30, 2024 Transfers of financial assets Assets related to transactions that do not 860, Transfers and Servicing not Transfers of financial assets are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when ( 1 2 3 not Recently issued accounting pronouncement In November 2023, 2023 07, 280 2023 07” 2023 07 may one December 15, 2023, December 15, 2024, Recently adopted accounting pronouncement In June 2022, No. 2022 03, 2022 03” 2022 03 2022 03 December 15, 2023, 2022 03 not

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 3. Investment Management Agreement At a meeting of the stockholders convened on May 25, 2023 June 28, 2023, June 30, 2023 ( March 7, 2019. The Advisor’s services under the Investment Management Agreement are not not two The base management fee is calculated at an annual rate of 2.00% of the Company’s gross assets (less cash and cash equivalents) including any assets acquired with the proceeds of leverage; provided, that, to the extent the Company’s gross assets (less cash and cash equivalents) exceed $250 $250 The base management fee payable at September 30, 2024 December 31, 2023 three September 30, 2024 2023 nine September 30, 2024 2023 The incentive fee has two The first zero not no 1.75%, 2.1875% 20.00% not Pre-Incentive Fee Net Investment Income does not may 2.00% three The incentive fee on Pre-Incentive Fee Net Investment Income is subject to a fee cap and deferral mechanism which is determined based upon a look-back period of up to three 11 may 20.00% zero not three The second 20.00% not There was no performance based incentive fee expense for the three September 30, 2024 2023. nine September 30, 2024 2023, three September 30, 2024 2023, nine September 30, 2024 2023, not may three The following table provides the expiration dates of the Company’s Incentive Fee Cap and Deferral Mechanism contingent future liability as of September 30, 2024 Expiration Total (In thousands) December 31, 2025 $ 1,037 March 31, 2026 219 June 30, 2026 3,120 September 30, 2026 3,471 December 31, 2026 3,002 March 31, 2027 2,285 June 30, 2027 2,582 September 30, 2027 2,368 Total $ 18,084 There was no performance based incentive fee payable as of September 30, 2024 December 31, 2023 Administration Agreement The Company entered into an administration agreement (the “Administration Agreement”) with the Advisor to provide administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Advisor for the Company’s allocable portion of overhead and other expenses incurred by the Advisor in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and the Company’s allocable portion of the costs of compensation and related expenses of the Company’s Chief Financial Officer and Chief Compliance Officer and their respective staffs. The administrative fee expense was $0.4 million for the three September 30, 2024 2023 nine September 30, 2024 2023 September 30, 2024 December 31, 2023

Note 4 - Investments

Note 4 - Investments	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Investment Holdings [Text Block]	Note 4. The following table shows the Company’s investments as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Investments Debt $ 654,127 $ 633,284 $ 721,231 $ 670,172 Warrants 17,292 18,735 16,526 24,594 Other 36,651 17,944 6,982 6,430 Equity 25,162 14,037 14,443 7,889 Total investments $ 733,232 $ 684,000 $ 759,182 $ 709,085 The following table shows the Company’s investments by industry sector as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Life Science Biotechnology $ 126,867 $ 106,865 $ 145,544 $ 117,781 Medical Device 185,751 179,092 147,064 145,019 Technology Communications 13,577 15,596 19,192 22,188 Consumer-Related 74,381 54,505 105,669 101,327 Data Storage 417 409 417 418 Internet and Media 329 984 329 1,582 Networking 10,064 9,818 5,451 5,297 Power Management 1,585 2,700 1,585 2,700 Semiconductors 45 — 45 — Software 136,309 132,951 164,133 160,749 Sustainability Energy Efficiency 9,812 9,712 111 13 Other Sustainability 66,501 66,163 98,906 80,370 Healthcare Information and Services Diagnostics 16,692 14,114 19,735 19,701 Other 39,511 40,186 102 1,366 Software 51,391 50,905 50,899 50,574 Total investments $ 733,232 $ 684,000 $ 759,182 $ 709,085

Note 5 - Transactions With Affi

Note 5 - Transactions With Affiliated Companies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	Note 5. A non-controlled affiliated company is generally a portfolio company in which the Company owns 5% not 25% Transactions related to investments in non-controlled affiliated companies for the three September 30, 2024 Three months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Company 2024 Purchases payments fair value accretion gain/(loss) gain/(loss) 2024 (In thousands) Aulea Medical, Inc. $ — $ — $ — $ — $ — $ — $ — $ — Evelo Biosciences, Inc. 3,503 — (318 ) — — (1,360 ) — 1,825 5,340 127 (476 ) — — (2,159 ) — 2,832 2,101 — (191 ) — — (815 ) — 1,095 2,101 — (191 ) — — (815 ) — 1,095 1,401 — (127 ) — — (544 ) — 730 1,401 — (127 ) — — (544 ) — 730 Total non-controlled affiliates $ 15,847 $ 127 $ (1,430 ) $ — $ — $ (6,237 ) $ — $ 8,307 Transactions related to investments in non-controlled affiliated companies for the three September 30, 2023 Three months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Aulea Medical, Inc. $ — $ — $ — $ — $ — $ — $ — $ — $ — Cadrenal Therapeutics, Inc. (1) 906 — — (906 ) — — — — — Evelo Biosciences, Inc. — — — 7,665 8 (5,007 ) — 2,666 277 — — — 11,496 11 (7,510 ) — 3,997 415 — — — 4,612 5 (3,013 ) — 1,604 166 — — — 4,598 3 (3,004 ) — 1,597 163 — — — 3,067 4 (2,003 ) — 1,068 114 — — — 3,067 4 (2,003 ) — 1,068 111 — — — 5,000 — 3,485 — 8,485 — Total non-controlled affiliates $ 906 $ — $ — $ 38,599 $ 35 $ (19,055 ) $ — $ 20,485 $ 1,246 ( 1 As of September 30, 2023 no Transactions related to investments in non-controlled affiliated companies for the nine September 30, 2024 Nine months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Aulea Medical, Inc. $ — $ 3 $ (40 ) $ — $ — $ — $ 37 $ — $ — Evelo Biosciences, Inc. 222 — (318 ) — — 1,921 — 1,825 — 336 231 (476 ) — — 2,741 — 2,832 — 133 — (191 ) — — 1,153 — 1,095 — 133 — (191 ) — — 1,153 — 1,095 — 88 — (127 ) — — 769 — 730 — 88 — (127 ) — — 769 — 730 — 132 — — — — (132 ) — — — Total non-controlled affiliates $ 1,132 $ 234 $ (1,470 ) $ — $ — $ 8,374 $ 37 $ 8,307 $ — Transactions related to investments in non-controlled affiliated companies for the nine September 30, 2023 Nine months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2022 Purchases payments fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Aulea Medical, Inc. $ — $ — $ — $ — $ — $ — $ — $ — $ — Cadrenal Therapeutics, Inc. (1) — — — (906 ) — 906 — — — Evelo Biosciences, Inc. — — — 7,665 8 (5,007 ) — 2,666 277 — — — 11,496 11 (7,510 ) — 3,997 415 — — — 4,612 5 (3,013 ) — 1,604 166 — — — 4,598 3 (3,004 ) — 1,597 163 — — — 3,067 4 (2,003 ) — 1,068 114 — — — 3,067 4 (2,003 ) — 1,068 111 — — — 5,000 — 3,485 — 8,485 — Total non-controlled affiliates $ — $ — $ — $ 38,599 $ 35 $ (18,149 ) $ — $ 20,485 $ 1,246 ( 1 As of September 30, 2023 no 5% A controlled affiliated company is generally a portfolio company in which the Company owns more than 25% Transactions related to investments in controlled affiliated companies for the three September 30, 2024 Three months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2024 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,166 $ — $ — $ 119 $ — $ 2 $ (53 ) $ — $ 3,234 $ 125 1,549 — — 59 — 1 (26 ) — 1,583 63 420 — — 16 — — 53 — 489 16 415 — — 16 — — 53 — 484 16 — 500 — 6 — — (32 ) — 474 6 HIMV LLC 5,836 — (45 ) — — — 499 — 6,290 — Nexii, Inc. — — — — 6,716 — (167 ) — 6,549 15 — 790 — — — — (162 ) — 628 — Total controlled affiliates $ 11,386 $ 1,290 $ (45 ) $ 216 $ 6,716 $ 3 $ 165 $ — $ 19,731 $ 241 Transactions related to investments in controlled affiliated companies for the three September 30, 2023 Three months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Better Place Forests Co. $ — $ 59 $ — $ 105 $ 1,759 $ 2 $ 1,080 $ — $ 3,005 $ 111 — — — 53 844 1 536 — 1,434 55 — — — — 2,061 — — — 2,061 — — 750 — — — — (259 ) — 491 — HIMV LLC — — — — 6,154 — — — 6,154 — Total controlled affiliates $ — $ 809 $ — $ 158 $ 10,818 $ 3 $ 1,357 $ — $ 13,145 $ 166 Transactions related to investments in controlled affiliated companies for the nine September 30, 2024 Nine months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,339 $ — $ — $ 345 $ — $ 6 $ (456 ) $ — $ 3,234 $ 363 1,630 — — 171 — 4 (222 ) — 1,583 184 — 500 — 21 — — (32 ) — 489 21 — 500 — 17 — — (33 ) — 484 17 — 500 — 6 — — (32 ) — 474 6 3,024 1,250 — — — — (4,274 ) — — — HIMV LLC 6,230 227 (592 ) — 463 — (38 ) — 6,290 — Nexii, Inc. — — — — 6,716 — (167 ) — 6,549 15 — 790 — — — — (162 ) — 628 — Total controlled affiliates $ 14,223 $ 3,767 $ (592 ) $ 560 $ 7,179 $ 10 $ (5,416 ) $ — $ 19,731 $ 606 Transactions related to investments in controlled affiliated companies for the nine September 30, 2023 Nine months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2022 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Better Place Forests Co. $ — $ 59 $ — $ 105 $ 1,759 $ 2 $ 1,080 $ — $ 3,005 $ 111 — — — 53 844 1 536 — 1,434 55 — — — — 2,061 — — — 2,061 — — 750 — — — — (259 ) — 491 — HIMV LLC — — — — 6,154 — — — 6,154 — Total controlled affiliates $ — $ 809 $ — $ 158 $ 10,818 $ 3 $ 1,357 $ — $ 13,145 $ 166

Note 6 - Fair Value

Note 6 - Fair Value	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 6. Prior to July 30, 2022, 2a 5 1940 July 29, 2022, twelve The Company uses fair value measurements made by the valuation designee to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in certain instances, there are no not may not Fair value measurements focus on exit prices in an orderly transaction (that is, not may The Company’s fair value measurements are classified into a fair value hierarchy in accordance with ASC Topic 820, Fair Value Measurement three Level 1 Quoted prices in active markets for identical assets and liabilities. Level 2 Observable inputs other than Level 1 not Level 3 Unobservable inputs that are supported by little or no 3 Due to the inherent uncertainty of determining the fair value of investments that do not may may may may Cash and interest receivable: not 1 Money market funds: 2 Debt investments: 3 Under certain circumstances, the Company may Warrant investments: ● Underlying asset value of the issuer is estimated based on information available, including any information regarding the most recent rounds of borrower funding. Significant increases (decreases) in this unobservable input would result in a significantly higher (lower) fair value measurement. ● Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on indices of publicly traded companies similar in nature to the underlying company issuing the warrant. A total of seven ● The risk-free interest rates are derived from the U.S. Treasury yield curve. The risk-free interest rates are calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant. ● Other adjustments, including a marketability discount on private company warrants, are estimated based on management’s judgment about the general industry environment. ● Historical portfolio experience on cancellations and exercises of the Company’s warrants are utilized as the basis for determining the estimated time to exit of the warrants in each financial reporting period. Warrants may Under certain circumstances the Company may may The fair value of the Company’s warrants held in publicly traded companies is determined based on inputs that are readily available in public markets or can be derived from information available in public markets. Therefore, the Company has categorized these warrants as Level 2 3 Equity investments: third may 3 1 Other investments: 3 The following tables detail the assets that are carried at fair value and measured at fair value on a recurring basis as of September 30, 2024 December 31, 2023 September 30, 2024 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 633,284 $ 633,284 Warrant investments — 430 18,305 18,735 Other investments — — 17,944 17,944 Equity investments 560 — 13,477 14,037 Total investments $ 560 $ 430 $ 683,010 $ 684,000 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,172 $ 670,172 Warrant investments — 1,619 22,975 24,594 Other investments — — 6,430 6,430 Equity investments 608 — 7,281 7,889 Total investments $ 608 $ 1,619 $ 706,858 $ 709,085 The following tables provide a summary of quantitative information about the Company’s Level 3 September 30, 2024 December 31, 2023 may The following table is not 3 September 30, 2024 September 30, 2024 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 597,137 Discounted Expected Future Cash Flows Hypothetical Market Yield 12% – 20% 14 % 36,147 Multiple Probability Weighted Cash Flow Model Probability Weighting 10% - 100% 77 % Warrant investments 18,305 Black-Scholes Valuation Model Price Per Share 0.000 –1,898.5858 $ 65.35 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 17 % Estimated Time to Exit (in years) 1 to 5 3 Other investments 17,944 Multiple Probability Weighted Cash Flow Model Discount Rate 15% – 100% 36 % Probability Weighting 30% – 100% 86 % Equity investments 13,477 Last Equity Financing Price Per Share 0.00 14,592.60 $ 3,532.29 Total Level 3 investments $ 683,010 ( 1 Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) ( 1 2 The following table is not 3 December 31, 2023 December 31, 2023 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 617,529 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 24% 15 % 52,643 Multiple Probability Weighted Cash Flow Model Probability Weighting 20% - 100% 50 % Warrant investments 22,913 Black-Scholes Valuation Model Price Per Share 0.000 –1,899.0000 $ 64.95 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 6,430 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 81 % Equity investments 7,281 Last Equity Financing Price Per Share 0.56 215.03 $ 17.15 Total Level 3 investments $ 706,858 ( 1 Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) ( 1 2 Borrowings: 2 2026 7 September 30, 2024 2026 1 2027 7 September 30, 2024 2027 1 September 30, 2024 2022 3 not Off-balance-sheet instruments: 3 The following table shows a reconciliation of the beginning and ending balances for Level 3 three September 30, 2024 Three months ended September 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 609,068 $ 21,131 $ 6,850 $ 9,183 $ 646,232 Purchase of investments 85,782 — — 45 85,827 Warrants received and classified as Level 3 — 411 — — 411 Principal payments received on investments (44,347 ) — — (45 ) (44,392 ) Payment-in-kind interest on investments 377 — — — 377 Proceeds from sale of investments (69 ) — — — (69 ) Net realized loss on investments (33,385 ) (509 ) — — (33,894 ) Unrealized appreciation (depreciation) included in earnings 37,574 (2,655 ) (162 ) (5,783 ) 28,974 Transfer out of warrant investments (21,260 ) (73 ) 6,789 14,544 — Other (456 ) — — — (456 ) Level 3 assets, end of period $ 633,284 $ 18,305 $ 13,477 $ 17,944 $ 683,010 During the three September 30, 2024, 3. The following table shows a reconciliation of the beginning and ending balances for Level 3 three September 30, 2023 Three months ended September 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 683,309 $ 24,376 $ 4,259 $ 1,300 $ 713,244 Purchase of investments 66,185 — 750 — 66,935 Warrants received and classified as Level 3 — 1,294 — — 1,294 Principal payments received on investments (25,726 ) — — — (25,726 ) Payment-in-kind interest on investments 3,934 — — — 3,934 Proceeds from sale of investments (2,528 ) (23 ) (6 ) — (2,557 ) Net realized (loss) gain on investments (11,440 ) (118 ) 6 — (11,552 ) Unrealized depreciation included in earnings (18,877 ) (296 ) (1,349 ) (200 ) (20,722 ) Transfer out of Level 3 (5,000 ) — — — (5,000 ) Transfer out of debt investments (9,304 ) — 3,150 6,154 — Other (715 ) — — — (715 ) Level 3 assets, end of period $ 679,838 $ 25,233 $ 6,810 $ 7,254 $ 719,135 During the three September 30, 2023 one 3. one 3 one 1 The following table shows a reconciliation of the beginning and ending balances for Level 3 nine September 30, 2024 Nine months ended September 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,172 $ 22,975 $ 7,281 $ 6,430 $ 706,858 Purchase of investments 119,564 — 1,250 397 121,211 Warrants received and classified as Level 3 — 1,628 — — 1,628 Principal payments received on investments (120,333 ) — — (115 ) (120,448 ) Payment-in-kind interest on investments 2,114 — — — 2,114 Proceeds from sale of investments (113 ) (4 ) — (40 ) (157 ) Net realized (loss) gain on investments (33,344 ) 2,091 — 40 (31,213 ) Unrealized appreciation (depreciation) included in earnings 18,564 (5,631 ) (4,524 ) (6,503 ) 1,906 Transfer out of debt and warrant investments (24,451 ) (2,754 ) 9,470 17,735 — Other 1,111 — — — 1,111 Level 3 assets, end of period $ 633,284 $ 18,305 $ 13,477 $ 17,944 $ 683,010 During the nine September 30, 2024 3. The change in unrealized appreciation included in the consolidated statement of operations attributable to Level 3 September 30, 2024 The following table shows a reconciliation of the beginning and ending balances for Level 3 nine September 30, 2023 Nine months ended September 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 686,458 $ 26,145 $ 2,416 $ 1,300 $ 716,319 Purchase of investments 153,728 — 760 — 154,488 Warrants and equity received and classified as Level 3 — 1,950 89 — 2,039 Principal payments received on investments (90,222 ) — — — (90,222 ) Payment-in-kind interest on investments 6,088 — — — 6,088 Proceeds from sale of investments (9,564 ) (1,493 ) (6 ) — (11,063 ) Net realized (loss) gain on investments (29,105 ) 1,028 (121 ) — (28,198 ) Unrealized depreciation included in earnings (21,325 ) (2,392 ) (2,467 ) (200 ) (26,384 ) Transfer out of Level 3 (5,000 ) — (111 ) — (5,111 ) Transfer out of debt investments (12,399 ) (5 ) 6,250 6,154 — Other 1,179 — — — 1,179 Level 3 assets, end of period $ 679,838 $ 25,233 $ 6,810 $ 7,254 $ 719,135 During the nine September 30, 2023 two 3. 3 one 1 one 1 The change in unrealized depreciation included in the consolidated statement of operations attributable to Level 3 September 30, 2023 The Company discloses fair value information about financial instruments, whether or not not The fair value amounts have been measured as of the reporting date and have not may As of September 30, 2024 December 31, 2023 Market risk The Company assumes interest rate risk (the risk that general interest rate levels will change) as a result of its normal operations. As a result, the fair values of the Company’s financial instruments may may

Note 7 - Borrowings

Note 7 - Borrowings	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7. The following table shows the Company’s borrowings as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Total Balance Unused Total Balance Unused Commitment Outstanding Commitment Commitment Outstanding Commitment (In thousands) Key Facility $ 150,000 $ — $ 150,000 $ 150,000 $ 70,000 $ 80,000 NYL Facility 250,000 181,000 69,000 250,000 181,000 69,000 Nuveen Facility 100,000 50,000 50,000 — — — 2022 Asset-Backed Notes 90,970 90,970 — 100,000 100,000 — 2027 Notes 57,500 57,500 — 57,500 57,500 — 2026 Notes 57,500 57,500 — 57,500 57,500 — Total before debt issuance costs 705,970 436,970 269,000 615,000 466,000 149,000 Unamortized debt issuance costs attributable to term borrowings — (3,001 ) — — (3,765 ) — Total borrowings outstanding, net $ 705,970 $ 433,969 $ 269,000 $ 615,000 $ 462,235 $ 149,000 As of September 30, 2024 1940 September 30, 2024 Credit Facilities Key Facility The Company entered into the Key Facility with Key effective November 4, 2013. June 20, 2024, may June 20, 2027 June 20, 2029 June 29, 2023, September 30, 2024 December 31, 2023, three September 30, 2024 2023 nine September 30, 2024 2023 September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 NYL Facility HFI entered into the NYL Facility with the NYL Noteholders for an aggregate purchase price of up to $100.0 million, with an accordion feature of up to $200.0 million at the mutual discretion and agreement of HSLFI and the NYL Noteholders. On June 1, 2018, three On May 24, 2023, May 24, 2023, 4.60% 3.50%, On May 6, 2024, June 2025 June 2030. May 6, 2024, There were $181.0 million in advances made by the NYL Noteholders as of September 30, 2024 December 31, 2023 September 30, 2024 2023, September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Under the terms of the NYL Facility, the Company is required to maintain a reserve cash balance, which may September 30, 2024 December 31, 2023 Nuveen Facility HFII entered into the Nuveen Facility with the Nuveen Noteholders for an aggregate purchase price of up to $100.0 million, with an accordion feature of up to $200.0 million at the mutual discretion and agreement of HFII and the Nuveen Noteholders. On June 21, 2024, H.15” may June 21, 2027 June 10, 2033. There were $50.0 million in advances made by the Nuveen Noteholders as of September 30, 2024 September 30, 2024 September 30, 2024 September 30, 2024 not December 31, 2023. Under the terms of the Nuveen Facility, the Company is required to maintain a reserve cash balance, which may September 30, 2024 Securitizations 2019 On August 13, 2019, 2019 2019 no August 13, 2019. 2019 November 22, 2023. The 2019 2019‑1 August 13, 2019, 2019 2019 July 15, 2021 September 15, 2027. As of December 31, 2023, 2019 2022 On November 9, 2022, 2022 2022 no November 9, 2022. The 2022 2022‑1 November 9, 2022, 2022 2022 November 15, 2024 November 15, 2030. As of September 30, 2024 December 31, 2023 2022 Under the terms of the 2022 2022 may 2022 September 30, 2024 December 31, 2023 Unsecured Notes 2026 On March 30, 2021, 2026 “2026 2026 2026 March 30, 2026 may March 30, 2023 2026 4.875% March 30, June 30, September 30 December 30 2026 2026 September 30, 2024 2026 2026 2027 On June 15, 2022, 2027 July 11, 2022, 30 “2027 2027 June 15, 2027 may June 15, 2024 2027 6.25% March 30, June 30, September 30 December 30 September 30, 2022. 2027 2027 September 30, 2024 2027 2027

Note 8 - Financial Instruments

Note 8 - Financial Instruments With Off-balance-sheet Risk	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	Note 8. In the normal course of business, the Company is party to financial instruments with off-balance-sheet risk to meet the financing needs of its borrowers. These financial instruments include commitments to extend credit and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the consolidated statement of assets and liabilities. The Company attempts to limit its credit risk by conducting extensive due diligence and obtaining collateral where appropriate. The balance of unfunded commitments to extend credit was $189.9 million and $180.5 million as of September 30, 2024 December 31, 2023 may not The following table provides the Company’s unfunded commitments by portfolio company as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Fair Value of Fair Value of Unfunded Unfunded Commitment Commitment Commitment Commitment Amount Liability Amount Liability (In thousands) (In thousands) Better Place Forests Co. $ 1,000 $ — $ — $ — BrightInsight, Inc. 10,000 132 15,500 241 Britecore Holdings, Inc. 2,500 36 5,000 72 Candesant Biomedical Corporation 10,000 151 10,000 151 Ceribell, Inc. 21,000 120 — — Divergent Technologies, Inc. — — 11,250 118 Elligo Healthcare Research, Inc. 7,500 97 15,000 194 Fictiv, Inc. 30,000 236 — — GT Medical Technologies, Inc. 20,000 100 — — Hometeam Technologies, Inc. 10,000 100 — — MicroTransponder, Inc. 22,500 — 22,500 — Mirantis, Inc. — — 15,000 136 Optoro, Inc. — — 6,250 — Parse Biosciences, Inc. 15,000 252 15,000 251 Pivot Bio, Inc. 20,000 209 — — SafelyYou, Inc. 10,000 147 20,000 270 Sonex Health, Inc. — — 15,000 176 Standvast Holdings, LLC 5,000 175 — — Supply Network Visibility Holdings, LLC 5,000 17 10,000 35 Swift Health Systems, Inc. 375 — — — Tallac Therapeutics, Inc. — — 10,000 229 Viken Detection Corporation — — 10,000 160 Total $ 189,875 $ 1,772 $ 180,500 $ 2,033 The table above also provides the fair value of the Company’s unfunded commitment liability as of September 30, 2024 December 31, 2023,

Note 9 - Concentrations of Cred

Note 9 - Concentrations of Credit Risk	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	Note 9. The Company’s debt investments consist primarily of loans to development-stage companies at various stages of development in the technology, life science, healthcare information and services and sustainability industries. Many of these companies may may The Company’s largest debt investments may five September 30, 2024 December 31, 2023 five September 30, 2024 December 31, 2023 No 10% September 30, 2024 December 31, 2023 five three September 30, 2024 2023 five three September 30, 2024 2023 five nine September 30, 2024 2023 five nine September 30, 2024 2023

Note 10 - Distributions

Note 10 - Distributions	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Equity [Text Block]	Note 10. The Company’s distributions are recorded on the declaration date. The following table summarizes the Company’s distribution activity for the nine September 30, 2024 December 31, 2023 DRIP DRIP Date Amount Cash Shares Share Declared Record Date Payment Date Per Share Distribution Issued Value (In thousands, except share and per share data) Nine Months Ended September 30, 2024 July 26, 2024 November 15, 2024 December 13, 2024 $ 0.11 $ — — $ — July 26, 2024 October 17, 2024 November 14, 2024 0.11 — — — July 26, 2024 September 16, 2024 October 16, 2024 0.11 3,914 18,539 195 April 26, 2024 August 16, 2024 September 13, 2024 0.11 3,818 17,441 192 April 26, 2024 July 17, 2024 August 15, 2024 0.11 3,775 16,852 192 April 26, 2024 June 17, 2024 July 16, 2024 0.11 3,766 15,860 199 February 23, 2024 June 17, 2024 June 14, 2024 0.11 3,701 16,686 201 February 23, 2024 April 18, 2024 May 15, 2024 0.11 3,654 16,687 199 February 23, 2024 March 19, 2024 April 16, 2024 0.05 1,625 7,598 85 February 23, 2024 March 19, 2024 April 16, 2024 0.11 3,574 16,717 188 $ 1.04 $ 27,827 126,380 $ 1,451 Year Ended December 31, 2023 October 27, 2023 February 16, 2024 March 15, 2024 $ 0.11 $ 3,463 18,257 $ 210 October 27, 2023 January 18, 2024 February 14, 2024 0.11 3,462 15,873 210 October 27, 2023 December 19, 2023 January 16, 2024 0.11 3,472 14,563 199 October 27, 2023 November 17, 2023 December 15, 2023 0.05 1,574 7,137 93 July 28, 2023 November 17, 2023 December 15, 2023 0.11 3,463 15,701 206 July 28, 2023 October 18, 2023 November 15, 2023 0.11 3,493 14,022 173 July 28, 2023 September 19, 2023 October 16, 2023 0.11 3,445 15,067 184 April 28, 2023 August 17, 2023 September 15, 2023 0.11 3,458 8,665 106 April 28, 2023 July 18, 2023 August 15, 2023 0.11 3,427 8,307 105 April 28, 2023 June 16, 2023 July 14, 2023 0.11 3,434 7,424 96 February 23, 2023 May 18, 2023 June 14, 2023 0.11 3,087 7,128 86 February 23, 2023 April 18, 2023 May 16, 2023 0.11 3,068 6,705 84 February 23, 2023 March 17, 2023 April 14, 2023 0.11 3,035 6,894 81 $ 1.37 $ 41,881 145,743 $ 1,833 On October 25, 2024, Monthly distributions Ex-Dividend Date Record Date Payment Date Distributions Declared February 18, 2025 February 18, 2025 March 14, 2025 $ 0.11 January 16, 2025 January 16, 2025 February 14, 2025 $ 0.11 December 16, 2024 December 16, 2024 January 15, 2025 $ 0.11 After paying distributions of $0.33 per share and earning net investment income of $0.32 per share for the quarter, the Company’s undistributed spillover income as of September 30, 2024 not

Note 11 - Financial Highlights

Note 11 - Financial Highlights	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Investment Company, Financial Highlights [Text Block]	Note 11. The following table shows financial highlights for the Company: Nine months ended September 30, 2024 2023 (In thousands, except share and per share data) Per share data: Net asset value at beginning of period $ 9.71 $ 11.47 Net investment income 1.06 1.54 Realized loss (0.89 ) (0.95 ) Unrealized appreciation (depreciation) on investments 0.02 (0.81 ) Net increase (decrease) in net assets resulting from operations 0.19 (0.22 ) Distributions declared (1) (1.04 ) (0.99 ) From net investment income (1.04 ) (0.99 ) From net realized gain on investments — — Return of capital — — Other (2) 0.20 0.15 Net asset value at end of period $ 9.06 $ 10.41 Per share market value, beginning of period $ 13.17 $ 11.60 Per share market value, end of period $ 10.65 $ 11.88 Total return based on a market value (3) (11.2 )% 10.9 % Shares outstanding at end of period 37,803,064 33,306,958 Ratios to average net assets: Expenses without incentive fee (4) 15.1 % 14.0 % Incentive fees (4) 0.1 1.2 % Net expenses (4) 15.2 % 15.2 % Net investment income with incentive fee (4) 15.0 % 18.5 % Net assets at the end of the period $ 342,533 $ 346,575 Average net asset value $ 331,853 $ 335,531 Average debt per share $ 12.70 $ 14.29 Portfolio turnover ratio 13.4 % (5) 10.0 % (5) ( 1 Distributions are determined based on taxable income calculated in accordance with income tax regulations, which may ( 2 Includes the impact of the different share amounts as a result of calculating per share data based on the weighted average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. The issuance of common stock on a per share basis reflects the incremental net asset value changes as a result of the issuance of common stock in the Company’s continuous public offering and pursuant to the Company’s distribution reinvestment plan. The issuance of common stock at an offering price, net of sales commissions and dealer manager fees, that is greater than the net asset value per share results in an increase in net asset value per share. ( 3 The total return equals the change in the ending market value over the beginning of period price per share plus distributions paid per share during the period, divided by the beginning price. ( 4 Annualized. ( 5 Calculated by dividing (A) the lesser of purchases or sales of portfolio securities for the fiscal year by (B) the monthly average of the value of portfolio securities owned by the Company during the fiscal year, with certain securities excluded from the numerator and denominator pursuant to applicable federal securities laws.

Note 12 - Subsequent Events

Note 12 - Subsequent Events	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	Note 12. On October 7, 2024, On October 15, 2025, On October 17, 2024, 2031, 4 2 1933. The Convertible Notes mature on October 16, 2031 March 31, June 30, September 30 December 31 December 31, 2024. may April 17, 2025 five On October 18, 2025, On October 22, 2024, first 2025, On October 23, 2024,

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]		5: Rule 10b5 1 During the fiscal quarter ended September 30, 2024, none 10b5 1 10b5 1
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation As required under GAAP and Regulation S- X, Assets related to transactions that do not 860, Transfers and Servicing 2019‑1 2022 1 not
Use of Estimates, Policy [Policy Text Block]	Use of estimates In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.
Fair Value Measurement, Policy [Policy Text Block]	Fair value The Company records all of its investments at fair value in accordance with relevant GAAP, which establishes a framework used to measure fair value and requires disclosures for fair value measurements. The Company has categorized its investments carried at fair value, based on the priority of the valuation technique, into a three 6. not The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3. See Note 6
Segment Reporting, Policy [Policy Text Block]	Segments The Company has determined that it has a single reporting segment and operating unit structure. The Company lends to and invests in portfolio companies in various technology, life science, healthcare information and services and sustainability industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these debt investments and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment.
Investment, Policy [Policy Text Block]	Investments Investments are recorded at fair value. Pursuant to the amended SEC Rule 2a 5 1940 July 29, 2022, Interest on debt investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. Interest income is determined using a method that results in a level rate of return on principal amounts outstanding. Generally, when a debt investment becomes 90 not may may September 30, 2024 four December 31, 2023 four three nine September 30, 2024 three nine September 30, 2023 not The Company has a limited number of debt investments that contain a PIK provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. For the three September 30, 2024 2023, 13.5%, nine September 30, 2024 2023, 7.1%, not three September 30, 2024, no nine September 30, 2024 one nine September 30, 2024 three nine September 30, 2023, three three nine September 30, 2023, The Company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees, success fees and prepayment fees. In a limited number of cases, the Company may Certain debt investment agreements also require the borrower to make an ETP, that is accrued into interest receivable and taken into income over the life of the debt investment to the extent such amounts are expected to be collected. The Company will generally cease accruing the income if there is insufficient value to support the accrual or the Company does not not three September 30, 2024 2023 not nine September 30, 2024 2023 In connection with substantially all lending arrangements, the Company receives warrants to purchase shares of stock from the borrower. The warrants are recorded as assets at estimated fair value on the grant date using the Black-Scholes valuation model. The warrants are considered loan fees and are recorded as unearned income on the grant date. The unearned income is recognized as interest income over the contractual life of the related debt investment in accordance with the Company’s income recognition policy. Subsequent to debt investment origination, the fair value of the warrants is determined using the Black-Scholes valuation model. Any adjustment to fair value is recorded through earnings as net unrealized appreciation or depreciation on investments. Gains and losses from the disposition of the warrants or stock acquired from the exercise of warrants are recognized as realized gains and losses on investments. Realized gains or losses on the sale of investments, or upon the determination that an investment balance, or portion thereof, is not
Debt, Policy [Policy Text Block]	Debt issuance costs Debt issuance costs are fees and other direct incremental costs incurred by the Company in obtaining debt financing from its lenders and issuing debt securities. The unamortized balance of debt issuance costs as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 three September 30, 2024 2023 nine September 30, 2024 2023
Income Tax, Policy [Policy Text Block]	Income taxes As a BDC, the Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC and to avoid the imposition of corporate-level income tax on the portion of its taxable income distributed to stockholders, among other things, the Company is required to meet certain source of income and asset diversification requirements and to timely distribute dividends out of assets legally available for distribution to its stockholders of an amount generally at least equal to 90% no 946, Financial Services Investment Companies no Depending on the level of taxable income earned in a tax year, the Company may three September 30, 2024 2023 nine September 30, 2024 2023 The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than- not” 740, Income Taxes 946. not not September 30, 2024 December 31, 2023 2024, 2023, 2022 2021
Distributions [Policy Text Block]	Distributions Distributions to common stockholders are recorded on the declaration date. The amount to be paid out as distributions is determined by the Board. Net realized capital gains, if any, may may The Company has adopted a dividend reinvestment plan that provides for reinvestment of cash distributions on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board declares a cash distribution, then stockholders who have not may
Stockholders' Equity, Policy [Policy Text Block]	Stockholders Equity On August 2, 2021, “2021 2021 may On September 22, 2023, 2021 “2023 2021 2023 may may 415 During the three September 30, 2024 2023 During the three September 30, 2023 2023 2021 During the nine September 30, 2024 2023 During the nine September 30, 2023 2023 2021 The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of September 30, 2024 2023 On June 2, 2023,
Stock Repurchase Program [Policy Text Block]	Stock Repurchase Program On April 26, 2024, may, not 10b‑18 1934, 1940 June 30, 2025 $5.0 three nine September 30, 2024 2023 not September 30, 2024
Transfers and Servicing of Financial Assets, Policy [Policy Text Block]	Transfers of financial assets Assets related to transactions that do not 860, Transfers and Servicing not Transfers of financial assets are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when ( 1 2 3 not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently issued accounting pronouncement In November 2023, 2023 07, 280 2023 07” 2023 07 may one December 15, 2023, December 15, 2024, Recently adopted accounting pronouncement In June 2022, No. 2022 03, 2022 03” 2022 03 2022 03 December 15, 2023, 2022 03 not

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments (Unaudited) (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Investment [Table Text Block]	Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 191.6 Non-Affiliate Debt Investments — 182.9 Non-Affiliate Debt Investments — Life Science — 76.0 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 3,958 $ 3,948 $ 3,948 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,958 3,948 3,948 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,375 2,368 2,368 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,958 3,948 3,948 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,958 3,949 3,949 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,375 2,369 2,369 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 12.72 % Prime 4.72 % 9.75 % — 5.00 % November 1, 2025 5,000 4,970 4,970 Term Loan 12.72 % Prime 4.72 % 9.75 % — 5.00 % May 1, 2026 5,000 4,975 4,975 Greenlight Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.75 % Prime 5.75 % 9.00 % — 3.00 % July 1, 2025 1,667 1,624 1,624 Term Loan 13.75 % Prime 5.75 % 9.00 % — 3.00 % July 1, 2025 833 812 812 KSQ Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.75 % Prime 4.75 % 8.50 % — 5.50 % May 1, 2027 6,250 6,215 6,215 Term Loan 12.75 % Prime 4.75 % 8.50 % — 5.50 % May 1, 2027 6,250 6,215 6,215 Native Microbials, Inc (2)(12) Biotechnology Term Loan 13.25 % Prime 5.25 % 8.50 % — 5.00 % November 1, 2026 3,250 3,234 3,234 Term Loan 13.25 % Prime 5.25 % 8.50 % — 5.00 % November 1, 2026 2,167 2,156 2,156 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Term Loan 13.75 % Prime 5.75 % 9.75 % — 3.75 % September 1, 2026 10,000 9,950 9,950 Term Loan 13.75 % Prime 5.75 % 9.75 % — 3.75 % September 1, 2026 3,750 3,731 3,731 Term Loan 13.75 % Prime 5.75 % 9.75 % — 3.75 % September 1, 2026 3,750 3,731 3,731 Provivi, Inc. (2)(12) Biotechnology Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.30 % January 1, 2027 3,482 3,410 3,218 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.30 % January 1, 2027 3,482 3,410 3,218 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,701 1,605 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,701 1,605 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,699 1,604 Term Loan 13.36 % Prime 5.36 % 9.50 % — 4.31 % January 1, 2027 1,741 1,699 1,604 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % October 1, 2025 2,631 2,598 2,598 Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % October 1, 2025 1,315 1,299 1,299 Tallac Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.25 % Prime 4.25 % 12.25 % — 4.00 % August 1, 2027 2,500 2,468 2,468 Term Loan 12.25 % Prime 4.25 % 12.25 % — 4.00 % August 1, 2027 2,500 2,468 2,468 Aerobiotix, LLC (2)(12) Medical Device Term Loan 9.00 % Fixed — — — 18.00 % April 1, 2028 2,500 2,477 2,205 Term Loan 9.00 % Fixed — — — 18.00 % April 1, 2028 2,500 2,477 2,205 Term Loan 9.00 % Fixed — — — 18.00 % April 1, 2028 200 188 168 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Candesant Biomedical, Inc. (2)(12) Medical Device Term Loan 11.50 % Prime 3.50 % 11.50 % — 5.00 % September 1, 2027 5,000 4,777 4,777 Term Loan 11.50 % Prime 3.50 % 11.50 % — 5.00 % September 1, 2027 2,500 2,464 2,464 Term Loan 11.50 % Prime 3.50 % 11.50 % — 5.00 % September 1, 2027 2,500 2,464 2,464 Ceribell, Inc. (2)(12) Medical Device Term Loan 10.75 % Prime 2.75 % 9.25 % — 4.00 % March 1, 2029 5,000 4,817 4,817 Term Loan 10.75 % Prime 2.75 % 9.25 % — 4.00 % March 1, 2029 5,000 4,938 4,938 Term Loan 10.75 % Prime 2.75 % 9.25 % — 4.00 % March 1, 2029 4,000 3,950 3,950 Cognoa, Inc. (2)(12) Medical Device Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % August 1, 2026 3,611 3,584 3,356 Term Loan 13.50 % Prime 5.50 % 8.75 % — 6.00 % August 1, 2026 1,806 1,792 1,678 Conventus Orthopaedics, Inc. (2)(12) Medical Device Term Loan 12.82 % Prime 4.82 % 9.25 % — 10.36 % July 1, 2025 3,477 3,448 3,448 Term Loan 12.82 % Prime 4.82 % 9.25 % — 10.36 % July 1, 2025 3,477 3,448 3,448 Infobionic, Inc. (2)(12) Medical Device Term Loan 13.00 % Prime 4.50 % 12.00 % — 2.00 % September 1, 2029 5,000 4,916 4,916 Term Loan 13.00 % Prime 4.50 % 12.00 % — 2.00 % September 1, 2029 5,000 4,916 4,916 Term Loan 13.00 % Prime 4.50 % 12.00 % — 2.00 % September 1, 2029 5,000 4,916 4,916 MicroTransponder, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % — 3.50 % January 1, 2029 3,750 3,696 3,696 Term Loan 12.25 % Prime 3.75 % 12.25 % — 3.50 % January 1, 2029 3,750 3,696 3,696 Scientia Vascular, Inc. (2)(12) Medical Device Term Loan 13.25 % Prime 4.75 % 8.50 % — 5.00 % January 1, 2027 3,750 3,734 3,734 Term Loan 13.25 % Prime 4.75 % 8.50 % — 5.00 % January 1, 2027 3,750 3,733 3,733 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % January 1, 2027 5,000 4,959 4,959 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % January 1, 2027 5,000 4,927 4,927 Sonex Health, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 2,500 2,479 2,479 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 2,500 2,479 2,479 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 5,000 4,957 4,957 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % September 1, 2027 5,000 4,957 4,957 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Term Loan 12.00 % Prime 3.50 % 11.75 % — 8.00 % April 1, 2028 3,750 3,711 3,711 Spineology, Inc. (2)(12) Medical Device Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 5,000 4,911 4,911 Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 4,250 4,174 4,174 Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 4,250 4,174 4,174 Term Loan 13.00 % Prime 5.00 % 12.00 % — 1.00 % August 1, 2029 2,500 2,455 2,455 Swift Health Systems Inc. (2)(12)(14) Medical Device Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,510 3,509 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,475 3,474 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,469 3,468 Term Loan 13.75 % Prime 5.25 % 9.00 % — 5.00 % July 1, 2027 3,500 3,469 3,468 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Term Loan 13.75 % Prime 5.25 % 9.00 % — 100.00 % July 1, 2027 300 300 300 Term Loan 13.75 % Prime 5.25 % 9.00 % — 100.00 % July 1, 2027 150 150 150 Term Loan 13.75 % Prime 5.25 % 9.00 % — — July 1, 2027 200 200 200 Term Loan 13.25 % Prime 5.25 % 9.00 % — — July 1, 2027 350 350 350 Vero Biotech, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 15,000 14,719 14,117 Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 10,000 9,813 9,411 Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 5,000 4,907 4,706 Term Loan 12.25 % Prime 3.75 % 12.25 % — 4.00 % January 1, 2029 2,500 2,453 2,353 Total Non-Affiliate Debt Investments — Life Science 263,158 260,177 Non-Affiliate Debt Investments — Sustainability — 19.8 Pivot Bio, Inc.(2)(12) Energy Efficiency Term Loan 12.00 % Prime 4.00 % 12.00 % — 4.00 % February 1, 2029 5,000 4,739 4,739 Term Loan 12.00 % Prime 4.00 % 12.00 % — 4.00 % February 1, 2029 5,000 4,948 4,948 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Term Loan 14.75 % Prime 6.75 % 10.00 % — 4.33 % December 1, 2026 3,750 3,712 3,712 Term Loan 14.75 % Prime 6.75 % 10.00 % — 4.33 % December 1, 2026 3,750 3,712 3,712 Soli Organic, Inc. (2)(12) Other Sustainability Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % April 1, 2026 5,000 4,937 4,937 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % April 1, 2026 2,500 2,469 2,469 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % May 1, 2026 5,000 4,938 4,938 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.75 % May 1, 2026 2,500 2,469 2,469 Term Loan 13.50 % Prime 5.50 % 11.75 % — 2.75 % December 1, 2026 5,000 4,946 4,946 Term Loan 13.50 % Prime 5.50 % 11.75 % — 2.75 % December 1, 2026 2,500 2,473 2,473 Temperpack Technologies, Inc. (2)(12) Other Sustainability Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,703 3,703 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,703 3,703 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 7,500 7,400 7,400 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 14.75 % Prime 6.75 % 10.00 % — 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 14.00 % Prime 6.00 % 10.00 % — 2.00 % January 1, 2029 4,500 4,452 4,452 Term Loan 14.00 % Prime 6.00 % 10.00 % — 2.00 % January 1, 2029 2,000 1,979 1,979 Total Non-Affiliate Debt Investments — Sustainability 67,980 67,980 Non-Affiliate Debt Investments — Technology — 56.7 Axiom Space, Inc. (2)(12) Communications Term Loan 14.50 % Prime 6.00 % 9.25 % — 2.50 % June 1, 2026 4,375 4,354 4,354 Term Loan 14.50 % Prime 6.00 % 9.25 % — 2.50 % June 1, 2026 4,375 4,353 4,353 Term Loan 14.50 % Prime 6.00 % 9.25 % — 2.50 % June 1, 2026 4,375 4,353 4,353 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Term Loan 15.25 % Prime 7.25 % 10.50 % — 3.00 % March 1, 2027 2,033 1,980 1,922 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Clara Foods Co. (2)(12) Consumer-related Technologies Term Loan 14.25 % Prime 5.75 % 9.00 % — 5.50 % August 1, 2025 833 828 828 Term Loan 14.25 % Prime 5.75 % 9.00 % — 5.50 % August 1, 2025 833 828 828 Havenly, Inc. (2)(12) Consumer-related Technologies Term Loan 13.00 % Prime 5.00 % 5.00 % — 10.40 % March 1, 2027 2,000 1,467 1,467 Term Loan 13.00 % Prime 5.00 % 5.00 % — 10.40 % March 1, 2027 3,000 2,441 2,441 Term Loan 11.50 % Prime 3.50 % 10.50 % — 7.78 % February 1, 2028 2,813 2,813 2,813 Term Loan 11.50 % Prime 3.50 % 10.50 % — 7.78 % February 1, 2028 2,813 2,813 2,813 Lyrical Foods, Inc. (2)(12) Consumer-related Technologies Term Loan 11.50 % (11) Prime 3.50 % 9.00 % — 5.00 % July 1, 2028 2,603 2,692 2,341 NextCar Holding Company, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 5,908 5,489 3,256 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,363 2,196 1,303 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 3,545 3,294 1,953 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 5,908 5,489 3,255 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % — 5.25 % October 31, 2023 2,954 2,745 1,628 Optoro, Inc. (2)(12) Consumer-related Technologies Term Loan 14.75 % Prime 6.25 % 9.50 % — 4.00 % August 1, 2027 2,500 2,440 2,440 Term Loan 14.75 % Prime 6.25 % 9.50 % — 4.00 % July 1, 2028 1,875 1,800 1,800 Standvast Holdings, LLC (2)(12) Consumer-related Technologies Term Loan 12.75 % Prime 4.25 % 12.75 % — 3.00 % June 1, 2028 2,500 2,245 2,245 Term Loan 12.75 % Prime 4.25 % 12.75 % — 3.00 % June 1, 2028 2,500 2,421 2,421 Unagi, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 15.75 % (11) Prime 7.75 % 11.00 % — — May 1, 2027 1,361 1,086 228 Term Loan 15.75 % (11) Prime 7.75 % 11.00 % — — May 1, 2027 680 543 114 Term Loan 15.75 % (11) Prime 7.75 % 11.00 % — — May 1, 2027 680 543 114 Fictiv, Inc. (2)(12) Networking Term Loan 11.25 % Prime 3.25 % 10.00 % — 4.00 % April 1, 2029 5,000 4,703 4,703 Term Loan 11.25 % Prime 3.25 % 10.00 % — 4.00 % April 1, 2029 5,000 4,938 4,938 BriteCore Holdings, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 5,000 4,905 4,905 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 2,500 2,471 2,471 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 2,500 2,471 2,471 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % October 1, 2028 2,500 2,471 2,471 Term Loan 14.00 % Prime 5.50 % 14.00 % — 3.00 % April 1, 2029 2,500 2,467 2,467 Dropoff, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.50 % 9.75 % — 3.50 % June 1, 2026 6,804 6,729 6,337 Term Loan 14.50 % Prime 6.50 % 9.75 % — 3.50 % June 1, 2026 6,280 6,211 5,849 Term Loan 14.50 % Prime 6.50 % 9.75 % — 3.50 % June 1, 2026 2,617 2,590 2,439 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Kodiak Robotics, Inc. (2)(12) Software Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 10,000 9,946 9,946 Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 10,000 9,946 9,946 Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 5,000 4,973 4,973 Term Loan 13.50 % Prime 5.50 % 10.25 % — 4.00 % April 1, 2026 5,000 4,973 4,973 Lytics, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.00 % 14.25 % — 5.00 % November 1, 2026 2,500 2,479 2,479 Term Loan 14.50 % Prime 6.00 % 14.25 % — 5.00 % December 1, 2026 1,250 1,242 1,242 Term Loan 14.50 % Prime 6.00 % 14.25 % — 5.00 % April 1, 2027 1,000 996 996 Mirantis, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Term Loan 12.00 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2028 5,000 4,929 4,929 Noodle Partners, Inc. (2)(12) Software Term Loan 13.00 % Prime 5.00 % 12.00 % — 3.00 % March 1, 2027 10,000 9,916 9,916 Term Loan 13.00 % Prime 5.00 % 12.00 % — 3.00 % March 1, 2027 5,000 4,958 4,958 Term Loan 13.00 % Prime 5.00 % 12.00 % — 3.00 % March 1, 2027 5,000 4,958 4,958 Reputation Institute, Inc. (2)(12) Software Term Loan 15.75 % Prime 7.25 % 10.50 % — 3.00 % August 1, 2025 1,933 1,901 1,901 Supply Network Visibility Holdings LLC (2)(12) Software Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 2,500 2,476 2,476 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 3,500 3,491 3,491 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 2,500 2,493 2,493 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % June 1, 2028 1,500 1,496 1,496 Term Loan 12.25 % Prime 4.25 % 12.00 % — 2.50 % July 1, 2029 5,000 4,983 4,983 Viken Detection Corporation (2)(12) Software Term Loan 12.00 % Prime 4.00 % 11.75 % — 3.50 % June 1, 2027 5,000 4,951 4,951 Term Loan 12.00 % Prime 4.00 % 11.75 % — 3.50 % June 1, 2027 2,500 2,476 2,476 Term Loan 12.00 % Prime 4.00 % 11.75 % — 3.50 % June 1, 2027 2,500 2,476 2,476 Total Non-Affiliate Debt Investments — Technology 208,250 194,051 Non-Affiliate Debt Investments — Healthcare information and services — 30.4 Hound Labs Inc. (12)(13) Diagnostics Term Loan 14.00 % Prime 6.00 % 9.25 % — 3.50 % June 1, 2026 1,607 1,577 1,034 Term Loan 14.00 % Prime 6.00 % 9.25 % — 3.50 % June 1, 2026 1,607 1,577 1,034 Term Loan 14.00 % Prime 6.00 % 9.25 % — 3.50 % June 1, 2026 3,214 3,151 2,068 Term Loan 14.00 % Fixed — — — 50.00 % March 1, 2025 300 300 197 Term Loan 14.00 % Fixed — — — 100.00 % March 1, 2025 250 250 164 Parse Biosciences, Inc. (2)(12) Diagnostics Term Loan 11.75 % Prime 3.25 % 11.50 % — 5.00 % January 1, 2028 5,000 4,652 4,652 Term Loan 11.75 % Prime 3.25 % 11.50 % — 5.00 % January 1, 2028 5,000 4,903 4,903 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) BrightInsight, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % August 1, 2027 7,000 6,814 6,814 Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % August 1, 2027 3,500 3,473 3,473 Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % August 1, 2027 3,500 3,473 3,473 Term Loan 14.00 % Prime 5.50 % 9.50 % — 3.00 % April 1, 2028 2,750 2,717 2,717 Elligo Health Research, Inc. (2)(12) Software Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 10,000 9,783 9,783 Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 5,000 4,940 4,940 Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 5,000 4,940 4,940 Term Loan 11.75 % Prime 3.50 % 11.75 % — 4.00 % October 1, 2027 5,000 4,940 4,940 SafelyYou, Inc. (2)(12) Software Term Loan 11.25 % Prime 3.25 % 11.00 % — 5.00 % June 1, 2027 5,000 4,791 4,791 Term Loan 11.25 % Prime 3.25 % 11.00 % — 5.00 % June 1, 2027 5,000 4,938 4,938 GT Medical Technologies, Inc. (2)(12) Other Healthcare Services Term Loan 11.25 % Prime 3.25 % 11.25 % — 4.00 % October 1, 2029 3,750 3,592 3,592 Term Loan 11.25 % Prime 3.25 % 11.25 % — 4.00 % October 1, 2029 3,750 3,692 3,692 Term Loan 11.25 % Prime 3.25 % 11.25 % — 4.00 % October 1, 2029 7,500 7,384 7,384 Hometeam Technologies, Inc. (2)(12) Other Healthcare Services Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,851 4,851 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Term Loan 11.25 % Prime 3.25 % 11.25 % — 3.50 % August 1, 2029 5,000 4,951 4,951 Total Non-Affiliate Debt Investments — Healthcare information and services $ 106,542 $ 104,184 Total Non- Affiliate Debt Investments $ 645,930 $ 626,392 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrant Investments 5.5 Non-Affiliate Warrants Life Science 1.5 Avalo Therapeutics, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 117 $ 311 $ — Castle Creek Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 7,404 214 169 Emalex Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 110,402 176 127 Imunon, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 19,671 64 — KSQ Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 48,076 49 53 Mustang Bio, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 16,611 146 — Native Microbials, Inc (2)(12) Biotechnology Preferred Stock Warrant 103,679 64 58 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Common Stock Warrant 299,848 160 316 Provivi, Inc. (2)(12) Biotechnology Common Stock Warrant 175,098 278 — Provivi, Inc. (2)(12) Biotechnology Preferred Stock Warrant 709,981 312 222 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Common Stock Warrant 318,181 265 110 Tallac Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 1,600,002 195 167 Xeris Pharmaceuticals, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 126,000 73 64 AccuVein Inc. (2)(12) Medical Device Common Stock Warrant 271 7 — Aerin Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 1,818,183 66 1,048 Aerobiotix, LLC (2)(12) Medical Device Preferred Stock Warrant 8,800 48 9 Canary Medical Inc. (2)(12) Medical Device Preferred Stock Warrant 12,153 87 171 Candesant Biomedical, Inc. (2)(12) Medical Device Preferred Stock Warrant 93,336 152 131 Ceribell, Inc. (2)(12) Medical Device Preferred Stock Warrant 231,050 147 192 Cognoa, Inc. (2)(12) Medical Device Common Stock Warrant 30,585 — — Cognoa, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,635,992 162 13 Conventus Orthopaedics, Inc. (2)(12) Medical Device Preferred Stock Warrant 9,313,541 256 197 CSA Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,917,794 174 471 CVRx, Inc. (2)(5)(12) Medical Device Common Stock Warrant 47,410 76 50 Infobionic, Inc. (2)(12) Medical Device Preferred Stock Warrant 5,361,130 231 169 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Magnolia Medical Technologies, Inc. (2)(12) Medical Device Preferred Stock Warrant 809,931 194 304 Meditrina, Inc. (2)(12) Medical Device Preferred Stock Warrant 233,993 83 29 MicroTransponder, Inc. (2)(12) Medical Device Preferred Stock Warrant 103,172 48 48 Scientia Vascular, Inc (2)(12) Medical Device Preferred Stock Warrant 34,410 103 273 Sonex Health, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,637,133 275 262 VERO Biotech LLC (2)(12) Medical Device Preferred Stock Warrant 4,109 432 196 Spineology, Inc. (2)(12) Medical Device Common Stock Warrant 2,714,033 143 108 Spineology, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,255,155 16 27 Swift Health Systems Inc. (2)(12) Medical Device Preferred Stock Warrant 135,484 71 — Total Non-Affiliate Warrants — Life Science 5,078 4,984 Non-Affiliate Warrants — Sustainability — 0.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Preferred Stock Warrant 400,000 82 69 LiquiGlide, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 61,359 40 25 Soli Organic, Inc. (2)(12) Other Sustainability Common Stock Warrant 65 20 19 Soli Organic, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 1,103 382 489 Temperpack Technologies, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 49,693 178 91 Pivot Bio, Inc. (2)(12) Energy Efficiency Preferred Stock Warrant 210,418 14 14 Total Non-Affiliate Warrants — Sustainability 716 707 Non-Affiliate Warrants — Technology — 3.5 Axiom Space Holdings, Inc. (2)(12) Communications Common Stock Warrant 1,991 46 57 Intelepeer Holdings, Inc. (2)(12) Communications Preferred Stock Warrant 2,936,535 137 2,100 Alula Holdings, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 20,000 93 7 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 112,356 36 39 Clara Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 46,745 30 121 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 9,801 79 55 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 53,264 454 622 Havenly, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 1,446,429 3,178 2,489 MyForest Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 250 28 24 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 12,618 188 — NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 3,913,723 9 — Optoro, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 11,550 181 144 Primary Kids, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 553,778 57 587 Quip NYC Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 6,191 325 — Standvast Holdings, LLC (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,225,492 275 258 Unagi, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 171,081 29 — Updater, Inc.(2)(12) Consumer-related Technologies Preferred Stock Warrant 108,333 34 26 CPG Beyond, Inc. (2)(12) Data Storage Preferred Stock Warrant 500,000 242 290 Silk, Inc. (2)(12) Data Storage Preferred Stock Warrant 394,110 175 119 Global Worldwide LLC (2)(12) Internet and Media Preferred Stock Warrant 245,810 75 — Rocket Lawyer Incorporated (2)(12) Internet and Media Preferred Stock Warrant 261,721 92 313 Skillshare, Inc. (2)(12) Internet and Media Preferred Stock Warrant 139,074 162 671 Liqid, Inc. (2)(12) Networking Preferred Stock Warrant 344,102 364 103 Fictiv, Inc. (2)(12) Networking Common Stock Warrant 126,841 59 74 Halio, Inc. (2)(12) Power Management Common Stock Warrant 38,241,466 1,585 2,700 Avalanche Technology, Inc. (2)(12) Semiconductors Preferred Stock Warrant 5,938 45 — BriteCore Holdings, Inc. (2)(12) Software Preferred Stock Warrant 161,215 98 254 Dropoff, Inc. (2)(12) Software Common Stock Warrant 516,732 455 90 E La Carte, Inc. (2)(5)(12) Software Common Stock Warrant 147,361 60 — Everstream Holdings, LLC (2)(12) Software Preferred Stock Warrant 350,000 70 21 Kodiak Robotics, Inc. (2)(12) Software Preferred Stock Warrant 639,918 273 9 Lemongrass Holdings, Inc. (2)(12) Software Preferred Stock Warrant 101,308 34 83 Lotame Solutions, Inc. (2)(12) Software Preferred Stock Warrant 71,305 18 40 Lytics, Inc. (2)(12) Software Preferred Stock Warrant 85,543 43 — Mirantis, Inc. (2)(12) Software Common Stock Warrant 948,275 223 240 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Noodle Partners, Inc. (2)(12) Software Preferred Stock Warrant 84,037 116 — Reputation Institute, Inc. (2)(12) Software Preferred Stock Warrant 4,104 63 33 Revinate Holdings, Inc. (2)(12) Software Preferred Stock Warrant 682,034 44 90 SIGNiX, Inc. (12) Software Preferred Stock Warrant 186,235 225 — Slingshot Aerospace, Inc. (2)(12) Software Preferred Stock Warrant 309,208 123 79 Supply Network Visibility Holdings LLC (2)(12) Software Preferred Stock Warrant 682 65 75 Topia Mobility, Inc. (2)(12) Software Preferred Stock Warrant 3,049,607 137 — Viken Detection Corporation (2)(12) Software Preferred Stock Warrant 345,443 120 203 xAd, Inc. (2)(12) Software Preferred Stock Warrant 4,343,348 176 7 Total Non-Affiliate Warrants — Technology 10,321 12,023 Non-Affiliate Warrants — Healthcare information and services — 0.3 Hound Labs, Inc (12) Diagnostics Preferred Stock Warrant 451,796 45 — Parse Biosciences, Inc. (2)(12) Diagnostics Common Stock Warrant 32,244 71 15 Parse Biosciences, Inc. (2)(12) Diagnostics Preferred Stock Warrant 184,253 166 47 Kate Farms, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 82,965 103 777 GT Medical Technologies, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 255,871 85 86 BrightInsight, Inc. (2)(12) Software Preferred Stock Warrant 85,066 167 — Elligo Health Research, Inc. (2)(12) Software Preferred Stock Warrant 652,250 191 85 Medsphere Systems Corporation (2)(12) Software Preferred Stock Warrant 7,097,792 61 — SafelyYou, Inc. (2)(12) Software Preferred Stock Warrant 150,353 163 11 Total Non-Affiliate Warrants — Healthcare information and services 1,052 1,021 Total Non-Affiliate Warrants 17,167 18,735 Non-Affiliate Other Investments — Life Science — 1.5 Lumithera, Inc. (12) Medical Device Royalty Agreement 1,147 100 Robin Healthcare, Inc. (2)(12) Medical Device Royalty Agreement 7,271 3,247 ZetrOZ, Inc. (12) Medical Device Royalty Agreement — — Total Non-Affiliate Other Investments 8,418 3,347 Non-Affiliate Equity — 2.2 Cadrenal Therapeutics, Inc. (5) Biotechnology Common Stock 600,000 — 546 Castle Creek Biosciences, Inc. (12) Biotechnology Common Stock 1,162 250 250 Emalex Biosciences, Inc. (12) Biotechnology Common Stock 32,831 356 356 Axiom Space, Inc. (12) Communications Preferred Stock 1,810 261 306 PebblePost, Inc. (2)(12) Communications Preferred Stock 598,850 73 73 Caastle, Inc. (2)(12) Consumer-related Technologies Preferred Stock 242,180 2,681 2,687 Getaround, Inc. (2)(5) Consumer-related Technologies Common Stock 87,082 253 5 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock 2,688,971 89 — SnagAJob.com, Inc. (12) Consumer-related Technologies Common Stock 82,974 7 83 Lumithera, Inc. (12) Medical Device Common Stock 392,651 2,000 1,700 Tigo Energy, Inc. (5) Other Sustainability Common Stock 5,205 111 11 Decisyon, Inc. (12) Software Preferred Stock 280,000 2,800 1,281 Lotame, Inc. (12) Software Preferred Stock 66,127 5 190 Total Non-Affiliate Equity 8,886 7,488 Total Non-Affiliate Portfolio Investment Assets $680,401 $655,962 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Controlled Affiliate Investments — 2.4 Non-Controlled Affiliate Other Investments — 2.4 Evelo Holdings, Inc. (2)(5)(12)(17) Biotechnology Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 $ 5,770 $ 4,910 $ 1,825 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 8,656 7,621 2,832 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 3,462 2,947 1,095 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 3,462 2,947 1,095 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 2,308 1,964 730 Other Investment 12.25 % (11) Prime 4.25 % 11.00 % — 4.25 % January 1, 2028 2,308 1,964 730 Total Non-Controlled Affiliate Other Investments 22,353 8,307 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-controlled Affiliate Equity 0.0 Aulea Medical, Inc. (12) Medical Device Common Stock 660,537 $ — $ — Evelo Holdings, Inc. (2)(5)(12) Biotechnology Common Stock 2,164,502 5,000 — Total Non-Controlled Affiliate Equity 5,000 — Non-controlled Affiliate Warrants 0.0 Evelo Holdings, Inc. (2)(5)(12) Biotechnology Common Stock 23,196 125 — Total Non-Controlled Affiliate Warrants 125 — Total Non-Controlled Affiliate Portfolio Investment Assets $ 27,478 $ 8,307 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Controlled Affiliate Investments 5.7 Controlled Affiliate Debt Investments 2.0 Better Place Forests Co. (12) Consumer-related Technologies Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — 2.78 % August 1, 2029 $ 3,891 $ 3,935 $ 3,234 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — 2.78 % August 1, 2029 1,946 1,927 1,583 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — — August 1, 2025 521 521 489 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — — August 1, 2025 516 517 484 Term Loan 12.00 % (11) Prime 3.75 % 12.00 % — — August 1, 2025 506 507 474 Nexii, Inc. (12) Other Sustainability Term Loan 10.00 % Fixed — — — — July 1, 2027 790 790 628 Total Controlled Affiliate Debt Investments 8,197 6,892 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Controlled Affiliate Equity — 1.9 Better Place Forests Co. (12) Consumer-related Technologies Common Stock 2,278,272 2,060 — Better Place Forests Co. (12) Consumer-related Technologies Preferred Stock 5,350,142 2,500 — Nexii, Inc. (2)(12) Other Sustainability Common Stock 108,320 3,297 3,309 Nexii, Inc. (2)(12) Other Sustainability Preferred Stock 542 3,419 3,240 Total Controlled Affiliate Equity 11,276 6,549 Controlled Affiliate Other Investments — 1.8 HIMV LLC (12)(16) Biotechnology Other Investment 5,880 6,290 Total Controlled Affiliate Other 5,880 6,290 Total Controlled Affiliate Portfolio Investment Assets $ 25,353 $ 19,731 Total Portfolio Investment Assets — 199.7 $ 733,232 $ 684,000 Short Term Investments - Unrestricted Investments - 9.1 US Bank Money Market Deposit Account 31,080 31,080 Total Short Term Investments - Unrestricted Investments $ 31,080 $ 31,080 Short Term Investments - Restricted Investments - 1.0 US Bank Money Market Deposit Account 3,266 3,266 Total Short Term Investments - Restricted Investments $ 3,266 $ 3,266 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 214.2 Non-Affiliate Debt Investments — 205.0 Non-Affiliate Debt Investments — Life Science — 75.6 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 5,000 $ 4,979 $ 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,987 2,987 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,987 2,987 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % — 5.00 % June 1, 2024 1,414 1,410 1,410 Term Loan 13.22 % Prime 4.72 % 9.75 % — 5.00 % June 1, 2024 1,414 1,410 1,410 Term Loan 13.22 % Prime 4.72 % 9.75 % — 5.00 % November 1, 2

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Related Party Transactions [Table Text Block]	Expiration Total (In thousands) December 31, 2025 $ 1,037 March 31, 2026 219 June 30, 2026 3,120 September 30, 2026 3,471 December 31, 2026 3,002 March 31, 2027 2,285 June 30, 2027 2,582 September 30, 2027 2,368 Total $ 18,084

Note 4 - Investments (Tables)

Note 4 - Investments (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Investment Holdings, Schedule of Investments [Table Text Block]	September 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Investments Debt $ 654,127 $ 633,284 $ 721,231 $ 670,172 Warrants 17,292 18,735 16,526 24,594 Other 36,651 17,944 6,982 6,430 Equity 25,162 14,037 14,443 7,889 Total investments $ 733,232 $ 684,000 $ 759,182 $ 709,085 September 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Life Science Biotechnology $ 126,867 $ 106,865 $ 145,544 $ 117,781 Medical Device 185,751 179,092 147,064 145,019 Technology Communications 13,577 15,596 19,192 22,188 Consumer-Related 74,381 54,505 105,669 101,327 Data Storage 417 409 417 418 Internet and Media 329 984 329 1,582 Networking 10,064 9,818 5,451 5,297 Power Management 1,585 2,700 1,585 2,700 Semiconductors 45 — 45 — Software 136,309 132,951 164,133 160,749 Sustainability Energy Efficiency 9,812 9,712 111 13 Other Sustainability 66,501 66,163 98,906 80,370 Healthcare Information and Services Diagnostics 16,692 14,114 19,735 19,701 Other 39,511 40,186 102 1,366 Software 51,391 50,905 50,899 50,574 Total investments $ 733,232 $ 684,000 $ 759,182 $ 709,085

Note 5 - Transactions With Af_2

Note 5 - Transactions With Affiliated Companies (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Investments in and Advances to Affiliates [Table Text Block]	Three months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Company 2024 Purchases payments fair value accretion gain/(loss) gain/(loss) 2024 (In thousands) Aulea Medical, Inc. $ — $ — $ — $ — $ — $ — $ — $ — Evelo Biosciences, Inc. 3,503 — (318 ) — — (1,360 ) — 1,825 5,340 127 (476 ) — — (2,159 ) — 2,832 2,101 — (191 ) — — (815 ) — 1,095 2,101 — (191 ) — — (815 ) — 1,095 1,401 — (127 ) — — (544 ) — 730 1,401 — (127 ) — — (544 ) — 730 Total non-controlled affiliates $ 15,847 $ 127 $ (1,430 ) $ — $ — $ (6,237 ) $ — $ 8,307 Three months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Aulea Medical, Inc. $ — $ — $ — $ — $ — $ — $ — $ — $ — Cadrenal Therapeutics, Inc. (1) 906 — — (906 ) — — — — — Evelo Biosciences, Inc. — — — 7,665 8 (5,007 ) — 2,666 277 — — — 11,496 11 (7,510 ) — 3,997 415 — — — 4,612 5 (3,013 ) — 1,604 166 — — — 4,598 3 (3,004 ) — 1,597 163 — — — 3,067 4 (2,003 ) — 1,068 114 — — — 3,067 4 (2,003 ) — 1,068 111 — — — 5,000 — 3,485 — 8,485 — Total non-controlled affiliates $ 906 $ — $ — $ 38,599 $ 35 $ (19,055 ) $ — $ 20,485 $ 1,246 Nine months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Aulea Medical, Inc. $ — $ 3 $ (40 ) $ — $ — $ — $ 37 $ — $ — Evelo Biosciences, Inc. 222 — (318 ) — — 1,921 — 1,825 — 336 231 (476 ) — — 2,741 — 2,832 — 133 — (191 ) — — 1,153 — 1,095 — 133 — (191 ) — — 1,153 — 1,095 — 88 — (127 ) — — 769 — 730 — 88 — (127 ) — — 769 — 730 — 132 — — — — (132 ) — — — Total non-controlled affiliates $ 1,132 $ 234 $ (1,470 ) $ — $ — $ 8,374 $ 37 $ 8,307 $ — Nine months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2022 Purchases payments fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Aulea Medical, Inc. $ — $ — $ — $ — $ — $ — $ — $ — $ — Cadrenal Therapeutics, Inc. (1) — — — (906 ) — 906 — — — Evelo Biosciences, Inc. — — — 7,665 8 (5,007 ) — 2,666 277 — — — 11,496 11 (7,510 ) — 3,997 415 — — — 4,612 5 (3,013 ) — 1,604 166 — — — 4,598 3 (3,004 ) — 1,597 163 — — — 3,067 4 (2,003 ) — 1,068 114 — — — 3,067 4 (2,003 ) — 1,068 111 — — — 5,000 — 3,485 — 8,485 — Total non-controlled affiliates $ — $ — $ — $ 38,599 $ 35 $ (18,149 ) $ — $ 20,485 $ 1,246 Three months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2024 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,166 $ — $ — $ 119 $ — $ 2 $ (53 ) $ — $ 3,234 $ 125 1,549 — — 59 — 1 (26 ) — 1,583 63 420 — — 16 — — 53 — 489 16 415 — — 16 — — 53 — 484 16 — 500 — 6 — — (32 ) — 474 6 HIMV LLC 5,836 — (45 ) — — — 499 — 6,290 — Nexii, Inc. — — — — 6,716 — (167 ) — 6,549 15 — 790 — — — — (162 ) — 628 — Total controlled affiliates $ 11,386 $ 1,290 $ (45 ) $ 216 $ 6,716 $ 3 $ 165 $ — $ 19,731 $ 241 Three months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio June 30, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Better Place Forests Co. $ — $ 59 $ — $ 105 $ 1,759 $ 2 $ 1,080 $ — $ 3,005 $ 111 — — — 53 844 1 536 — 1,434 55 — — — — 2,061 — — — 2,061 — — 750 — — — — (259 ) — 491 — HIMV LLC — — — — 6,154 — — — 6,154 — Total controlled affiliates $ — $ 809 $ — $ 158 $ 10,818 $ 3 $ 1,357 $ — $ 13,145 $ 166 Nine months ended September 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2023 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,339 $ — $ — $ 345 $ — $ 6 $ (456 ) $ — $ 3,234 $ 363 1,630 — — 171 — 4 (222 ) — 1,583 184 — 500 — 21 — — (32 ) — 489 21 — 500 — 17 — — (33 ) — 484 17 — 500 — 6 — — (32 ) — 474 6 3,024 1,250 — — — — (4,274 ) — — — HIMV LLC 6,230 227 (592 ) — 463 — (38 ) — 6,290 — Nexii, Inc. — — — — 6,716 — (167 ) — 6,549 15 — 790 — — — — (162 ) — 628 — Total controlled affiliates $ 14,223 $ 3,767 $ (592 ) $ 560 $ 7,179 $ 10 $ (5,416 ) $ — $ 19,731 $ 606 Nine months ended September 30, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized September 30, Interest Company 2022 Purchases payments PIK fair value accretion gain/(loss) gain/(loss) 2023 income (In thousands) Better Place Forests Co. $ — $ 59 $ — $ 105 $ 1,759 $ 2 $ 1,080 $ — $ 3,005 $ 111 — — — 53 844 1 536 — 1,434 55 — — — — 2,061 — — — 2,061 — — 750 — — — — (259 ) — 491 — HIMV LLC — — — — 6,154 — — — 6,154 — Total controlled affiliates $ — $ 809 $ — $ 158 $ 10,818 $ 3 $ 1,357 $ — $ 13,145 $ 166

Note 6 - Fair Value (Tables)

Note 6 - Fair Value (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	September 30, 2024 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 633,284 $ 633,284 Warrant investments — 430 18,305 18,735 Other investments — — 17,944 17,944 Equity investments 560 — 13,477 14,037 Total investments $ 560 $ 430 $ 683,010 $ 684,000 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,172 $ 670,172 Warrant investments — 1,619 22,975 24,594 Other investments — — 6,430 6,430 Equity investments 608 — 7,281 7,889 Total investments $ 608 $ 1,619 $ 706,858 $ 709,085
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	September 30, 2024 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 597,137 Discounted Expected Future Cash Flows Hypothetical Market Yield 12% – 20% 14 % 36,147 Multiple Probability Weighted Cash Flow Model Probability Weighting 10% - 100% 77 % Warrant investments 18,305 Black-Scholes Valuation Model Price Per Share 0.000 –1,898.5858 $ 65.35 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 17 % Estimated Time to Exit (in years) 1 to 5 3 Other investments 17,944 Multiple Probability Weighted Cash Flow Model Discount Rate 15% – 100% 36 % Probability Weighting 30% – 100% 86 % Equity investments 13,477 Last Equity Financing Price Per Share 0.00 14,592.60 $ 3,532.29 Total Level 3 investments $ 683,010 December 31, 2023 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 617,529 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 24% 15 % 52,643 Multiple Probability Weighted Cash Flow Model Probability Weighting 20% - 100% 50 % Warrant investments 22,913 Black-Scholes Valuation Model Price Per Share 0.000 –1,899.0000 $ 64.95 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 6,430 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 81 % Equity investments 7,281 Last Equity Financing Price Per Share 0.56 215.03 $ 17.15 Total Level 3 investments $ 706,858
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three months ended September 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 609,068 $ 21,131 $ 6,850 $ 9,183 $ 646,232 Purchase of investments 85,782 — — 45 85,827 Warrants received and classified as Level 3 — 411 — — 411 Principal payments received on investments (44,347 ) — — (45 ) (44,392 ) Payment-in-kind interest on investments 377 — — — 377 Proceeds from sale of investments (69 ) — — — (69 ) Net realized loss on investments (33,385 ) (509 ) — — (33,894 ) Unrealized appreciation (depreciation) included in earnings 37,574 (2,655 ) (162 ) (5,783 ) 28,974 Transfer out of warrant investments (21,260 ) (73 ) 6,789 14,544 — Other (456 ) — — — (456 ) Level 3 assets, end of period $ 633,284 $ 18,305 $ 13,477 $ 17,944 $ 683,010 Three months ended September 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 683,309 $ 24,376 $ 4,259 $ 1,300 $ 713,244 Purchase of investments 66,185 — 750 — 66,935 Warrants received and classified as Level 3 — 1,294 — — 1,294 Principal payments received on investments (25,726 ) — — — (25,726 ) Payment-in-kind interest on investments 3,934 — — — 3,934 Proceeds from sale of investments (2,528 ) (23 ) (6 ) — (2,557 ) Net realized (loss) gain on investments (11,440 ) (118 ) 6 — (11,552 ) Unrealized depreciation included in earnings (18,877 ) (296 ) (1,349 ) (200 ) (20,722 ) Transfer out of Level 3 (5,000 ) — — — (5,000 ) Transfer out of debt investments (9,304 ) — 3,150 6,154 — Other (715 ) — — — (715 ) Level 3 assets, end of period $ 679,838 $ 25,233 $ 6,810 $ 7,254 $ 719,135 Nine months ended September 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,172 $ 22,975 $ 7,281 $ 6,430 $ 706,858 Purchase of investments 119,564 — 1,250 397 121,211 Warrants received and classified as Level 3 — 1,628 — — 1,628 Principal payments received on investments (120,333 ) — — (115 ) (120,448 ) Payment-in-kind interest on investments 2,114 — — — 2,114 Proceeds from sale of investments (113 ) (4 ) — (40 ) (157 ) Net realized (loss) gain on investments (33,344 ) 2,091 — 40 (31,213 ) Unrealized appreciation (depreciation) included in earnings 18,564 (5,631 ) (4,524 ) (6,503 ) 1,906 Transfer out of debt and warrant investments (24,451 ) (2,754 ) 9,470 17,735 — Other 1,111 — — — 1,111 Level 3 assets, end of period $ 633,284 $ 18,305 $ 13,477 $ 17,944 $ 683,010 Nine months ended September 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 686,458 $ 26,145 $ 2,416 $ 1,300 $ 716,319 Purchase of investments 153,728 — 760 — 154,488 Warrants and equity received and classified as Level 3 — 1,950 89 — 2,039 Principal payments received on investments (90,222 ) — — — (90,222 ) Payment-in-kind interest on investments 6,088 — — — 6,088 Proceeds from sale of investments (9,564 ) (1,493 ) (6 ) — (11,063 ) Net realized (loss) gain on investments (29,105 ) 1,028 (121 ) — (28,198 ) Unrealized depreciation included in earnings (21,325 ) (2,392 ) (2,467 ) (200 ) (26,384 ) Transfer out of Level 3 (5,000 ) — (111 ) — (5,111 ) Transfer out of debt investments (12,399 ) (5 ) 6,250 6,154 — Other 1,179 — — — 1,179 Level 3 assets, end of period $ 679,838 $ 25,233 $ 6,810 $ 7,254 $ 719,135

Note 7 - Borrowings (Tables)

Note 7 - Borrowings (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Debt [Table Text Block]	September 30, 2024 December 31, 2023 Total Balance Unused Total Balance Unused Commitment Outstanding Commitment Commitment Outstanding Commitment (In thousands) Key Facility $ 150,000 $ — $ 150,000 $ 150,000 $ 70,000 $ 80,000 NYL Facility 250,000 181,000 69,000 250,000 181,000 69,000 Nuveen Facility 100,000 50,000 50,000 — — — 2022 Asset-Backed Notes 90,970 90,970 — 100,000 100,000 — 2027 Notes 57,500 57,500 — 57,500 57,500 — 2026 Notes 57,500 57,500 — 57,500 57,500 — Total before debt issuance costs 705,970 436,970 269,000 615,000 466,000 149,000 Unamortized debt issuance costs attributable to term borrowings — (3,001 ) — — (3,765 ) — Total borrowings outstanding, net $ 705,970 $ 433,969 $ 269,000 $ 615,000 $ 462,235 $ 149,000

Note 8 - Financial Instrument_2

Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block]	September 30, 2024 December 31, 2023 Fair Value of Fair Value of Unfunded Unfunded Commitment Commitment Commitment Commitment Amount Liability Amount Liability (In thousands) (In thousands) Better Place Forests Co. $ 1,000 $ — $ — $ — BrightInsight, Inc. 10,000 132 15,500 241 Britecore Holdings, Inc. 2,500 36 5,000 72 Candesant Biomedical Corporation 10,000 151 10,000 151 Ceribell, Inc. 21,000 120 — — Divergent Technologies, Inc. — — 11,250 118 Elligo Healthcare Research, Inc. 7,500 97 15,000 194 Fictiv, Inc. 30,000 236 — — GT Medical Technologies, Inc. 20,000 100 — — Hometeam Technologies, Inc. 10,000 100 — — MicroTransponder, Inc. 22,500 — 22,500 — Mirantis, Inc. — — 15,000 136 Optoro, Inc. — — 6,250 — Parse Biosciences, Inc. 15,000 252 15,000 251 Pivot Bio, Inc. 20,000 209 — — SafelyYou, Inc. 10,000 147 20,000 270 Sonex Health, Inc. — — 15,000 176 Standvast Holdings, LLC 5,000 175 — — Supply Network Visibility Holdings, LLC 5,000 17 10,000 35 Swift Health Systems, Inc. 375 — — — Tallac Therapeutics, Inc. — — 10,000 229 Viken Detection Corporation — — 10,000 160 Total $ 189,875 $ 1,772 $ 180,500 $ 2,033

Note 10 - Distributions (Tables

Note 10 - Distributions (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Dividends Declared [Table Text Block]	DRIP DRIP Date Amount Cash Shares Share Declared Record Date Payment Date Per Share Distribution Issued Value (In thousands, except share and per share data) Nine Months Ended September 30, 2024 July 26, 2024 November 15, 2024 December 13, 2024 $ 0.11 $ — — $ — July 26, 2024 October 17, 2024 November 14, 2024 0.11 — — — July 26, 2024 September 16, 2024 October 16, 2024 0.11 3,914 18,539 195 April 26, 2024 August 16, 2024 September 13, 2024 0.11 3,818 17,441 192 April 26, 2024 July 17, 2024 August 15, 2024 0.11 3,775 16,852 192 April 26, 2024 June 17, 2024 July 16, 2024 0.11 3,766 15,860 199 February 23, 2024 June 17, 2024 June 14, 2024 0.11 3,701 16,686 201 February 23, 2024 April 18, 2024 May 15, 2024 0.11 3,654 16,687 199 February 23, 2024 March 19, 2024 April 16, 2024 0.05 1,625 7,598 85 February 23, 2024 March 19, 2024 April 16, 2024 0.11 3,574 16,717 188 $ 1.04 $ 27,827 126,380 $ 1,451 Year Ended December 31, 2023 October 27, 2023 February 16, 2024 March 15, 2024 $ 0.11 $ 3,463 18,257 $ 210 October 27, 2023 January 18, 2024 February 14, 2024 0.11 3,462 15,873 210 October 27, 2023 December 19, 2023 January 16, 2024 0.11 3,472 14,563 199 October 27, 2023 November 17, 2023 December 15, 2023 0.05 1,574 7,137 93 July 28, 2023 November 17, 2023 December 15, 2023 0.11 3,463 15,701 206 July 28, 2023 October 18, 2023 November 15, 2023 0.11 3,493 14,022 173 July 28, 2023 September 19, 2023 October 16, 2023 0.11 3,445 15,067 184 April 28, 2023 August 17, 2023 September 15, 2023 0.11 3,458 8,665 106 April 28, 2023 July 18, 2023 August 15, 2023 0.11 3,427 8,307 105 April 28, 2023 June 16, 2023 July 14, 2023 0.11 3,434 7,424 96 February 23, 2023 May 18, 2023 June 14, 2023 0.11 3,087 7,128 86 February 23, 2023 April 18, 2023 May 16, 2023 0.11 3,068 6,705 84 February 23, 2023 March 17, 2023 April 14, 2023 0.11 3,035 6,894 81 $ 1.37 $ 41,881 145,743 $ 1,833 Ex-Dividend Date Record Date Payment Date Distributions Declared February 18, 2025 February 18, 2025 March 14, 2025 $ 0.11 January 16, 2025 January 16, 2025 February 14, 2025 $ 0.11 December 16, 2024 December 16, 2024 January 15, 2025 $ 0.11

Note 11 - Financial Highlights

Note 11 - Financial Highlights (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Investment Company, Financial Highlights [Table Text Block]	Nine months ended September 30, 2024 2023 (In thousands, except share and per share data) Per share data: Net asset value at beginning of period $ 9.71 $ 11.47 Net investment income 1.06 1.54 Realized loss (0.89 ) (0.95 ) Unrealized appreciation (depreciation) on investments 0.02 (0.81 ) Net increase (decrease) in net assets resulting from operations 0.19 (0.22 ) Distributions declared (1) (1.04 ) (0.99 ) From net investment income (1.04 ) (0.99 ) From net realized gain on investments — — Return of capital — — Other (2) 0.20 0.15 Net asset value at end of period $ 9.06 $ 10.41 Per share market value, beginning of period $ 13.17 $ 11.60 Per share market value, end of period $ 10.65 $ 11.88 Total return based on a market value (3) (11.2 )% 10.9 % Shares outstanding at end of period 37,803,064 33,306,958 Ratios to average net assets: Expenses without incentive fee (4) 15.1 % 14.0 % Incentive fees (4) 0.1 1.2 % Net expenses (4) 15.2 % 15.2 % Net investment income with incentive fee (4) 15.0 % 18.5 % Net assets at the end of the period $ 342,533 $ 346,575 Average net asset value $ 331,853 $ 335,531 Average debt per share $ 12.70 $ 14.29 Portfolio turnover ratio 13.4 % (5) 10.0 % (5)

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Unaudited) (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Jul. 31, 2023	Nov. 09, 2022
Debt Instrument, Face Amount	$ 705,970	$ 615,000
Percentage of Nonqualifying Assets on a Cost Basis		4.70%
Percentage of Nonqualifying Assets on a Fair Value Basis		2.70%
Investment, Affiliated Issuer, Noncontrolled [Member] | Medical Device Sector [Member] | Aulea Medical Inc 1[Member]
Investment Owned, Balance, Shares (in shares)			660,537
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Investment Owned, Net Assets, Percentage		30%
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member]
Investment, Interest Rate, Paid in Kind		4.50%
Horizon Technology Finance Corporation [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Net Assets, Percentage	70%	70%
Asset-backed Notes 2022 [Member]
Debt Instrument, Face Amount	$ 90,970	$ 100,000		$ 157,800
Asset-backed Notes 2022 [Member] | Affiliated Entity [Member]
Debt Instrument, Face Amount				$ 100,000

Consolidated Schedule of Inve_4

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands		Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Investments at cost		$ 733,232		$ 759,182
Investments at fair value		684,000		709,085
Medical Device Sector [Member]
Investments at cost		185,751		147,064
Investments at fair value		179,092		145,019
Biotechnology Sector [Member]
Investments at cost		126,867		145,544
Investments at fair value		106,865		117,781
Software Sector [Member]
Investments at cost		136,309		164,133
Investments at fair value		132,951		160,749
Communications Sector [Member]
Investments at cost		13,577		19,192
Investments at fair value		15,596		22,188
Diagnostics Sector [Member]
Investments at cost		16,692		19,735
Investments at fair value		14,114		19,701
Other Sustainability Sector [Member]
Investments at cost		66,501		98,906
Investments at fair value		66,163		80,370
Other Healthcare Sector [Member]
Investments at cost		39,511		102
Investments at fair value		40,186		1,366
Energy Efficiency [Member]
Investments at cost		9,812		111
Investments at fair value		9,712		13
Networking Sector [Member]
Investments at cost		10,064		5,451
Investments at fair value		9,818		5,297
Data Storage Sector [Member]
Investments at cost		417		417
Investments at fair value		409		418
Internet and Media Sector [Member]
Investments at cost		329		329
Investments at fair value		984		1,582
Power Management Sector [Member]
Investments at cost		1,585		1,585
Investments at fair value		2,700		2,700
Semiconductor Sector [Member]
Investments at cost		45		45
Investments at fair value		0		0
Software, Healthcare Information and Service [Member]
Investments at cost		51,391		50,899
Investments at fair value		50,905		50,574
Unrestricted Short Term Investments [Member]
Investments at cost		31,080		26,450
Investments at fair value		31,080		26,450
Unrestricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member]
Investments at cost		31,080		26,450
Investments at fair value		31,080		26,450
Equity Securities [Member]
Investments at cost		25,162		14,443
Investments at fair value		14,037		7,889
Restricted Short Term Investments [Member]
Investments at cost		3,266		2,642
Investments at fair value		3,266		2,642
Restricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member]
Investments at cost		3,266		2,642
Investments at fair value		3,266		2,642
Warrant [Member]
Investments at cost		17,292		16,526
Investments at fair value		18,735		24,594
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost		27,478		28,677
Investments at fair value		8,307	$ 15,847	1,132	$ 20,485	$ 906	$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments at fair value		0	0	$ 0	0	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments at fair value	[1]				0	906	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				11%
Ceiling				0%
ETP				2.27%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 5,532
Investments at cost				5,228
Investments at fair value				$ 222
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				11%
Ceiling				0%
ETP				2.27%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 8,298
Investments at cost				7,867
Investments at fair value				$ 336
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				11%
Ceiling				0%
ETP				2.27%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 3,319
Investments at cost				3,137
Investments at fair value				$ 133
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				11%
Ceiling				0%
ETP				2.27%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 3,319
Investments at cost				3,137
Investments at fair value				$ 133
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				11%
Ceiling				0%
ETP				2.27%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 2,213
Investments at cost				2,091
Investments at fair value				$ 88
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				11%
Ceiling				0%
ETP				2.27%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 2,213
Investments at cost				2,091
Investments at fair value				88
Investment, Affiliated Issuer, Noncontrolled [Member] | Common Stock [Member] | Medical Device Sector [Member] | Aulea Medical, Inc. [Member]
Investments at cost		0
Investments at fair value		$ 0
Number of Shares (in shares)		660,537		660,537
Investment, Affiliated Issuer, Noncontrolled [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Investments at cost		$ 5,000		$ 5,000
Investments at fair value		$ 0		$ 132
Number of Shares (in shares)		2,164,502		2,164,502
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, One [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		11%
Ceiling		0%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 5,770
Investments at cost		4,910
Investments at fair value		$ 1,825
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Two [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		11%
Ceiling		0%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 8,656
Investments at cost		7,621
Investments at fair value		2,832
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member]
Investments at cost		5,000
Investments at fair value		$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] | Life Science [Member]
Investments at cost				$ 5,000
Investments at fair value				$ 132
Number of Shares (in shares)
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Three [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		11%
Ceiling		0%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 3,462
Investments at cost		2,947
Investments at fair value		1,095
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member]
Investments at cost		125		$ 126
Investments at fair value		0
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Investments at cost		125		126
Investments at fair value		$ 0
Number of Shares (in shares)		23,196		23,196
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] | Life Science [Member]
Investments at cost				$ 23,551
Investments at fair value				1,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Four [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		11%
Ceiling		0%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 3,462
Investments at cost		2,947
Investments at fair value		$ 1,095
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Five [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		11%
Ceiling		0%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 2,308
Investments at cost		1,964
Investments at fair value		730
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments [Member]
Investments at cost		22,353
Investments at fair value		$ 8,307
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Six [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		11%
Ceiling		0%
ETP		4.25%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 2,308
Investments at cost		1,964
Investments at fair value		730
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost		25,353		14,428
Investments at fair value		19,731	11,386	14,223	13,145	0	0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments at fair value		6,290	$ 5,836	$ 6,230	$ 6,154	$ 0	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12%
Ceiling				0%
ETP				1.85%
Maturity Date				Aug. 01, 2029
Principal Amount				$ 3,547
Investments at cost				3,585
Investments at fair value				$ 3,339
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12%
Ceiling				0%
ETP				1.85%
Maturity Date				Aug. 01, 2029
Principal Amount				$ 1,773
Investments at cost				1,750
Investments at fair value				1,630
Investment, Affiliated Issuer, Controlled [Member] | Common Stock [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Investments at cost		2,060
Investments at fair value		$ 0
Number of Shares (in shares)		2,278,272
Investment, Affiliated Issuer, Controlled [Member] | Common Stock [Member] | Technology Sector [Member] | Better Place Forests Co. [Member]
Investments at cost				2,061
Investments at fair value				$ 2,165
Number of Shares (in shares)				2,278,272
Investment, Affiliated Issuer, Controlled [Member] | Common Stock [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member]
Investments at cost		$ 3,297
Investments at fair value		$ 3,309
Number of Shares (in shares)		108,320
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Cash Rate		12%
Margin		3.75%
Floor		12%
Ceiling		0%
ETP		2.78%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 3,891
Investments at cost		3,935
Investments at fair value		$ 3,234
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, Five [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Cash Rate		12%
Margin		3.75%
Floor		12%
Ceiling		0%
ETP		0%
Maturity Date		Aug. 01, 2025
Principal Amount		$ 506
Investments at cost		507
Investments at fair value		$ 474
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Cash Rate		12%
Margin		3.75%
Floor		12%
Ceiling		0%
ETP		2.78%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 1,946
Investments at cost		1,927
Investments at fair value		1,583
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member]
Investments at cost		11,276
Investments at fair value		$ 6,549
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] | Technology Sector [Member]
Investments at cost				$ 3,311
Investments at fair value				3,024
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Cash Rate		12%
Margin		3.75%
Floor		12%
Ceiling		0%
ETP		0%
Maturity Date		Aug. 01, 2025
Principal Amount		$ 521
Investments at cost		521
Investments at fair value		$ 489
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, Four [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Cash Rate		12%
Margin		3.75%
Floor		12%
Ceiling		0%
ETP		0%
Maturity Date		Aug. 01, 2025
Principal Amount		$ 516
Investments at cost		517
Investments at fair value		484
Investment, Affiliated Issuer, Controlled [Member] | Preferred Stock [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member]
Investments at cost		2,500
Investments at fair value		$ 0
Number of Shares (in shares)		5,350,142
Investment, Affiliated Issuer, Controlled [Member] | Preferred Stock [Member] | Technology Sector [Member] | Better Place Forests Co. [Member]
Investments at cost				1,250
Investments at fair value				$ 859
Number of Shares (in shares)				3,124,448
Investment, Affiliated Issuer, Controlled [Member] | Preferred Stock [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member]
Investments at cost		$ 3,419
Investments at fair value		$ 3,240
Number of Shares (in shares)		542
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member]
Investments at cost		$ 8,197
Investments at fair value		$ 6,892
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] | Consumer-related Technologies [Member]
Investments at cost				$ 5,335
Investments at fair value				4,969
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member]
Cash Rate		10%
Margin		0%
Floor		0%
Ceiling		0%
ETP		0%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 790
Investments at cost		790
Investments at fair value		628
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member]
Investments at cost		5,880
Investments at fair value		6,290
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] | Biotechnology Sector [Member] | HIMV LLC [Member]
Investments at cost		5,880
Investments at fair value		6,290
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] | Life Science [Member]
Investments at cost				5,782
Investments at fair value				6,230
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] | Life Science [Member] | HIMV LLC [Member]
Investments at cost				5,782
Investments at fair value				6,230
Investment, Unaffiliated Issuer [Member]
Investments at cost		680,401		716,077
Investments at fair value		$ 655,962		$ 693,730
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.50%
Ceiling				0%
ETP				5%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,757
Investments at fair value				$ 4,757
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.50%
Ceiling				0%
ETP				5%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,454
Investments at fair value				2,454
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				152
Investments at fair value				$ 135
Number of Shares (in shares)				93,336
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.50%
Ceiling				0%
ETP				5%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,454
Investments at fair value				$ 2,454
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.75%
Margin				5.25%
Floor				9%
Ceiling				0%
ETP				5%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,467
Investments at fair value				$ 3,467
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.75%
Margin				5.25%
Floor				9%
Ceiling				0%
ETP				5%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,467
Investments at fair value				3,467
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				71
Investments at fair value				$ 1
Number of Shares (in shares)				135,484
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.75%
Margin				5.25%
Floor				9%
Ceiling				0%
ETP				5%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,456
Investments at fair value				$ 3,456
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				13.75%
Margin				5.25%
Floor				9%
Ceiling				0%
ETP				5%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,456
Investments at fair value				$ 3,456
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14%
Margin				5.50%
Floor				10.25%
Ceiling				0%
ETP				4%
Maturity Date				Nov. 01, 2026
Principal Amount				$ 3,500
Investments at cost				3,469
Investments at fair value				$ 1,574
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14%
Margin				5.50%
Floor				10.25%
Ceiling				0%
ETP				4%
Maturity Date				Nov. 01, 2026
Principal Amount				$ 3,500
Investments at cost				3,563
Investments at fair value				1,617
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				194
Investments at fair value				$ 368
Number of Shares (in shares)				809,931
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 83
Investments at fair value				$ 93
Number of Shares (in shares)				233,993
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.25%
Margin				4.75%
Floor				8.50%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,722
Investments at fair value				$ 3,722
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.25%
Margin				4.75%
Floor				8.50%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,722
Investments at fair value				3,722
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				103
Investments at fair value				$ 215
Number of Shares (in shares)				34,410
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.75%
Margin				5.25%
Floor				9%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,943
Investments at fair value				$ 4,943
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				13.75%
Margin				5.25%
Floor				9%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,900
Investments at fair value				$ 4,900
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12%
Margin				3.50%
Floor				8.25%
Ceiling				0%
ETP				5.50%
Maturity Date				Oct. 01, 2024
Principal Amount				$ 3,750
Investments at cost				3,738
Investments at fair value				$ 3,738
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12%
Margin				3.50%
Floor				8.25%
Ceiling				0%
ETP				5.50%
Maturity Date				Oct. 01, 2024
Principal Amount				$ 3,750
Investments at cost				3,738
Investments at fair value				3,738
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				69
Investments at fair value				$ 229
Number of Shares (in shares)				145,483
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12%
Margin				3.50%
Floor				8.25%
Ceiling				0%
ETP				5.50%
Maturity Date				Oct. 01, 2024
Principal Amount				$ 1,875
Investments at cost				1,866
Investments at fair value				$ 1,866
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12%
Margin				3.50%
Floor				8.25%
Ceiling				0%
ETP				5.50%
Maturity Date				Oct. 01, 2024
Principal Amount				$ 1,875
Investments at cost				1,866
Investments at fair value				$ 1,866
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12.25%
Ceiling				0%
ETP				3.50%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 3,750
Investments at cost				3,689
Investments at fair value				$ 3,689
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12.25%
Ceiling				0%
ETP				3.50%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 3,750
Investments at cost				3,689
Investments at fair value				3,689
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				47
Investments at fair value				$ 47
Number of Shares (in shares)				103,172
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12.25%
Ceiling				0%
ETP				4%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 15,000
Investments at cost				14,675
Investments at fair value				$ 14,675
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12.25%
Ceiling				0%
ETP				4%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 10,000
Investments at cost				9,784
Investments at fair value				9,784
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost				432
Investments at fair value				$ 379
Number of Shares (in shares)				4,109
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12.25%
Ceiling				0%
ETP				4%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 5,000
Investments at cost				4,892
Investments at fair value				$ 4,892
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12.25%
Margin				3.75%
Floor				12.25%
Ceiling				0%
ETP				4%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 2,500
Investments at cost				2,446
Investments at fair value				$ 2,446
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				8%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,297
Investments at fair value				$ 2,297
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				8%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,473
Investments at fair value				2,473
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				275
Investments at fair value				$ 269
Number of Shares (in shares)				2,637,043
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				8%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,946
Investments at fair value				$ 4,946
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				8%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,946
Investments at fair value				$ 4,946
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14%
Margin				5.50%
Floor				8.75%
Ceiling				0%
ETP				6%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 4,583
Investments at cost				4,546
Investments at fair value				$ 4,546
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14%
Margin				5.50%
Floor				8.75%
Ceiling				0%
ETP				6%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 2,292
Investments at cost				2,273
Investments at fair value				2,273
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				149
Investments at fair value				$ 167
Number of Shares (in shares)				4,106,174
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				1%
Maturity Date				Oct. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,978
Investments at fair value				$ 4,978
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				1%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,489
Investments at fair value				$ 2,489
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.32%
Margin				4.82%
Floor				9.25%
Ceiling				0%
ETP				10.36%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 3,960
Investments at cost				3,923
Investments at fair value				$ 3,923
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.32%
Margin				4.82%
Floor				9.25%
Ceiling				0%
ETP				10.36%
Maturity Date				Jul. 01, 2025
Principal Amount				$ 3,960
Investments at cost				3,923
Investments at fair value				3,923
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				221
Investments at fair value				$ 206
Number of Shares (in shares)				7,972,222
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 124
Investments at fair value				$ 26
Number of Shares (in shares)				2,010,424
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member]
Investments at cost				$ 1,200
Investments at fair value				200
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | ZetrOZ, Inc [Member] | Royalty Agreement [Member]
Investments at cost
Investments at fair value
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member]
Investments at cost				24
Investments at fair value
Number of Shares (in shares)				1,175
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 66
Investments at fair value				$ 1,199
Number of Shares (in shares)				1,818,183
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 48
Investments at fair value				$ 9
Number of Shares (in shares)				8,800
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member]
Cash Rate				9%
Margin				0%
Floor				0%
Ceiling				0%
ETP				18%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,468
Investments at fair value				$ 2,342
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Two [Member]
Cash Rate				9%
Margin				0%
Floor				0%
Ceiling				0%
ETP				18%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,468
Investments at fair value				$ 2,342
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Three [Member]
Cash Rate				9%
Margin				0%
Floor				0%
Ceiling				0%
ETP				18%
Maturity Date				Jun. 30, 2024
Principal Amount				$ 200
Investments at cost				200
Investments at fair value				190
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				86
Investments at fair value				$ 1,305
Number of Shares (in shares)				12,153
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.59%
Margin				5.09%
Floor				10%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2024
Principal Amount				$ 500
Investments at cost				500
Investments at fair value				$ 500
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.59%
Margin				5.09%
Floor				10%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2024
Principal Amount				$ 33
Investments at cost				33
Investments at fair value				33
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				174
Investments at fair value				$ 124
Number of Shares (in shares)				3,341,376
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.59%
Margin				5.09%
Floor				10%
Ceiling				0%
ETP				5%
Maturity Date				Mar. 01, 2024
Principal Amount				$ 800
Investments at cost				794
Investments at fair value				794
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				76
Investments at fair value				$ 980
Number of Shares (in shares)				47,410
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.50%
Maturity Date				Aug. 01, 2025
Principal Amount				$ 1,667
Investments at cost				1,656
Investments at fair value				$ 1,656
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.50%
Maturity Date				Aug. 01, 2025
Principal Amount				$ 1,583
Investments at cost				1,573
Investments at fair value				1,573
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member]
Investments at cost				29
Investments at fair value				$ 122
Number of Shares (in shares)				46,745
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.50%
Margin				5%
Floor				5%
Ceiling				0%
ETP				4%
Maturity Date				Mar. 01, 2027
Principal Amount				$ 2,000
Investments at cost				1,421
Investments at fair value				$ 1,421
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.50%
Margin				5%
Floor				5%
Ceiling				0%
ETP				4%
Maturity Date				Mar. 01, 2027
Principal Amount				$ 3,000
Investments at cost				2,131
Investments at fair value				2,131
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost				2,947
Investments at fair value				$ 2,259
Number of Shares (in shares)				1,312,500
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12%
Margin				3.50%
Floor				10.50%
Ceiling				0%
ETP				7.78%
Maturity Date				Feb. 01, 2028
Principal Amount				$ 2,813
Investments at cost				2,813
Investments at fair value				$ 2,813
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12%
Margin				3.50%
Floor				10.50%
Ceiling				0%
ETP				7.78%
Maturity Date				Feb. 01, 2028
Principal Amount				$ 2,813
Investments at cost				2,813
Investments at fair value				$ 2,813
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | CAMP NYC, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.75%
Margin				7.25%
Floor				10.50%
Ceiling				0%
ETP				3%
Maturity Date				May 01, 2026
Principal Amount				$ 3,383
Investments at cost				3,356
Investments at fair value				3,356
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				22
Investments at fair value				$ 27
Number of Shares (in shares)				75,997
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12%
Margin				3.50%
Floor				9%
Ceiling				0%
ETP				1%
Maturity Date				Sep. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,591
Investments at fair value				$ 2,429
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,608
Investments at fair value				$ 3,608
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 1,250
Investments at cost				1,242
Investments at fair value				1,242
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				94
Investments at fair value				$ 250
Number of Shares (in shares)				37,282
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,726
Investments at fair value				$ 3,726
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 1,250
Investments at cost				1,242
Investments at fair value				$ 1,242
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,726
Investments at fair value				$ 3,726
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 1,250
Investments at cost				1,242
Investments at fair value				$ 1,242
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,712
Investments at fair value				$ 3,712
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,712
Investments at fair value				$ 3,712
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Nine [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,706
Investments at fair value				$ 3,706
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Ten [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,707
Investments at fair value				$ 3,707
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eleven [Member]
Cash Rate				11.25%
Margin				6%
Floor				9.50%
Ceiling				11.25%
ETP				3%
Maturity Date				Jul. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,707
Investments at fair value				$ 3,707
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 5,752
Investments at cost				5,752
Investments at fair value				$ 5,018
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 2,301
Investments at cost				2,301
Investments at fair value				2,007
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				188
Investments at fair value
Number of Shares (in shares)				12,618
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 9
Investments at fair value
Number of Shares (in shares)				1,224,752
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 2,876
Investments at cost				2,876
Investments at fair value				$ 2,509
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 3,451
Investments at cost				3,451
Investments at fair value				$ 3,011
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 2,876
Investments at cost				2,876
Investments at fair value				$ 2,510
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 2,876
Investments at cost				2,876
Investments at fair value				$ 2,510
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 5,752
Investments at cost				5,752
Investments at fair value				$ 5,018
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9%
Ceiling				0%
ETP				5.25%
Maturity Date				Oct. 31, 2023
Principal Amount				$ 2,876
Investments at cost				2,876
Investments at fair value				2,510
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				93
Investments at fair value
Number of Shares (in shares)				20,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Aterian, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 195
Investments at fair value
Number of Shares (in shares)				76,923
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Caastle, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 65
Investments at fair value				$ 1,055
Number of Shares (in shares)				268,591
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,416
Investments at fair value				$ 2,416
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Jul. 01, 2028
Principal Amount				$ 1,875
Investments at cost				1,787
Investments at fair value				1,787
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				182
Investments at fair value				$ 145
Number of Shares (in shares)				11,550
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | CZV, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 81
Investments at fair value				$ 71
Number of Shares (in shares)				65,569
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				16.25%
Margin				7.75%
Floor				11%
Ceiling				0%
ETP				0%
Maturity Date				May 01, 2027
Principal Amount				$ 1,204
Investments at cost				1,086
Investments at fair value				$ 872
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				16.25%
Margin				7.75%
Floor				11%
Ceiling				0%
ETP				0%
Maturity Date				May 01, 2027
Principal Amount				$ 602
Investments at cost				543
Investments at fair value				436
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				32
Investments at fair value
Number of Shares (in shares)				171,081
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				16.25%
Margin				7.75%
Floor				11%
Ceiling				0%
ETP				0%
Maturity Date				May 01, 2027
Principal Amount				$ 602
Investments at cost				543
Investments at fair value				$ 436
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				3%
Maturity Date				Oct. 01, 2025
Principal Amount				$ 3,667
Investments at cost				3,647
Investments at fair value				$ 3,647
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				3%
Maturity Date				Oct. 01, 2025
Principal Amount				$ 1,833
Investments at cost				1,824
Investments at fair value				1,824
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member]
Investments at cost				29
Investments at fair value				$ 56
Number of Shares (in shares)				250
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 57
Investments at fair value				$ 591
Number of Shares (in shares)				553,778
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 325
Investments at fair value				$ 533
Number of Shares (in shares)				6,191
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 34
Investments at fair value
Number of Shares (in shares)				114,659
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 214
Investments at fair value				$ 318
Number of Shares (in shares)				7,404
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost				$ 311
Investments at fair value
Number of Shares (in shares)				117
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 178
Investments at fair value				$ 246
Number of Shares (in shares)				110,402
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 65
Investments at fair value
Number of Shares (in shares)				19,671
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 50
Investments at fair value				$ 53
Number of Shares (in shares)				48,076
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 146
Investments at fair value
Number of Shares (in shares)				16,611
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 64
Investments at fair value				$ 157
Number of Shares (in shares)				103,679
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member]
Investments at cost				$ 160
Investments at fair value				$ 606
Number of Shares (in shares)				299,848
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost				$ 278
Investments at fair value
Number of Shares (in shares)				175,098
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 312
Investments at fair value				$ 225
Number of Shares (in shares)				691,895
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member]
Investments at cost				$ 264
Investments at fair value				$ 113
Number of Shares (in shares)				318,181
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				12.25%
Ceiling				0%
ETP				4%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,459
Investments at fair value				2,459
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				194
Investments at fair value				$ 172
Number of Shares (in shares)				1,600,002
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 72
Investments at fair value				$ 33
Number of Shares (in shares)				126,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14%
Margin				5.50%
Floor				10.25%
Ceiling				0%
ETP				4%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 10,000
Investments at cost				9,895
Investments at fair value				$ 9,895
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14%
Margin				5.50%
Floor				10.25%
Ceiling				0%
ETP				4%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 10,000
Investments at cost				9,895
Investments at fair value				9,895
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				273
Investments at fair value				$ 13
Number of Shares (in shares)				639,918
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14%
Margin				5.50%
Floor				10.25%
Ceiling				0%
ETP				4%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,947
Investments at fair value				$ 4,947
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				14%
Margin				5.50%
Floor				10.25%
Ceiling				0%
ETP				4%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,947
Investments at fair value				4,947
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				167
Investments at fair value
Number of Shares (in shares)				85,066
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15%
Margin				6.50%
Floor				9.75%
Ceiling				0%
ETP				3.50%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 6,625
Investments at cost				6,519
Investments at fair value				$ 6,176
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15%
Margin				6.50%
Floor				9.75%
Ceiling				0%
ETP				3.50%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 6,116
Investments at cost				6,018
Investments at fair value				5,701
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost				455
Investments at fair value				$ 46
Number of Shares (in shares)				516,732
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				15%
Margin				6.50%
Floor				9.75%
Ceiling				0%
ETP				3.50%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 2,548
Investments at cost				2,507
Investments at fair value				$ 2,375
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				13.50%
Margin				5%
Floor				12%
Ceiling				0%
ETP				3%
Maturity Date				Mar. 01, 2027
Principal Amount				$ 10,000
Investments at cost				9,885
Investments at fair value				$ 9,885
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				13.50%
Margin				5%
Floor				12%
Ceiling				0%
ETP				3%
Maturity Date				Mar. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,942
Investments at fair value				4,942
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				115
Investments at fair value				$ 2
Number of Shares (in shares)				84,037
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				13.50%
Margin				5%
Floor				12%
Ceiling				0%
ETP				3%
Maturity Date				Mar. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,942
Investments at fair value				$ 4,942
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Reputation Institute, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.75%
Margin				7.25%
Floor				10.50%
Ceiling				0%
ETP				3%
Maturity Date				Aug. 01, 2025
Principal Amount				$ 3,667
Investments at cost				3,625
Investments at fair value				3,625
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Reputation Institute, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				56
Investments at fair value				$ 80
Number of Shares (in shares)				3,731
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 44
Investments at fair value				$ 91
Number of Shares (in shares)				682,034
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Engage3, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.75%
Ceiling				0%
ETP				4.50%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,728
Investments at fair value				$ 3,728
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Engage3, LLC [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.75%
Ceiling				0%
ETP				4.50%
Maturity Date				Jul. 01, 2027
Principal Amount				$ 3,750
Investments at cost				3,728
Investments at fair value				$ 3,728
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.50%
Margin				6%
Floor				14.25%
Ceiling				0%
ETP				4%
Maturity Date				Nov. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,471
Investments at fair value				$ 2,373
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.50%
Margin				6%
Floor				14.25%
Ceiling				0%
ETP				4%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 1,250
Investments at cost				1,237
Investments at fair value				1,188
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				43
Investments at fair value				$ 1
Number of Shares (in shares)				85,543
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14.50%
Margin				6%
Floor				14.25%
Ceiling				0%
ETP				4%
Maturity Date				Apr. 01, 2027
Principal Amount				$ 1,000
Investments at cost				994
Investments at fair value				954
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				225
Investments at fair value
Number of Shares (in shares)				186,235
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9.75%
Ceiling				0%
ETP				5%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,959
Investments at fair value				$ 4,959
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9.75%
Ceiling				0%
ETP				5%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,959
Investments at fair value				4,959
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				123
Investments at fair value				$ 135
Number of Shares (in shares)				309,208
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9.75%
Ceiling				0%
ETP				5%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,959
Investments at fair value				$ 4,959
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				14.25%
Margin				5.75%
Floor				9.75%
Ceiling				0%
ETP				5%
Maturity Date				Aug. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,959
Investments at fair value				4,959
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Health Research, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				192
Investments at fair value				$ 99
Number of Shares (in shares)				652,250
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,779
Investments at fair value				$ 4,779
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,915
Investments at fair value				4,915
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				223
Investments at fair value				$ 247
Number of Shares (in shares)				948,275
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,915
Investments at fair value				$ 4,915
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,915
Investments at fair value				4,915
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				138
Investments at fair value
Number of Shares (in shares)				3,049,607
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 60
Investments at fair value				$ 108
Number of Shares (in shares)				7,097,792
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 163
Investments at fair value				$ 50
Number of Shares (in shares)				150,353
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.50%
Margin				4%
Floor				11.75%
Ceiling				0%
ETP				3.50%
Maturity Date				Jun. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,773
Investments at fair value				$ 4,773
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.50%
Margin				4%
Floor				11.75%
Ceiling				0%
ETP				3.50%
Maturity Date				Jun. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,467
Investments at fair value				2,467
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member]
Investments at cost				120
Investments at fair value				$ 105
Number of Shares (in shares)				345,443
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12.50%
Margin				4%
Floor				11.75%
Ceiling				0%
ETP				3.50%
Maturity Date				Jun. 01, 2027
Principal Amount				$ 2,500
Investments at cost				2,467
Investments at fair value				2,467
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				177
Investments at fair value				$ 5
Number of Shares (in shares)				4,343,348
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15%
Margin				6.50%
Floor				9.75%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,971
Investments at fair value				$ 4,971
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15%
Margin				6.50%
Floor				9.75%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,486
Investments at fair value				2,486
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				32
Investments at fair value				$ 120
Number of Shares (in shares)				101,308
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				12%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,457
Investments at fair value				$ 2,457
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				12%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2028
Principal Amount				$ 3,500
Investments at cost				3,489
Investments at fair value				3,489
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost				64
Investments at fair value				$ 135
Number of Shares (in shares)				682
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				12%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,492
Investments at fair value				$ 2,492
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12.75%
Margin				4.25%
Floor				12%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2028
Principal Amount				$ 1,500
Investments at cost				1,495
Investments at fair value				$ 1,495
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14%
Margin				5.50%
Floor				14%
Ceiling				0%
ETP				3%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,860
Investments at fair value				$ 4,860
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14%
Margin				5.50%
Floor				14%
Ceiling				0%
ETP				3%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,466
Investments at fair value				2,466
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				98
Investments at fair value				$ 174
Number of Shares (in shares)				161,215
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14%
Margin				5.50%
Floor				14%
Ceiling				0%
ETP				3%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,466
Investments at fair value				$ 2,466
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				14%
Margin				5.50%
Floor				14%
Ceiling				0%
ETP				3%
Maturity Date				Oct. 01, 2028
Principal Amount				$ 2,500
Investments at cost				2,466
Investments at fair value				2,466
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				18
Investments at fair value				$ 42
Number of Shares (in shares)				71,305
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 60
Investments at fair value
Number of Shares (in shares)				147,361
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 70
Investments at fair value				$ 63
Number of Shares (in shares)				350,000
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member]
Cash Rate		14.50%
Margin		6%
Floor		9.25%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 4,375
Investments at cost		4,354
Investments at fair value		4,354
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.50%
Margin				6%
Floor				9.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2026
Principal Amount				$ 6,250
Investments at cost				6,218
Investments at fair value				$ 6,218
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.50%
Margin				6%
Floor				9.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2026
Principal Amount				$ 6,250
Investments at cost				6,218
Investments at fair value				6,218
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				47
Investments at fair value				$ 61
Number of Shares (in shares)				1,991
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14.50%
Margin				6%
Floor				9.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Jun. 01, 2026
Principal Amount				$ 6,250
Investments at cost				6,218
Investments at fair value				6,218
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				138
Investments at fair value				$ 3,036
Number of Shares (in shares)				2,936,535
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | PebblePost, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 92
Investments at fair value				$ 131
Number of Shares (in shares)				598,850
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
Investments at cost		10,321
Investments at fair value		12,023
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.50%
Margin				6%
Floor				9.25%
Ceiling				0%
ETP				3.50%
Maturity Date				Jun. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,484
Investments at fair value				$ 2,484
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.50%
Margin				6%
Floor				9.25%
Ceiling				0%
ETP				3.50%
Maturity Date				Jun. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,484
Investments at fair value				2,484
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				46
Investments at fair value				$ 12
Number of Shares (in shares)				171,370
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14.50%
Margin				6%
Floor				9.25%
Ceiling				0%
ETP				3.50%
Maturity Date				Jun. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,968
Investments at fair value				$ 4,968
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				11.75%
Margin				3.25%
Floor				11.50%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,633
Investments at fair value				$ 4,633
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				11.75%
Margin				3.25%
Floor				11.50%
Ceiling				0%
ETP				5%
Maturity Date				Jan. 01, 2028
Principal Amount				$ 5,000
Investments at cost				4,884
Investments at fair value				4,884
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost				70
Investments at fair value				$ 70
Number of Shares (in shares)				32,244
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 166
Investments at fair value				$ 166
Number of Shares (in shares)				184,253
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				4.33%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 3,750
Investments at cost				3,685
Investments at fair value				$ 3,685
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				4.33%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 3,750
Investments at cost				3,685
Investments at fair value				3,685
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				81
Investments at fair value				$ 72
Number of Shares (in shares)				400,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 8,425
Investments at cost				8,353
Investments at fair value				$ 4,549
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 8,425
Investments at cost				8,229
Investments at fair value				4,481
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				490
Investments at fair value
Number of Shares (in shares)				215,171
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 8,425
Investments at cost				8,229
Investments at fair value				$ 4,481
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 5,617
Investments at cost				5,480
Investments at fair value				$ 2,984
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				2.50%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 5,617
Investments at cost				5,480
Investments at fair value				$ 2,984
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 735
Investments at cost				726
Investments at fair value				$ 395
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 586
Investments at cost				578
Investments at fair value				$ 315
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 292
Investments at cost				288
Investments at fair value				$ 157
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Nine [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 290
Investments at cost				286
Investments at fair value				$ 156
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Ten [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 174
Investments at cost				172
Investments at fair value				$ 93
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eleven [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 802
Investments at cost				791
Investments at fair value				$ 431
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Twelve [Member]
Cash Rate				15.50%
Margin				7%
Floor				10.25%
Ceiling				0%
ETP				0%
Maturity Date				Mar. 31, 2024
Principal Amount				$ 1,091
Investments at cost				1,083
Investments at fair value				590
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | LiquiGlide, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				39
Investments at fair value				$ 50
Number of Shares (in shares)				61,359
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.75%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,959
Investments at fair value				$ 4,959
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.75%
Maturity Date				Apr. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,479
Investments at fair value				2,479
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				214
Investments at fair value				$ 340
Number of Shares (in shares)				681
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.75%
Maturity Date				May 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,956
Investments at fair value				$ 4,956
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.75%
Maturity Date				May 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,478
Investments at fair value				$ 2,478
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				14%
Margin				5.50%
Floor				11.75%
Ceiling				0%
ETP				2.75%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,934
Investments at fair value				$ 4,934
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				14%
Margin				5.50%
Floor				11.75%
Ceiling				0%
ETP				2.75%
Maturity Date				Dec. 01, 2026
Principal Amount				$ 2,500
Investments at cost				2,467
Investments at fair value				$ 2,467
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.50%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,694
Investments at fair value				$ 3,694
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.50%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,694
Investments at fair value				3,694
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				175
Investments at fair value				$ 80
Number of Shares (in shares)				46,311
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.50%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 7,500
Investments at cost				7,379
Investments at fair value				$ 7,379
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.50%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,690
Investments at fair value				$ 3,690
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				15.25%
Margin				6.75%
Floor				10%
Ceiling				0%
ETP				2.50%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 3,750
Investments at cost				3,690
Investments at fair value				$ 3,690
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate				14.50%
Margin				6%
Floor				10%
Ceiling				0%
ETP				2%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 4,500
Investments at cost				4,446
Investments at fair value				$ 4,446
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate				14.50%
Margin				6%
Floor				10%
Ceiling				0%
ETP				2%
Maturity Date				Jan. 01, 2029
Principal Amount				$ 2,000
Investments at cost				1,976
Investments at fair value				1,976
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				102
Investments at fair value				$ 1,366
Number of Shares (in shares)				82,965
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Sep. 01, 2024
Principal Amount				$ 1,500
Investments at cost				1,481
Investments at fair value				$ 1,481
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Sep. 01, 2024
Principal Amount				$ 1,500
Investments at cost				1,481
Investments at fair value				1,481
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				364
Investments at fair value				$ 210
Number of Shares (in shares)				344,102
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Sep. 01, 2024
Principal Amount				$ 750
Investments at cost				740
Investments at fair value				$ 740
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Sep. 01, 2024
Principal Amount				$ 667
Investments at cost				656
Investments at fair value				$ 656
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate				14.75%
Margin				6.25%
Floor				9.50%
Ceiling				0%
ETP				4%
Maturity Date				Sep. 01, 2024
Principal Amount				$ 750
Investments at cost				729
Investments at fair value				729
Investment, Unaffiliated Issuer [Member] | Data Storage Sector [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				242
Investments at fair value				$ 294
Number of Shares (in shares)				500,000
Investment, Unaffiliated Issuer [Member] | Data Storage Sector [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 175
Investments at fair value				$ 124
Number of Shares (in shares)				394,110
Investment, Unaffiliated Issuer [Member] | Internet and Media Sector [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 75
Investments at fair value				$ 63
Number of Shares (in shares)				245,810
Investment, Unaffiliated Issuer [Member] | Internet and Media Sector [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 92
Investments at fair value				$ 318
Number of Shares (in shares)				261,721
Investment, Unaffiliated Issuer [Member] | Internet and Media Sector [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 162
Investments at fair value				$ 1,201
Number of Shares (in shares)				139,074
Investment, Unaffiliated Issuer [Member] | Power Management Sector [Member] | Halio, Inc [Member] | Common Stock Warrants [Member]
Investments at cost				$ 1,585
Investments at fair value				$ 2,700
Number of Shares (in shares)				38,241,466
Investment, Unaffiliated Issuer [Member] | Semiconductor Sector [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost				$ 45
Investments at fair value
Number of Shares (in shares)				5,938
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				14%
Margin				5.50%
Floor				9.50%
Ceiling				0%
ETP				3%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 7,000
Investments at cost				6,684
Investments at fair value				$ 6,684
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				14%
Margin				5.50%
Floor				9.50%
Ceiling				0%
ETP				3%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,463
Investments at fair value				$ 3,463
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				14%
Margin				5.50%
Floor				9.50%
Ceiling				0%
ETP				3%
Maturity Date				Aug. 01, 2027
Principal Amount				$ 3,500
Investments at cost				3,463
Investments at fair value				$ 3,463
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				14%
Margin				5.50%
Floor				9.50%
Ceiling				0%
ETP				3%
Maturity Date				Apr. 01, 2028
Principal Amount				$ 2,750
Investments at cost				2,710
Investments at fair value				$ 2,710
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2027
Principal Amount				$ 10,000
Investments at cost				9,656
Investments at fair value				$ 9,656
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,925
Investments at fair value				$ 4,925
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,925
Investments at fair value				$ 4,925
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate				12%
Margin				3.50%
Floor				11.75%
Ceiling				0%
ETP				4%
Maturity Date				Oct. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,925
Investments at fair value				$ 4,925
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate				11.75%
Margin				3.25%
Floor				11%
Ceiling				0%
ETP				5%
Maturity Date				Jun. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,648
Investments at fair value				$ 4,648
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate				11.75%
Margin				3.25%
Floor				11%
Ceiling				0%
ETP				5%
Maturity Date				Jun. 01, 2027
Principal Amount				$ 5,000
Investments at cost				4,918
Investments at fair value				4,918
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Castle Creek Biosciences, Inc [Member]
Investments at cost		250
Investments at fair value		$ 250
Number of Shares (in shares)		1,162
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Emalex Biosciences, Inc. [Member]
Investments at cost		$ 356
Investments at fair value		$ 356
Number of Shares (in shares)		32,831
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Lumithera, Inc. [Member]
Investments at cost		$ 2,000
Investments at fair value		$ 1,700
Number of Shares (in shares)		392,651
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments at cost
Investments at fair value		$ 546
Number of Shares (in shares)		600,000
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Getaround, Inc [Member]
Investments at cost		$ 253
Investments at fair value		$ 5
Number of Shares (in shares)		87,082
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | SnagAJob.com, Inc [Member]
Investments at cost		$ 7
Investments at fair value		$ 83
Number of Shares (in shares)		82,974
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Tigo Energy, Inc. [Member]
Investments at cost		$ 111
Investments at fair value		$ 11
Number of Shares (in shares)		5,205
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Medical Device Sector [Member] | Lumithera, Inc. [Member]
Investments at cost				2,000
Investments at fair value				$ 1,700
Number of Shares (in shares)				392,651
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Consumer-related Technologies [Member] | Getaround, Inc [Member]
Investments at cost				$ 253
Investments at fair value				$ 20
Number of Shares (in shares)				87,082
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Consumer-related Technologies [Member] | SnagAJob.com, Inc [Member]
Investments at cost				$ 9
Investments at fair value				$ 83
Number of Shares (in shares)				82,974
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Investments at cost				$ 250
Investments at fair value				$ 250
Number of Shares (in shares)				1,162
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member]
Investments at cost				$ 355
Investments at fair value				$ 355
Number of Shares (in shares)				32,831
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments at cost
Investments at fair value				$ 443
Number of Shares (in shares)				600,000
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Other Sustainability Sector [Member] | Tigo Energy, Inc. [Member]
Investments at cost				$ 111
Investments at fair value				$ 13
Number of Shares (in shares)				5,205
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		11.50%
Ceiling		0%
ETP		5%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,777
Investments at fair value		$ 4,777
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,510
Investments at fair value		$ 3,509
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member]
Cash Rate		13.25%
Margin		4.75%
Floor		8.50%
Ceiling		0%
ETP		5%
Maturity Date		Jan. 01, 2027
Principal Amount		$ 3,750
Investments at cost		3,734
Investments at fair value		$ 3,734
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member]
Cash Rate		10.75%
Margin		2.75%
Floor		9.25%
Ceiling		0%
ETP		4%
Maturity Date		Mar. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,817
Investments at fair value		$ 4,817
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 3,750
Investments at cost		3,696
Investments at fair value		$ 3,696
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.25%
Ceiling		0%
ETP		4%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 15,000
Investments at cost		14,719
Investments at fair value		$ 14,117
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,479
Investments at fair value		$ 2,479
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		8.75%
Ceiling		0%
ETP		6%
Maturity Date		Aug. 01, 2026
Principal Amount		$ 3,611
Investments at cost		3,584
Investments at fair value		$ 3,356
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Spineology, Inc [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		1%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,911
Investments at fair value		$ 4,911
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member]
Cash Rate		12.82%
Margin		4.82%
Floor		9.25%
Ceiling		0%
ETP		10.36%
Maturity Date		Jul. 01, 2025
Principal Amount		$ 3,477
Investments at cost		3,448
Investments at fair value		$ 3,448
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member]
Cash Rate		13%
Margin		4.50%
Floor		12%
Ceiling		0%
ETP		2%
Maturity Date		Sep. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,916
Investments at fair value		$ 4,916
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.50%
Maturity Date		Aug. 01, 2025
Principal Amount		$ 833
Investments at cost		828
Investments at fair value		$ 828
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member]
Cash Rate		13%
Margin		5%
Floor		5%
Ceiling		0%
ETP		10.40%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 2,000
Investments at cost		1,467
Investments at fair value		$ 1,467
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | CAMP NYC, Inc [Member]
Cash Rate		15.25%
Margin		7.25%
Floor		10.50%
Ceiling		0%
ETP		3%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 2,033
Investments at cost		1,980
Investments at fair value		$ 1,922
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jul. 01, 2028
Principal Amount		$ 2,603
Investments at cost		2,692
Investments at fair value		$ 2,341
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 5,908
Investments at cost		5,489
Investments at fair value		$ 3,256
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member]
Cash Rate		14.75%
Margin		6.25%
Floor		9.50%
Ceiling		0%
ETP		4%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,440
Investments at fair value		$ 2,440
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		12.75%
Ceiling		0%
ETP		3%
Maturity Date		Jun. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,245
Investments at fair value		$ 2,245
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member]
Cash Rate		15.75%
Margin		7.75%
Floor		11%
Ceiling		0%
ETP		0%
Maturity Date		May 01, 2027
Principal Amount		$ 1,361
Investments at cost		1,086
Investments at fair value		$ 228
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Cash Rate		13.25%		13.25%
Margin		4.75%		4.75%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,958		$ 5,000
Investments at cost		3,948		4,979
Investments at fair value		$ 3,948		$ 4,979
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member]
Cash Rate		12.72%		13.22%
Margin		4.72%		4.72%
Floor		9.75%		9.75%
Ceiling		0%		0%
ETP		5%		5%
Maturity Date		Nov. 01, 2025		Jun. 01, 2024
Principal Amount		$ 5,000		$ 1,414
Investments at cost		4,970		1,410
Investments at fair value		$ 4,970		$ 1,410
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member]
Cash Rate		12.75%		13.25%
Margin		4.75%		4.75%
Floor		8.50%		8.50%
Ceiling		0%		0%
ETP		5.50%		5.50%
Maturity Date		May 01, 2027		May 01, 2027
Principal Amount		$ 6,250		$ 6,250
Investments at cost		6,215		6,199
Investments at fair value		$ 6,215		$ 6,199
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member]
Cash Rate		13.25%		13.75%
Margin		5.25%		5.25%
Floor		8.50%		8.50%
Ceiling		0%		0%
ETP		5%		5%
Maturity Date		Nov. 01, 2026		Nov. 01, 2026
Principal Amount		$ 3,250		$ 3,750
Investments at cost		3,234		3,716
Investments at fair value		$ 3,234		$ 3,716
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member]
Cash Rate		13.75%		14.25%
Margin		5.75%		5.75%
Floor		9%		9%
Ceiling		0%		0%
ETP		3%		3%
Maturity Date		Jul. 01, 2025		Jul. 01, 2025
Principal Amount		$ 1,667		$ 3,000
Investments at cost		1,624		2,914
Investments at fair value		$ 1,624		$ 2,870
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member]
Cash Rate		13.75%		14.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0%		0%
ETP		3.75%		3.75%
Maturity Date		Sep. 01, 2026		Sep. 01, 2026
Principal Amount		$ 10,000		$ 10,000
Investments at cost		9,950		9,911
Investments at fair value		$ 9,950		$ 9,911
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Cash Rate		13.36%		13.86%
Margin		5.36%		5.36%
Floor		9.50%		9.50%
Ceiling		0%		0%
ETP		4.30%		5.50%
Maturity Date		Jan. 01, 2027		Dec. 01, 2024
Principal Amount		$ 3,482		$ 4,666
Investments at cost		3,410		4,579
Investments at fair value		$ 3,218		$ 4,414
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member]
Cash Rate		13.50%		14%
Margin		5.50%		5.50%
Floor		8.75%		8.75%
Ceiling		0%		0%
ETP		6%		6%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 2,631		$ 4,250
Investments at cost		2,598		4,193
Investments at fair value		$ 2,598		$ 4,193
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member]
Cash Rate		12.25%		12.75%
Margin		4.25%		4.25%
Floor		12.25%		12.25%
Ceiling		0%		0%
ETP		4%		4%
Maturity Date		Aug. 01, 2027		Aug. 01, 2027
Principal Amount		$ 2,500		$ 2,500
Investments at cost		2,468		2,230
Investments at fair value		$ 2,468		$ 2,230
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		10.25%
Ceiling		0%
ETP		4%
Maturity Date		Apr. 01, 2026
Principal Amount		$ 10,000
Investments at cost		9,946
Investments at fair value		$ 9,946
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | BrightInsight, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		9.50%
Ceiling		0%
ETP		3%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 7,000
Investments at cost		6,814
Investments at fair value		$ 6,814
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | DropOff, Inc. [Member]
Cash Rate		14.50%
Margin		6.50%
Floor		9.75%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 6,804
Investments at cost		6,729
Investments at fair value		$ 6,337
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		3%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 10,000
Investments at cost		9,916
Investments at fair value		$ 9,916
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Reputation Institute, Inc [Member]
Cash Rate		15.75%
Margin		7.25%
Floor		10.50%
Ceiling		0%
ETP		3%
Maturity Date		Aug. 01, 2025
Principal Amount		$ 1,933
Investments at cost		1,901
Investments at fair value		$ 1,901
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Lytics, Inc. [Member]
Cash Rate		14.50%
Margin		6%
Floor		14.25%
Ceiling		0%
ETP		5%
Maturity Date		Nov. 01, 2026
Principal Amount		$ 2,500
Investments at cost		2,479
Investments at fair value		$ 2,479
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member]
Cash Rate		11.75%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 10,000
Investments at cost		9,783
Investments at fair value		$ 9,783
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Mirantis, Inc [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,929
Investments at fair value		$ 4,929
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | SafelyYou, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11%
Ceiling		0%
ETP		5%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,791
Investments at fair value		$ 4,791
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Viken Detection Corporation [Member]
Cash Rate		12%
Margin		4%
Floor		11.75%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,951
Investments at fair value		$ 4,951
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		12%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,476
Investments at fair value		$ 2,476
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		14%
Ceiling		0%
ETP		3%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,905
Investments at fair value		$ 4,905
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member]
Cash Rate		14%
Margin		6%
Floor		9.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 1,607
Investments at cost		1,577
Investments at fair value		$ 1,034
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member]
Cash Rate		11.75%
Margin		3.25%
Floor		11.50%
Ceiling		0%
ETP		5%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,652
Investments at fair value		$ 4,652
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		4.33%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 3,750
Investments at cost		3,712
Investments at fair value		$ 3,712
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.75%
Maturity Date		Apr. 01, 2026
Principal Amount		$ 5,000
Investments at cost		4,937
Investments at fair value		$ 4,937
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.50%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,703
Investments at fair value		$ 3,703
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2029
Principal Amount		$ 3,750
Investments at cost		3,592
Investments at fair value		$ 3,592
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,851
Investments at fair value		$ 4,851
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member]
Cash Rate		12%
Margin		4%
Floor		12%
Ceiling		0%
ETP		4%
Maturity Date		Feb. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,739
Investments at fair value		$ 4,739
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Networking Sector [Member] | Fictiv, Inc. [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		10%
Ceiling		0%
ETP		4%
Maturity Date		Apr. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,703
Investments at fair value		$ 4,703
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		100%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 300
Investments at cost		300
Investments at fair value		$ 300
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,711
Investments at fair value		$ 3,711
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 2,954
Investments at cost		2,745
Investments at fair value		$ 1,628
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Cash Rate		13.25%		13.25%
Margin		4.75%		4.75%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,958		$ 5,000
Investments at cost		3,949		4,979
Investments at fair value		$ 3,949		$ 4,979
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Cash Rate		13.36%		13.86%
Margin		5.36%		5.36%
Floor		9.50%		9.50%
Ceiling		0%		0%
ETP		4.31%		5.50%
Maturity Date		Jan. 01, 2027		Dec. 01, 2024
Principal Amount		$ 1,741		$ 2,333
Investments at cost		1,699		2,278
Investments at fair value		$ 1,604		$ 2,196
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		12%
Ceiling		0%
ETP		2.50%
Maturity Date		Jul. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,983
Investments at fair value		$ 4,983
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		14%
Ceiling		0%
ETP		3%
Maturity Date		Apr. 01, 2029
Principal Amount		$ 2,500
Investments at cost		2,467
Investments at fair value		$ 2,467
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		11.75%
Ceiling		0%
ETP		2.75%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 5,000
Investments at cost		4,946
Investments at fair value		$ 4,946
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.50%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,700
Investments at fair value		$ 3,700
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,951
Investments at fair value		$ 4,951
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		11.50%
Ceiling		0%
ETP		5%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,464
Investments at fair value		$ 2,464
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,475
Investments at fair value		$ 3,474
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member]
Cash Rate		13.25%
Margin		4.75%
Floor		8.50%
Ceiling		0%
ETP		5%
Maturity Date		Jan. 01, 2027
Principal Amount		$ 3,750
Investments at cost		3,733
Investments at fair value		$ 3,733
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member]
Cash Rate		10.75%
Margin		2.75%
Floor		9.25%
Ceiling		0%
ETP		4%
Maturity Date		Mar. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,938
Investments at fair value		$ 4,938
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 3,750
Investments at cost		3,696
Investments at fair value		$ 3,696
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.25%
Ceiling		0%
ETP		4%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 10,000
Investments at cost		9,813
Investments at fair value		$ 9,411
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,479
Investments at fair value		$ 2,479
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		8.75%
Ceiling		0%
ETP		6%
Maturity Date		Aug. 01, 2026
Principal Amount		$ 1,806
Investments at cost		1,792
Investments at fair value		$ 1,678
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Spineology, Inc [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		1%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 4,250
Investments at cost		4,174
Investments at fair value		$ 4,174
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member]
Cash Rate		12.82%
Margin		4.82%
Floor		9.25%
Ceiling		0%
ETP		10.36%
Maturity Date		Jul. 01, 2025
Principal Amount		$ 3,477
Investments at cost		3,448
Investments at fair value		$ 3,448
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member]
Cash Rate		13%
Margin		4.50%
Floor		12%
Ceiling		0%
ETP		2%
Maturity Date		Sep. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,916
Investments at fair value		$ 4,916
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.50%
Maturity Date		Aug. 01, 2025
Principal Amount		$ 833
Investments at cost		828
Investments at fair value		$ 828
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member]
Cash Rate		13%
Margin		5%
Floor		5%
Ceiling		0%
ETP		10.40%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 3,000
Investments at cost		2,441
Investments at fair value		$ 2,441
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 2,363
Investments at cost		2,196
Investments at fair value		$ 1,303
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member]
Cash Rate		14.75%
Margin		6.25%
Floor		9.50%
Ceiling		0%
ETP		4%
Maturity Date		Jul. 01, 2028
Principal Amount		$ 1,875
Investments at cost		1,800
Investments at fair value		$ 1,800
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member]
Cash Rate		12.75%
Margin		4.25%
Floor		12.75%
Ceiling		0%
ETP		3%
Maturity Date		Jun. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,421
Investments at fair value		$ 2,421
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member]
Cash Rate		15.75%
Margin		7.75%
Floor		11%
Ceiling		0%
ETP		0%
Maturity Date		May 01, 2027
Principal Amount		$ 680
Investments at cost		543
Investments at fair value		$ 114
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Cash Rate		13.25%		13.25%
Margin		4.75%		4.75%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,958		$ 5,000
Investments at cost		3,948		4,979
Investments at fair value		$ 3,948		$ 4,979
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member]
Cash Rate		12.72%		13.22%
Margin		4.72%		4.72%
Floor		9.75%		9.75%
Ceiling		0%		0%
ETP		5%		5%
Maturity Date		May 01, 2026		Jun. 01, 2024
Principal Amount		$ 5,000		$ 1,414
Investments at cost		4,975		1,410
Investments at fair value		$ 4,975		$ 1,410
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member]
Cash Rate		12.75%		13.25%
Margin		4.75%		4.75%
Floor		8.50%		8.50%
Ceiling		0%		0%
ETP		5.50%		5.50%
Maturity Date		May 01, 2027		May 01, 2027
Principal Amount		$ 6,250		$ 6,250
Investments at cost		6,215		6,199
Investments at fair value		$ 6,215		$ 6,199
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member]
Cash Rate		13.25%		13.75%
Margin		5.25%		5.25%
Floor		8.50%		8.50%
Ceiling		0%		0%
ETP		5%		5%
Maturity Date		Nov. 01, 2026		Nov. 01, 2026
Principal Amount		$ 2,167		$ 2,500
Investments at cost		2,156		2,478
Investments at fair value		$ 2,156		$ 2,478
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member]
Cash Rate		13.75%		14.25%
Margin		5.75%		5.75%
Floor		9%		9%
Ceiling		0%		0%
ETP		3%		3%
Maturity Date		Jul. 01, 2025		Jul. 01, 2025
Principal Amount		$ 833		$ 1,500
Investments at cost		812		1,458
Investments at fair value		$ 812		$ 1,436
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member]
Cash Rate		13.75%		14.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0%		0%
ETP		3.75%		3.75%
Maturity Date		Sep. 01, 2026		Sep. 01, 2026
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,731		3,717
Investments at fair value		$ 3,731		$ 3,717
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Cash Rate		13.36%		13.86%
Margin		5.36%		5.36%
Floor		9.50%		9.50%
Ceiling		0%		0%
ETP		4.30%		5.50%
Maturity Date		Jan. 01, 2027		Dec. 01, 2024
Principal Amount		$ 3,482		$ 4,666
Investments at cost		3,410		4,579
Investments at fair value		$ 3,218		$ 4,414
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member]
Cash Rate		13.50%		14%
Margin		5.50%		5.50%
Floor		8.75%		8.75%
Ceiling		0%		0%
ETP		6%		6%
Maturity Date		Oct. 01, 2025		Oct. 01, 2025
Principal Amount		$ 1,315
Investments at cost		1,299		2,096
Investments at fair value		$ 1,299		$ 2,096
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		12.25%
Ceiling		0%
ETP		4%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,468
Investments at fair value		$ 2,468
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		10.25%
Ceiling		0%
ETP		4%
Maturity Date		Apr. 01, 2026
Principal Amount		$ 10,000
Investments at cost		9,946
Investments at fair value		$ 9,946
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | BrightInsight, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		9.50%
Ceiling		0%
ETP		3%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,473
Investments at fair value		$ 3,473
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | DropOff, Inc. [Member]
Cash Rate		14.50%
Margin		6.50%
Floor		9.75%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 6,280
Investments at cost		6,211
Investments at fair value		$ 5,849
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		3%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,958
Investments at fair value		$ 4,958
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Lytics, Inc. [Member]
Cash Rate		14.50%
Margin		6%
Floor		14.25%
Ceiling		0%
ETP		5%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 1,250
Investments at cost		1,242
Investments at fair value		$ 1,242
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member]
Cash Rate		11.75%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,940
Investments at fair value		$ 4,940
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Mirantis, Inc [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,929
Investments at fair value		$ 4,929
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | SafelyYou, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11%
Ceiling		0%
ETP		5%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,938
Investments at fair value		$ 4,938
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Viken Detection Corporation [Member]
Cash Rate		12%
Margin		4%
Floor		11.75%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,476
Investments at fair value		$ 2,476
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		12%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2028
Principal Amount		$ 3,500
Investments at cost		3,491
Investments at fair value		$ 3,491
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		14%
Ceiling		0%
ETP		3%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,471
Investments at fair value		$ 2,471
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Communications Sector [Member] | Axiom Space, Inc [Member]
Cash Rate		14.50%
Margin		6%
Floor		9.25%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 4,375
Investments at cost		4,353
Investments at fair value		$ 4,353
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member]
Cash Rate		14%
Margin		6%
Floor		9.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 1,607
Investments at cost		1,577
Investments at fair value		$ 1,034
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member]
Cash Rate		11.75%
Margin		3.25%
Floor		11.50%
Ceiling		0%
ETP		5%
Maturity Date		Jan. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,903
Investments at fair value		$ 4,903
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.75%
Maturity Date		Apr. 01, 2026
Principal Amount		$ 2,500
Investments at cost		2,469
Investments at fair value		$ 2,469
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.50%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,703
Investments at fair value		$ 3,703
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2029
Principal Amount		$ 3,750
Investments at cost		3,692
Investments at fair value		$ 3,692
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,951
Investments at fair value		$ 4,951
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member]
Cash Rate		12%
Margin		4%
Floor		12%
Ceiling		0%
ETP		4%
Maturity Date		Feb. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,948
Investments at fair value		$ 4,948
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Networking Sector [Member] | Fictiv, Inc. [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		10%
Ceiling		0%
ETP		4%
Maturity Date		Apr. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,938
Investments at fair value		$ 4,938
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		100%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 150
Investments at cost		150
Investments at fair value		$ 150
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,711
Investments at fair value		$ 3,711
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 2,954
Investments at cost		2,745
Investments at fair value		$ 1,628
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Cash Rate		13.25%		13.25%
Margin		4.75%		4.75%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 2,375		$ 3,000
Investments at cost		2,369		2,987
Investments at fair value		$ 2,369		$ 2,987
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Cash Rate		13.36%		13.86%
Margin		5.36%		5.36%
Floor		9.50%		9.50%
Ceiling		0%		0%
ETP		4.31%		5.50%
Maturity Date		Jan. 01, 2027		Dec. 01, 2024
Principal Amount		$ 1,741		$ 2,333
Investments at cost		1,699		2,278
Investments at fair value		$ 1,604		2,196
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		11.75%
Ceiling		0%
ETP		2.75%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 2,500
Investments at cost		2,473
Investments at fair value		$ 2,473
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14%
Margin		6%
Floor		10%
Ceiling		0%
ETP		2%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 4,500
Investments at cost		4,452
Investments at fair value		4,452
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member]
Investments at cost		0
Investments at fair value		$ 0
Number of Shares (in shares)		30,585
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Medical Device Sector [Member] | AccuVein Inc [Member]
Investments at cost		$ 7
Investments at fair value		$ 0
Number of Shares (in shares)		271
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Medical Device Sector [Member] | CVRx, Inc [Member]
Investments at cost		$ 76
Investments at fair value		$ 50
Number of Shares (in shares)		47,410
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member]
Investments at cost		$ 311
Investments at fair value		$ 0
Number of Shares (in shares)		117
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member]
Investments at cost		$ 64
Investments at fair value		$ 0
Number of Shares (in shares)		19,671
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member]
Investments at cost		$ 146
Investments at fair value		$ 0
Number of Shares (in shares)		16,611
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member]
Investments at cost		$ 160
Investments at fair value		$ 316
Number of Shares (in shares)		299,848
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Investments at cost		$ 278
Investments at fair value		$ 0
Number of Shares (in shares)		175,098
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member]
Investments at cost		$ 265
Investments at fair value		$ 110
Number of Shares (in shares)		318,181
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member]
Investments at cost		$ 73
Investments at fair value		$ 64
Number of Shares (in shares)		126,000
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Life Science Segment [Member] | Spineology, Inc [Member]
Investments at cost		$ 143
Investments at fair value		$ 108
Number of Shares (in shares)		2,714,033
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Axiom Space, Inc [Member]
Investments at cost		$ 46
Investments at fair value		$ 57
Number of Shares (in shares)		1,991
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | DropOff, Inc. [Member]
Investments at cost		$ 455
Investments at fair value		$ 90
Number of Shares (in shares)		516,732
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Havenly, Inc. [Member]
Investments at cost		$ 3,178
Investments at fair value		$ 2,489
Number of Shares (in shares)		1,446,429
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member]
Investments at cost		$ 79
Investments at fair value		$ 55
Number of Shares (in shares)		9,801
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member]
Investments at cost		$ 188
Investments at fair value
Number of Shares (in shares)		12,618
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Mirantis, Inc [Member]
Investments at cost		$ 223
Investments at fair value		$ 240
Number of Shares (in shares)		948,275
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Fictiv, Inc. [Member]
Investments at cost		$ 59
Investments at fair value		$ 74
Number of Shares (in shares)		126,841
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Halio, Inc [Member]
Investments at cost		$ 1,585
Investments at fair value		$ 2,700
Number of Shares (in shares)		38,241,466
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | E La Carte, Inc [Member]
Investments at cost		$ 60
Investments at fair value
Number of Shares (in shares)		147,361
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member]
Investments at cost		$ 71
Investments at fair value		$ 15
Number of Shares (in shares)		32,244
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member]
Investments at cost		$ 20
Investments at fair value		$ 19
Number of Shares (in shares)		65
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member]
Investments at cost		$ 152
Investments at fair value		$ 131
Number of Shares (in shares)		93,336
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member]
Investments at cost		$ 147
Investments at fair value		$ 192
Number of Shares (in shares)		231,050
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member]
Investments at cost		$ 162
Investments at fair value		$ 13
Number of Shares (in shares)		4,635,992
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member]
Investments at cost		$ 256
Investments at fair value		$ 197
Number of Shares (in shares)		9,313,541
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member]
Investments at cost		$ 231
Investments at fair value		$ 169
Number of Shares (in shares)		5,361,130
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member]
Investments at cost		$ 66
Investments at fair value		$ 1,048
Number of Shares (in shares)		1,818,183
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member]
Investments at cost		$ 48
Investments at fair value		$ 9
Number of Shares (in shares)		8,800
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member]
Investments at cost		$ 87
Investments at fair value		$ 171
Number of Shares (in shares)		12,153
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member]
Investments at cost		$ 174
Investments at fair value		$ 471
Number of Shares (in shares)		4,917,794
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Investments at cost		$ 214
Investments at fair value		$ 169
Number of Shares (in shares)		7,404
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member]
Investments at cost		$ 176
Investments at fair value		$ 127
Number of Shares (in shares)		110,402
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member]
Investments at cost		$ 49
Investments at fair value		$ 53
Number of Shares (in shares)		48,076
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member]
Investments at cost		$ 64
Investments at fair value		$ 58
Number of Shares (in shares)		103,679
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Investments at cost		$ 312
Investments at fair value		$ 222
Number of Shares (in shares)		709,981
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member]
Investments at cost		$ 195
Investments at fair value		$ 167
Number of Shares (in shares)		1,600,002
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Swift Health Systems Inc. [Member]
Investments at cost		$ 71
Investments at fair value
Number of Shares (in shares)		135,484
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Magnolia Medical Technologies, Inc [Member]
Investments at cost		$ 194
Investments at fair value		$ 304
Number of Shares (in shares)		809,931
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Meditrina, Inc [Member]
Investments at cost		$ 83
Investments at fair value		$ 29
Number of Shares (in shares)		233,993
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Scientia Vascular, Inc. [Member]
Investments at cost		$ 103
Investments at fair value		$ 273
Number of Shares (in shares)		34,410
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | MicroTransponder, Inc. [Member]
Investments at cost		$ 48
Investments at fair value		$ 48
Number of Shares (in shares)		103,172
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | VERO Biotech LLC [Member]
Investments at cost		$ 432
Investments at fair value		$ 196
Number of Shares (in shares)		4,109
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Sonex Health, Inc. [Member]
Investments at cost		$ 275
Investments at fair value		$ 262
Number of Shares (in shares)		2,637,133
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Spineology, Inc [Member]
Investments at cost		$ 16
Investments at fair value		$ 27
Number of Shares (in shares)		2,255,155
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Clara Foods Co [Member]
Investments at cost		$ 30
Investments at fair value		$ 121
Number of Shares (in shares)		46,745
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Kodiak Robotics, Inc. [Member]
Investments at cost		$ 273
Investments at fair value		$ 9
Number of Shares (in shares)		639,918
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Noodle Partners, Inc. [Member]
Investments at cost		$ 116
Investments at fair value
Number of Shares (in shares)		84,037
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Reputation Institute, Inc [Member]
Investments at cost		$ 63
Investments at fair value		$ 33
Number of Shares (in shares)		4,104
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Revinate Holdings, Inc [Member]
Investments at cost		$ 44
Investments at fair value		$ 90
Number of Shares (in shares)		682,034
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | CAMP NYC, Inc [Member]
Investments at cost		$ 36
Investments at fair value		$ 39
Number of Shares (in shares)		112,356
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Lytics, Inc. [Member]
Investments at cost		$ 43
Investments at fair value
Number of Shares (in shares)		85,543
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | SIGNiX, Inc [Member]
Investments at cost		$ 225
Investments at fair value
Number of Shares (in shares)		186,235
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Slingshot Aerospace, Inc. [Member]
Investments at cost		$ 123
Investments at fair value		$ 79
Number of Shares (in shares)		309,208
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Supply Network Visiblity Holdings LLC [Member]
Investments at cost		$ 65
Investments at fair value		$ 75
Number of Shares (in shares)		682
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member]
Investments at cost		$ 454
Investments at fair value		$ 622
Number of Shares (in shares)		53,264
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member]
Investments at cost		$ 9
Investments at fair value
Number of Shares (in shares)		3,913,723
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Topia Mobility, Inc [Member]
Investments at cost		$ 137
Investments at fair value
Number of Shares (in shares)		3,049,607
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Viken Detection Corporation [Member]
Investments at cost		$ 120
Investments at fair value		$ 203
Number of Shares (in shares)		345,443
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | xAd, Inc [Member]
Investments at cost		$ 176
Investments at fair value		$ 7
Number of Shares (in shares)		4,343,348
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Lemongrass Holdings, Inc [Member]
Investments at cost		$ 34
Investments at fair value		$ 83
Number of Shares (in shares)		101,308
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Intelepeer Holdings, Inc [Member]
Investments at cost		$ 137
Investments at fair value		$ 2,100
Number of Shares (in shares)		2,936,535
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Alula Holdings, Inc [Member]
Investments at cost		$ 93
Investments at fair value		$ 7
Number of Shares (in shares)		20,000
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Optoro, Inc. [Member]
Investments at cost		$ 181
Investments at fair value		$ 144
Number of Shares (in shares)		11,550
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Standvast Holdings, LLC [Member]
Investments at cost		$ 275
Investments at fair value		$ 258
Number of Shares (in shares)		1,225,492
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Unagi, Inc [Member]
Investments at cost		$ 29
Investments at fair value
Number of Shares (in shares)		171,081
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | MyForest Foods Co [Member]
Investments at cost		$ 28
Investments at fair value		$ 24
Number of Shares (in shares)		250
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Primary Kids, Inc [Member]
Investments at cost		$ 57
Investments at fair value		$ 587
Number of Shares (in shares)		553,778
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Britecore Holdings, Inc. [Member]
Investments at cost		$ 98
Investments at fair value		$ 254
Number of Shares (in shares)		161,215
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Quip NYC Inc [Member]
Investments at cost		$ 325
Investments at fair value
Number of Shares (in shares)		6,191
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Lotame Solutions, Inc. [Member]
Investments at cost		$ 18
Investments at fair value		$ 40
Number of Shares (in shares)		71,305
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Updater, Inc [Member]
Investments at cost		$ 34
Investments at fair value		$ 26
Number of Shares (in shares)		108,333
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | CPG Beyond, Inc [Member]
Investments at cost		$ 242
Investments at fair value		$ 290
Number of Shares (in shares)		500,000
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Silk, Inc [Member]
Investments at cost		$ 175
Investments at fair value		$ 119
Number of Shares (in shares)		394,110
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Global Worldwide LLC [Member]
Investments at cost		$ 75
Investments at fair value
Number of Shares (in shares)		245,810
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Rocket Lawyer Incorporated [Member]
Investments at cost		$ 92
Investments at fair value		$ 313
Number of Shares (in shares)		261,721
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Skillshare, Inc [Member]
Investments at cost		$ 162
Investments at fair value		$ 671
Number of Shares (in shares)		139,074
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Liqid, Inc [Member]
Investments at cost		$ 364
Investments at fair value		$ 103
Number of Shares (in shares)		344,102
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Avalanche Technology, Inc [Member]
Investments at cost		$ 45
Investments at fair value
Number of Shares (in shares)		5,938
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Everstream Holdings, LLC [Member]
Investments at cost		$ 70
Investments at fair value		$ 21
Number of Shares (in shares)		350,000
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | BrightInsight, Inc. [Member]
Investments at cost		$ 167
Investments at fair value
Number of Shares (in shares)		85,066
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Hound Labs, Inc. [Member]
Investments at cost		$ 45
Investments at fair value
Number of Shares (in shares)		451,796
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member]
Investments at cost		$ 166
Investments at fair value		$ 47
Number of Shares (in shares)		184,253
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Elligo Healthcare Research, Inc. [Member]
Investments at cost		$ 191
Investments at fair value		$ 85
Number of Shares (in shares)		652,250
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Kate Farms, Inc [Member]
Investments at cost		$ 103
Investments at fair value		$ 777
Number of Shares (in shares)		82,965
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Medsphere Systems Corporation [Member]
Investments at cost		$ 61
Investments at fair value
Number of Shares (in shares)		7,097,792
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | SafelyYou, Inc [Member]
Investments at cost		$ 163
Investments at fair value		$ 11
Number of Shares (in shares)		150,353
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | GT Medical Technologies, Inc. [Member]
Investments at cost		$ 85
Investments at fair value		$ 86
Number of Shares (in shares)		255,871
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member]
Investments at cost		$ 82
Investments at fair value		$ 69
Number of Shares (in shares)		400,000
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | LiquiGlide, Inc [Member]
Investments at cost		$ 40
Investments at fair value		$ 25
Number of Shares (in shares)		61,359
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member]
Investments at cost		$ 382
Investments at fair value		$ 489
Number of Shares (in shares)		1,103
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | Temperpack Technologies, Inc [Member]
Investments at cost		$ 178
Investments at fair value		$ 91
Number of Shares (in shares)		49,693
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | Pivot Bio, Inc. [Member]
Investments at cost		$ 14
Investments at fair value		$ 14
Number of Shares (in shares)		210,418
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member]
Investments at cost		$ 8,886		6,132
Investments at fair value		$ 7,488		$ 4,733
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		11.50%
Ceiling		0%
ETP		5%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,464
Investments at fair value		$ 2,464
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,469
Investments at fair value		$ 3,468
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jan. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,959
Investments at fair value		$ 4,959
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member]
Cash Rate		10.75%
Margin		2.75%
Floor		9.25%
Ceiling		0%
ETP		4%
Maturity Date		Mar. 01, 2029
Principal Amount		$ 4,000
Investments at cost		3,950
Investments at fair value		$ 3,950
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.25%
Ceiling		0%
ETP		4%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,907
Investments at fair value		$ 4,706
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,957
Investments at fair value		$ 4,957
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Spineology, Inc [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		1%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 4,250
Investments at cost		4,174
Investments at fair value		$ 4,174
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member]
Cash Rate		13%
Margin		4.50%
Floor		12%
Ceiling		0%
ETP		2%
Maturity Date		Sep. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,916
Investments at fair value		$ 4,916
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		10.50%
Ceiling		0%
ETP		7.78%
Maturity Date		Feb. 01, 2028
Principal Amount		$ 2,813
Investments at cost		2,813
Investments at fair value		$ 2,813
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 2,954
Investments at cost		2,745
Investments at fair value		$ 1,628
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member]
Cash Rate		15.75%
Margin		7.75%
Floor		11%
Ceiling		0%
ETP		0%
Maturity Date		May 01, 2027
Principal Amount		$ 680
Investments at cost		543
Investments at fair value		$ 114
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Cash Rate		13.25%		13.25%
Margin		4.75%		4.75%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 2,375		$ 3,000
Investments at cost		2,368		2,987
Investments at fair value		$ 2,368		$ 2,987
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member]
Cash Rate				13.22%
Margin				4.72%
Floor				9.75%
Ceiling				0%
ETP				5%
Maturity Date				Nov. 01, 2025
Principal Amount				$ 5,000
Investments at cost				4,950
Investments at fair value				$ 4,950
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member]
Cash Rate		13.75%		14.25%
Margin		5.75%		5.75%
Floor		9.75%		9.75%
Ceiling		0%		0%
ETP		3.75%		3.75%
Maturity Date		Sep. 01, 2026		Sep. 01, 2026
Principal Amount		$ 3,750		$ 3,750
Investments at cost		3,731		3,717
Investments at fair value		$ 3,731		$ 3,717
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Cash Rate		13.36%		13.86%
Margin		5.36%		5.36%
Floor		9.50%		9.50%
Ceiling		0%		0%
ETP		4.31%		5.50%
Maturity Date		Jan. 01, 2027		Dec. 01, 2024
Principal Amount		$ 1,741		$ 2,333
Investments at cost		1,701		2,281
Investments at fair value		$ 1,605		2,199
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		10.25%
Ceiling		0%
ETP		4%
Maturity Date		Apr. 01, 2026
Principal Amount		$ 5,000
Investments at cost		4,973
Investments at fair value		$ 4,973
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | BrightInsight, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		9.50%
Ceiling		0%
ETP		3%
Maturity Date		Aug. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,473
Investments at fair value		$ 3,473
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | DropOff, Inc. [Member]
Cash Rate		14.50%
Margin		6.50%
Floor		9.75%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 2,617
Investments at cost		2,590
Investments at fair value		$ 2,439
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		3%
Maturity Date		Mar. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,958
Investments at fair value		$ 4,958
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Lytics, Inc. [Member]
Cash Rate		14.50%
Margin		6%
Floor		14.25%
Ceiling		0%
ETP		5%
Maturity Date		Apr. 01, 2027
Principal Amount		$ 1,000
Investments at cost		996
Investments at fair value		$ 996
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member]
Cash Rate		11.75%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,940
Investments at fair value		$ 4,940
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Mirantis, Inc [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,929
Investments at fair value		$ 4,929
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Viken Detection Corporation [Member]
Cash Rate		12%
Margin		4%
Floor		11.75%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2027
Principal Amount		$ 2,500
Investments at cost		2,476
Investments at fair value		$ 2,476
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		12%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,493
Investments at fair value		$ 2,493
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		14%
Ceiling		0%
ETP		3%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,471
Investments at fair value		$ 2,471
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Communications Sector [Member] | Axiom Space, Inc [Member]
Cash Rate		14.50%
Margin		6%
Floor		9.25%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 4,375
Investments at cost		4,353
Investments at fair value		$ 4,353
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member]
Cash Rate		14%
Margin		6%
Floor		9.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 3,214
Investments at cost		3,151
Investments at fair value		$ 2,068
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		4.33%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 3,750
Investments at cost		3,712
Investments at fair value		$ 3,712
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.75%
Maturity Date		May 01, 2026
Principal Amount		$ 5,000
Investments at cost		4,938
Investments at fair value		$ 4,938
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.50%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 7,500
Investments at cost		7,400
Investments at fair value		$ 7,400
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2029
Principal Amount		$ 7,500
Investments at cost		7,384
Investments at fair value		$ 7,384
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,951
Investments at fair value		$ 4,951
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		0%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 200
Investments at cost		200
Investments at fair value		$ 200
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,711
Investments at fair value		$ 3,711
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 5,908
Investments at cost		5,489
Investments at fair value		$ 3,255
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14%
Margin		6%
Floor		10%
Ceiling		0%
ETP		2%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 2,000
Investments at cost		1,979
Investments at fair value		1,979
Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost		17,167		16,400
Investments at fair value		18,735		24,594
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Life Science Segment [Member]
Investments at cost		5,078		4,702
Investments at fair value		4,984		7,675
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Technology Sector [Member]
Investments at cost				9,733
Investments at fair value				14,506
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Other Sustainability Sector [Member]
Investments at cost				999
Investments at fair value				$ 542
Number of Shares (in shares)
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Healthcare Information and Services Segment [Member]
Investments at cost		1,052		$ 966
Investments at fair value		1,021		$ 1,871
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Sustainability Segment [Member]
Investments at cost		716
Investments at fair value		$ 707
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,500
Investments at cost		3,469
Investments at fair value		$ 3,468
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member]
Cash Rate		13.75%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		5%
Maturity Date		Jan. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,927
Investments at fair value		$ 4,927
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member]
Cash Rate		12.25%
Margin		3.75%
Floor		12.25%
Ceiling		0%
ETP		4%
Maturity Date		Jan. 01, 2029
Principal Amount		$ 2,500
Investments at cost		2,453
Investments at fair value		$ 2,353
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,957
Investments at fair value		$ 4,957
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Spineology, Inc [Member]
Cash Rate		13%
Margin		5%
Floor		12%
Ceiling		0%
ETP		1%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 2,500
Investments at cost		2,455
Investments at fair value		$ 2,455
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		10.50%
Ceiling		0%
ETP		7.78%
Maturity Date		Feb. 01, 2028
Principal Amount		$ 2,813
Investments at cost		2,813
Investments at fair value		$ 2,813
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 3,545
Investments at cost		3,294
Investments at fair value		$ 1,953
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member]
Cash Rate		13.25%		13.25%
Margin		4.75%		4.75%
Floor		9.55%		9.55%
Ceiling		13.50%		13.50%
ETP		5.50%		5.50%
Maturity Date		May 01, 2026		May 01, 2026
Principal Amount		$ 3,958		$ 5,000
Investments at cost		3,948		4,979
Investments at fair value		$ 3,948		$ 4,979
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member]
Cash Rate				13.22%
Margin				4.72%
Floor				9.75%
Ceiling				0%
ETP				5%
Maturity Date				May 01, 2026
Principal Amount				$ 5,000
Investments at cost				4,949
Investments at fair value				$ 4,949
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member]
Cash Rate		13.36%		13.86%
Margin		5.36%		5.36%
Floor		9.50%		9.50%
Ceiling		0%		0%
ETP		4.31%		5.50%
Maturity Date		Jan. 01, 2027		Dec. 01, 2024
Principal Amount		$ 1,741		$ 2,333
Investments at cost		1,701		2,281
Investments at fair value		$ 1,605		2,199
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member]
Cash Rate		13.50%
Margin		5.50%
Floor		10.25%
Ceiling		0%
ETP		4%
Maturity Date		Apr. 01, 2026
Principal Amount		$ 5,000
Investments at cost		4,973
Investments at fair value		$ 4,973
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | BrightInsight, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		9.50%
Ceiling		0%
ETP		3%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,750
Investments at cost		2,717
Investments at fair value		$ 2,717
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member]
Cash Rate		11.75%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2027
Principal Amount		$ 5,000
Investments at cost		4,940
Investments at fair value		$ 4,940
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Mirantis, Inc [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		4%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 5,000
Investments at cost		4,929
Investments at fair value		$ 4,929
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member]
Cash Rate		12.25%
Margin		4.25%
Floor		12%
Ceiling		0%
ETP		2.50%
Maturity Date		Jun. 01, 2028
Principal Amount		$ 1,500
Investments at cost		1,496
Investments at fair value		$ 1,496
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member]
Cash Rate		14%
Margin		5.50%
Floor		14%
Ceiling		0%
ETP		3%
Maturity Date		Oct. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,471
Investments at fair value		$ 2,471
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.75%
Maturity Date		May 01, 2026
Principal Amount		$ 2,500
Investments at cost		2,469
Investments at fair value		$ 2,469
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member]
Cash Rate		14.75%
Margin		6.75%
Floor		10%
Ceiling		0%
ETP		2.50%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,700
Investments at fair value		$ 3,700
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member]
Cash Rate		11.25%
Margin		3.25%
Floor		11.25%
Ceiling		0%
ETP		3.50%
Maturity Date		Aug. 01, 2029
Principal Amount		$ 5,000
Investments at cost		4,951
Investments at fair value		4,951
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Axiom Space, Inc [Member]
Investments at cost		261
Investments at fair value		$ 306
Number of Shares (in shares)		1,810
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | NextCar Holding Company, Inc [Member]
Investments at cost		$ 89
Investments at fair value
Number of Shares (in shares)		2,688,971
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | PebblePost, Inc [Member]
Investments at cost		$ 73
Investments at fair value		$ 73
Number of Shares (in shares)		598,850
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Caastle, Inc [Member]
Investments at cost		$ 2,681
Investments at fair value		$ 2,687
Number of Shares (in shares)		242,180
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Decisyon, Inc [Member]
Investments at cost		$ 2,800
Investments at fair value		$ 1,281
Number of Shares (in shares)		280,000
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Lotame Solutions, Inc. [Member]
Investments at cost		$ 5
Investments at fair value		$ 190
Number of Shares (in shares)		66,127
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Investments at cost				89
Investments at fair value				$ 89
Number of Shares (in shares)				2,688,971
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Software Sector [Member] | Decisyon, Inc [Member]
Investments at cost				$ 2,800
Investments at fair value				$ 1,281
Number of Shares (in shares)				280,000
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Software Sector [Member] | Lotame Solutions, Inc. [Member]
Investments at cost				$ 4
Investments at fair value				$ 193
Number of Shares (in shares)				66,127
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Communications Sector [Member] | Axiom Space, Inc [Member]
Investments at cost				$ 261
Investments at fair value				$ 306
Number of Shares (in shares)				1,810
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost		$ 645,930		$ 692,345
Investments at fair value		626,392		664,203
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Life Science Segment [Member]
Investments at cost		263,158
Investments at fair value		260,177
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Technology Sector [Member]
Investments at cost		208,250		275,026
Investments at fair value		194,051		269,790
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Life Science [Member]
Investments at cost				249,642
Investments at fair value				244,815
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Healthcare Information and Services Segment [Member]
Investments at cost		106,542		69,770
Investments at fair value		104,184		69,770
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Sustainability Segment [Member]
Investments at cost		67,980		97,907
Investments at fair value		$ 67,980		79,828
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member]
Cash Rate		13.25%
Margin		5.25%
Floor		9%
Ceiling		0%
ETP		0%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 350
Investments at cost		350
Investments at fair value		$ 350
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member]
Cash Rate		12%
Margin		3.50%
Floor		11.75%
Ceiling		0%
ETP		8%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 3,750
Investments at cost		3,711
Investments at fair value		$ 3,711
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member]
Cash Rate		14.25%
Margin		5.75%
Floor		9%
Ceiling		0%
ETP		5.25%
Maturity Date		Oct. 31, 2023
Principal Amount		$ 2,954
Investments at cost		2,745
Investments at fair value		1,628
Investment, Unaffiliated Issuer [Member] | Other Investments [Member]
Investments at cost		8,418
Investments at fair value		3,347
Investment, Unaffiliated Issuer [Member] | Other Investments [Member] | Life Science [Member]
Investments at cost				1,200
Investments at fair value				$ 200
Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] | Life Science Segment [Member] | Robin Healthcare, Inc. [Member]
Investments at cost		7,271
Investments at fair value		3,247
Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] | Life Science Segment [Member] | Lumithera, Inc. [Member]
Investments at cost		1,147
Investments at fair value		100
Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] | Life Science Segment [Member] | ZetrOZ, Inc [Member]
Investments at cost
Investments at fair value
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index One [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member]
Cash Rate		9%
Margin		0%
Floor		0%
Ceiling		0%
ETP		18%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,477
Investments at fair value		$ 2,205
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index One [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member]
Cash Rate		14%
Margin		0%
Floor		0%
Ceiling		0%
ETP		50%
Maturity Date		Mar. 01, 2025
Principal Amount		$ 300
Investments at cost		300
Investments at fair value		$ 197
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Two [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member]
Cash Rate		9%
Margin		0%
Floor		0%
Ceiling		0%
ETP		18%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,500
Investments at cost		2,477
Investments at fair value		$ 2,205
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Two [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member]
Cash Rate		14%
Margin		0%
Floor		0%
Ceiling		0%
ETP		100%
Maturity Date		Mar. 01, 2025
Principal Amount		$ 250
Investments at cost		250
Investments at fair value		$ 164
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Three [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member]
Cash Rate		9%
Margin		0%
Floor		0%
Ceiling		0%
ETP		18%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 200
Investments at cost		188
Investments at fair value		$ 168
[1]As of September 30, 2023, the Company no longer owns 5% or more of the portfolio company.

Consolidated Schedule of Inve_5

Consolidated Schedule of Investments (Unaudited) - Investments (Details) (Parentheticals)	Sep. 30, 2024	Dec. 31, 2023
NAV %	199.70%	218.90%
Investment, Affiliated Issuer, Controlled [Member]
NAV %	5.70%	4.40%
Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %	2.40%	0.30%
Investment, Unaffiliated Issuer [Member]
NAV %	191.60%	214.20%
Unrestricted Short Term Investments [Member]
NAV %	9.10%	1%
Restricted Short Term Investments [Member]
NAV %	1%	0.80%
Debt Securities [Member] | Investment, Affiliated Issuer, Controlled [Member]
NAV %	2%
Debt Securities [Member] | Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member]
NAV %		1.60%
Debt Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member]
NAV %		0.30%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member]
NAV %	182.90%	205%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Life Science [Member]
NAV %		75.60%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
NAV %	56.70%	83.30%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member]
NAV %	76%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member]
NAV %	30.40%	21.50%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member]
NAV %	19.80%	24.60%
Equity Securities [Member] | Investment, Affiliated Issuer, Controlled [Member]
NAV %	1.90%
Equity Securities [Member] | Investment, Affiliated Issuer, Controlled [Member] | Technology Sector [Member]
NAV %		0.90%
Equity Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %	0%
Equity Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member]
NAV %		0%
Equity Securities [Member] | Investment, Unaffiliated Issuer [Member]
NAV %	2.20%	1.50%
Warrant [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %	0%
Warrant [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member]
NAV %		0%
Warrant [Member] | Investment, Unaffiliated Issuer [Member]
NAV %	5.50%	7.60%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
NAV %	3.50%	4.50%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member]
NAV %	1.50%	2.30%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member]
NAV %	0.30%	0.60%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member]
NAV %	0.20%	0.20%
Other Investments [Member] | Investment, Affiliated Issuer, Controlled [Member]
NAV %	1.80%
Other Investments [Member] | Investment, Affiliated Issuer, Controlled [Member] | Life Science [Member]
NAV %		1.90%
Other Investments [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %	2.40%
Other Investments [Member] | Investment, Unaffiliated Issuer [Member] | Life Science [Member]
NAV %		0.10%
Other Investments [Member] | Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member]
NAV %	1.50%

Note 1 - Organization (Details

Note 1 - Organization (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Aug. 13, 2019
Debt Instrument, Face Amount	$ 705,970	$ 615,000
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Subsidiary, Ownership Percentage, Noncontrolling Owner	30%
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Investment Owned, Net Assets, Percentage		30%
Horizon Technology Finance Corporation [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Net Assets, Percentage	70%	70%
Asset-backed Notes 2019 [Member]
Debt Instrument, Face Amount			$ 160,000
Asset-backed Notes 2019 [Member] | Affiliated Entity [Member]
Debt Instrument, Face Amount			$ 100,000

Note 2 - Basis of Presentatio_2

Note 2 - Basis of Presentation and Significant Accounting Policies (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended		41 Months Ended
	Jun. 02, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Apr. 26, 2024	Dec. 31, 2023	Sep. 22, 2023	Aug. 02, 2021
Investments, Nonaccrual, Interest Income		$ 200	$ 0	$ 200	$ 0
Investment, Income Attributable to Non-cash Paid-in-Kind Interest, Percent		1.50%	13.50%	2.80%	7.10%
Interest Income, Operating, Paid in Kind				$ 2,114	$ 6,088
Investment, Nonaccrual, Income Not Received in Cash, Percent		4.60%	5.10%	6%	4.90%
Debt Issuance Costs, Net		$ 7,900		$ 7,900		$ 7,900		$ 5,800
Accumulated Amortization, Debt Issuance Costs		6,700		6,700		$ 6,700		5,200
Amortization of Debt Issuance Costs		$ 500	$ 500	$ 1,272	$ 1,433
Federal Excise Tax, Percent		4%		4%		4%
Excise and Sales Taxes		$ 400	$ 200	$ 1,100	500
Unrecognized Tax Benefits, Ending Balance		$ 0		$ 0		$ 0		0
Open Tax Year				2024 2023 2022 2021
Proceeds from Issuance of Common Stock				$ 47,527	$ 65,031
Share Repurchase Program, Authorized, Amount							$ 5,000
Stock Repurchased During Period, Shares (in shares)		0	0	0	0	167,465
Stock Repurchased During Period, Per Share (in dollars per share)						$ 11.22
Stock Repurchased During Period, Value						$ 1,900
The 2021 Equity Distribution Agreement [Member]
Equity Sales Agreement, Maximum Value										$ 100,000
Equity Sales Agreement, Remaining Amount Available for Issuance									$ 0
The 2023 Equity Distribution Agreement [Member]
Equity Sales Agreement, Maximum Value									$ 150,000
Equity Sales Agreement, Remaining Amount Available for Issuance		$ 98,200		$ 98,200		98,200
Stock Issued During Period, Shares, New Issues (in shares)		1,709,096	1,186,303	4,279,141	2,240,326
Proceeds from Issuance of Common Stock		$ 18,400	$ 13,900	$ 47,500	$ 26,100
Payments of Stock Issuance Costs		400	400	1,000	700
Public Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)	3,250,000
Proceeds from Issuance of Common Stock	$ 12,500
Payments of Stock Issuance Costs	$ 38,900
Four Investments [Member]
Investments, Cost, Nonaccrual Status		51,400		51,400		51,400		72,500
Investments, Fair Value, Nonaccrual Status		$ 36,100		36,100		$ 36,100		$ 27,600
One Investment [Member]
Interest Income, Operating, Paid in Kind				$ 1,000
Three Investments [Member]
Interest Income, Operating, Paid in Kind			$ 3,700		$ 5,800

Note 3 - Related Party Transa_3

Note 3 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Management Fee Payable	$ 1,025		$ 1,025		$ 1,052
Management Fee Expense	2,989	$ 3,213	9,178	$ 9,621
Administrative Fees Expense	400	441	$ 1,259	1,249
Investment Management Agreement [Member]
Base Management Fee, Annual, Percent			2%
Base Management Fee, Annual, Percent, Gross Assets Exceeding $250 Million			1.60%
Management Fee Payable	1,000		$ 1,000		1,100
Incentive Fee to Pre-incentive Net Investment Income			20%
Pre-Incentive Fee Net Investment Income, Hurdle Rate			1.75%
Pre-Incentive Fee Net Investment Income, Hurdle Rate, Annualized			7%
Pre-Incentive Fee Net Investment Income, Catch-up, Percent			100%
Pre-Incentive Fee Net Investment Income, Maximum Rate to Trigger Catch-up			2.1875%
Pre-Incentive Fee Net Investment Income, Maximum Rate to Trigger Catch-up, Annualized			8.75%
Incentive Fee Expense	0		$ 300	3,100
Incentive Fee Cap and Deferral Mechanism Reduction to Expense	2,400	3,500	7,200	6,800
Incentive Fee Payable	0		0		0
Administration Agreement [Member]
Administrative Fees Expense	400	$ 400	1,300	$ 1,200
Administrative Fees Payable	$ 400		$ 400		$ 400

Note 3 - Related Party Transa_4

Note 3 - Related Party Transactions - Expiration Dates of Contingent Future Liability (Details) - Investment Management Agreement [Member] $ in Thousands	Sep. 30, 2024 USD ($)
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	$ 18,084
December 31, 2025 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	1,037
March 31, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	219
June 30, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,120
September 30, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,471
December 31, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,002
March 31, 2027 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	2,285
June 30, 2027 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	2,582
September 30, 2027 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	$ 2,368

Note 4 - Investments - Investme

Note 4 - Investments - Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Investments at cost	$ 733,232	$ 759,182
Investments at fair value	684,000	709,085
Biotechnology Sector [Member]
Investments at cost	126,867	145,544
Investments at fair value	106,865	117,781
Medical Device Sector [Member]
Investments at cost	185,751	147,064
Investments at fair value	179,092	145,019
Communications Sector [Member]
Investments at cost	13,577	19,192
Investments at fair value	15,596	22,188
Consumer-related Sector [Member]
Investments at cost	74,381	105,669
Investments at fair value	54,505	101,327
Data Storage Sector [Member]
Investments at cost	417	417
Investments at fair value	409	418
Internet and Media Sector [Member]
Investments at cost	329	329
Investments at fair value	984	1,582
Networking Sector [Member]
Investments at cost	10,064	5,451
Investments at fair value	9,818	5,297
Power Management Sector [Member]
Investments at cost	1,585	1,585
Investments at fair value	2,700	2,700
Semiconductor Sector [Member]
Investments at cost	45	45
Investments at fair value	0	0
Software Sector [Member]
Investments at cost	136,309	164,133
Investments at fair value	132,951	160,749
Energy Efficiency [Member]
Investments at cost	9,812	111
Investments at fair value	9,712	13
Other Sustainability Sector [Member]
Investments at cost	66,501	98,906
Investments at fair value	66,163	80,370
Diagnostics Sector [Member]
Investments at cost	16,692	19,735
Investments at fair value	14,114	19,701
Other Healthcare Sector [Member]
Investments at cost	39,511	102
Investments at fair value	40,186	1,366
Software, Healthcare Information and Service [Member]
Investments at cost	51,391	50,899
Investments at fair value	50,905	50,574
Debt [Member]
Investments at cost	654,127	721,231
Investments at fair value	633,284	670,172
Warrant [Member]
Investments at cost	17,292	16,526
Investments at fair value	18,735	24,594
Other Debt Obligations [Member]
Investments at cost	36,651	6,982
Investments at fair value	17,944	6,430
Equity Securities [Member]
Investments at cost	25,162	14,443
Investments at fair value	$ 14,037	$ 7,889

Note 5 - Transactions With Af_3

Note 5 - Transactions With Affiliated Companies (Details Textual)	Sep. 30, 2023
Cadrenal Therapeutics, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage	5%

Note 5 - Transactions With Af_4

Note 5 - Transactions With Affiliated Companies - Investments in Affiliated Companies (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investments, fair value				$ 709,085
Net unrealized appreciation (depreciation) on investments		$ 29,335	$ (17,518)	864	$ (24,448)
Net realized gain (loss) on investments		(33,894)	(11,816)	(31,422)	(28,513)
Investments, fair value		684,000		684,000
Interest Income, Operating, Paid in Kind				2,114	6,088
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments, fair value		15,847	906	1,132	0
Purchases		127	0	234	0
Reductions		(1,430)	0	(1,470)	0
Transfers in/(out) at fair value		0	38,599	0	38,599
Discount accretion		0	35	0	35
Net unrealized appreciation (depreciation) on investments		(6,237)	(19,055)	8,374	(18,149)
Net realized gain (loss) on investments		0	0	37	0
Investments, fair value		8,307	20,485	8,307	20,485
Interest income		0	1,246	0	1,246
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments, fair value		0	0	0	0
Purchases		0	0	3	0
Reductions		0	0	(40)	0
Transfers in/(out) at fair value		0	0	0	0
Discount accretion		0	0	0	0
Net unrealized appreciation (depreciation) on investments		0	0	0	0
Net realized gain (loss) on investments		0	0	37	0
Investments, fair value		0	0	0	0
Interest income			0	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment One [Member]
Investments, fair value		3,503	0	222	0
Purchases		0	0	0	0
Reductions		(318)	0	(318)	0
Transfers in/(out) at fair value		0	7,665	0	7,665
Discount accretion		0	8	0	8
Net unrealized appreciation (depreciation) on investments		(1,360)	(5,007)	1,921	(5,007)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		1,825	2,666	1,825	2,666
Interest income			277	0	277
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Two [Member]
Investments, fair value		5,340	0	336	0
Purchases		127	0	231	0
Reductions		(476)	0	(476)	0
Transfers in/(out) at fair value		0	11,496	0	11,496
Discount accretion		0	11	0	11
Net unrealized appreciation (depreciation) on investments		(2,159)	(7,510)	2,741	(7,510)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		2,832	3,997	2,832	3,997
Interest income			415	0	415
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Three [Member]
Investments, fair value		2,101	0	133	0
Purchases		0	0	0	0
Reductions		(191)	0	(191)	0
Transfers in/(out) at fair value		0	4,612	0	4,612
Discount accretion		0	5	0	5
Net unrealized appreciation (depreciation) on investments		(815)	(3,013)	1,153	(3,013)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		1,095	1,604	1,095	1,604
Interest income			166	0	166
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Four [Member]
Investments, fair value		2,101	0	133	0
Purchases		0	0	0	0
Reductions		(191)	0	(191)	0
Transfers in/(out) at fair value		0	4,598	0	4,598
Discount accretion		0	3	0	3
Net unrealized appreciation (depreciation) on investments		(815)	(3,004)	1,153	(3,004)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		1,095	1,597	1,095	1,597
Interest income			163	0	163
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Five [Member]
Investments, fair value		1,401	0	88	0
Purchases		0	0	0	0
Reductions		(127)	0	(127)	0
Transfers in/(out) at fair value		0	3,067	0	3,067
Discount accretion		0	4	0	4
Net unrealized appreciation (depreciation) on investments		(544)	(2,003)	769	(2,003)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		730	1,068	730	1,068
Interest income			114	0	114
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Six [Member]
Investments, fair value		1,401	0	88	0
Purchases		0	0	0	0
Reductions		(127)	0	(127)	0
Transfers in/(out) at fair value		0	3,067	0	3,067
Discount accretion		0	4	0	4
Net unrealized appreciation (depreciation) on investments		(544)	(2,003)	769	(2,003)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		730	1,068	730	1,068
Interest income			111	0	111
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Seven [Member]
Investments, fair value			0	132	0
Purchases			0	0	0
Reductions			0	0	0
Transfers in/(out) at fair value			5,000	0	5,000
Discount accretion			0	0	0
Net unrealized appreciation (depreciation) on investments			3,485	(132)	3,485
Net realized gain (loss) on investments			0	0	0
Investments, fair value		0	8,485	0	8,485
Interest income			0	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments, fair value	[1]		906		0
Purchases	[1]		0		0
Reductions	[1]		0		0
Transfers in/(out) at fair value	[1]		(906)		(906)
Discount accretion	[1]		0		0
Net unrealized appreciation (depreciation) on investments	[1]		0		906
Net realized gain (loss) on investments	[1]		0		0
Investments, fair value	[1]		0		0
Interest income	[1]		0		0
Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value		11,386	0	14,223	0
Purchases		1,290	809	3,767	809
Reductions		(45)	0	(592)	0
Transfers in/(out) at fair value		6,716	10,818	7,179	10,818
Discount accretion		3	3	10	3
Net unrealized appreciation (depreciation) on investments		165	1,357	(5,416)	1,357
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		19,731	13,145	19,731	13,145
Interest income		25	8	46	8
Interest Income, Operating, Paid in Kind		216	158	560	158
Investment, Affiliated Issuer, Controlled [Member] | Investment [Member]
Interest income		241	166	606	166
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment One [Member]
Investments, fair value		3,166	0	3,339	0
Purchases		0	59	0	59
Reductions		0	0	0	0
Transfers in/(out) at fair value		0	1,759	0	1,759
Discount accretion		2	2	6	2
Net unrealized appreciation (depreciation) on investments		(53)	1,080	(456)	1,080
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		3,234	3,005	3,234	3,005
Interest income		125	111	363	111
Interest Income, Operating, Paid in Kind		119	105	345	105
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Two [Member]
Investments, fair value		1,549	0	1,630	0
Purchases		0	0	0	0
Reductions		0	0	0	0
Transfers in/(out) at fair value		0	844	0	844
Discount accretion		1	1	4	1
Net unrealized appreciation (depreciation) on investments		(26)	536	(222)	536
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		1,583	1,434	1,583	1,434
Interest income		63	55	184	55
Interest Income, Operating, Paid in Kind		59	53	171	53
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Three [Member]
Investments, fair value		420	0	0	0
Purchases		0	0	500	0
Reductions		0	0	0	0
Transfers in/(out) at fair value		0	2,061	0	2,061
Discount accretion		0	0	0	0
Net unrealized appreciation (depreciation) on investments		53	0	(32)	0
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		489	2,061	489	2,061
Interest income		16	0	21	0
Interest Income, Operating, Paid in Kind		16	0	21	0
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Four [Member]
Investments, fair value		415	0	0	0
Purchases		0	750	500	750
Reductions		0	0	0	0
Transfers in/(out) at fair value		0	0	0	0
Discount accretion		0	0	0	0
Net unrealized appreciation (depreciation) on investments		53	(259)	(33)	(259)
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		484	491	484	491
Interest income		16	0	17	0
Interest Income, Operating, Paid in Kind		16	0	17	0
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Five [Member]
Investments, fair value		0		0
Purchases		500		500
Reductions		0		0
Transfers in/(out) at fair value		0		0
Discount accretion		0		0
Net unrealized appreciation (depreciation) on investments		(32)		(32)
Net realized gain (loss) on investments		0		0
Investments, fair value		474		474
Interest income		6		6
Interest Income, Operating, Paid in Kind		6		6
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Six [Member]
Investments, fair value				3,024
Purchases				1,250
Reductions				0
Transfers in/(out) at fair value				0
Discount accretion				0
Net unrealized appreciation (depreciation) on investments				(4,274)
Net realized gain (loss) on investments				0
Investments, fair value		0		0
Interest income				0
Interest Income, Operating, Paid in Kind				0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments, fair value		5,836	0	6,230	0
Purchases		0	0	227	0
Reductions		(45)	0	(592)	0
Transfers in/(out) at fair value		0	6,154	463	6,154
Discount accretion		0	0	0	0
Net unrealized appreciation (depreciation) on investments		499	0	(38)	0
Net realized gain (loss) on investments		0	0	0	0
Investments, fair value		6,290	6,154	6,290	6,154
Interest income		0	0	0	0
Interest Income, Operating, Paid in Kind		0	$ 0	0	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Nexii Building Solutions, Inc [Member] | Investment One [Member]
Investments, fair value		0		0
Purchases		0		0
Reductions		0		0
Transfers in/(out) at fair value		6,716		6,716
Discount accretion		0		0
Net unrealized appreciation (depreciation) on investments		(167)		(167)
Net realized gain (loss) on investments		0		0
Investments, fair value		6,549		6,549
Interest income		15		15
Interest Income, Operating, Paid in Kind		0		0
Investment, Affiliated Issuer, Controlled [Member] | Nexii Building Solutions, Inc [Member] | Investment Two [Member]
Investments, fair value		0		0
Purchases		790		790
Reductions		0		0
Transfers in/(out) at fair value		0		0
Discount accretion		0		0
Net unrealized appreciation (depreciation) on investments		(162)		(162)
Net realized gain (loss) on investments		0		0
Investments, fair value		628		628
Interest income		0		0
Interest Income, Operating, Paid in Kind		$ 0		$ 0
[1]As of September 30, 2023, the Company no longer owns 5% or more of the portfolio company.

Note 6 - Fair Value (Details Te

Note 6 - Fair Value (Details Textual) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($)	Jun. 30, 2022
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	$ 0	$ (5,000)	$ 0	$ (5,111)
Unrealized Gain (Loss) on Investments	$ 29,335	(17,518)	864	(24,448)
Equity Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0		(111)
Warrant [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0		0
Fair Value, Inputs, Level 1 [Member] | Debt Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3		$ 5,000		5,000
Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3				100
Fair Value, Inputs, Level 3 [Member] | Debt Securities [Member]
Unrealized Gain (Loss) on Investments			(6,000)	(33,600)
Fair Value, Inputs, Level 3 [Member] | Equity Securities [Member]
Unrealized Gain (Loss) on Investments			(4,500)	(1,600)
Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Unrealized Gain (Loss) on Investments			$ (300)	$ (2,100)
The 2026 Notes [Member]
Debt Instrument, Share Price (in dollars per share) | $ / shares	$ 24.3		$ 24.3
The 2026 Notes [Member] | Fair Value, Inputs, Level 1 [Member]
Debt Instrument, Fair Value Disclosure	$ 55,900		$ 55,900
The 2027 Notes [Member]
Debt Instrument, Share Price (in dollars per share) | $ / shares	$ 24.16		$ 24.16
The 2027 Notes [Member] | Fair Value, Inputs, Level 1 [Member]
Debt Instrument, Fair Value Disclosure	$ 55,600		$ 55,600
Asset-backed Notes 2022 [Member] | Fair Value, Inputs, Level 3 [Member]
Debt Instrument, Fair Value Disclosure	$ 91,000		$ 91,000
Measurement Input, Hypothetical Market Yields [Member]
Debt Instrument, Measurement Input					0.25

Note 6 - Fair Value - Assets at

Note 6 - Fair Value - Assets at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Recurring [Member]
Investments, fair value	$ 684,000	$ 709,085
Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	633,284	670,172
Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	18,735	24,594
Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	17,944	6,430
Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	14,037	7,889
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Investments, fair value	560	608
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	560	608
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Investments, fair value	430	1,619
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	430	1,619
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 3 [Member]
Investments, fair value	683,010	706,858
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]
Investments, fair value	683,010	706,858
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	633,284	670,172
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	18,305	22,975
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	17,944	6,430
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	$ 13,477	$ 7,281

Note 6 - Fair Value - Significa

Note 6 - Fair Value - Significant Level 3 Fair Value Measurement Inputs (Details) - Fair Value, Inputs, Level 3 [Member] $ in Thousands		Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Investments, fair value		$ 683,010	$ 706,858
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member]
Investments, fair value		$ 597,137	$ 617,529
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Minimum [Member] | Hypothetical Market Yield [Member]
Investments, measurement input		0.12	0.11
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Maximum [Member] | Hypothetical Market Yield [Member]
Investments, measurement input		0.20	0.24
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Weighted Average [Member] | Hypothetical Market Yield [Member]
Investments, measurement input	[1]	0.14	0.15
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member]
Investments, fair value		$ 36,147	$ 52,643
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0.10	0.20
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		1	1
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Probability Weighting [Member]
Investments, measurement input	[1]	0.77	0.50
Warrant [Member] | Black-scholes Valuation Model [Member]
Investments, fair value		$ 18,305	$ 22,913
Warrant [Member] | Black-scholes Valuation Model [Member] | Measurement Input, Price Volatility [Member]
Investments, measurement input		0.25	0.25
Warrant [Member] | Black-scholes Valuation Model [Member] | Expected Proceeds [Member]
Investments, fair value			$ 62
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0	0
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input		0	0
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Estimated Time to Exit [Member]
Investments, measurement input		1	1
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		1,898.58	1,899
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input		0.20	0.20
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Estimated Time to Exit [Member]
Investments, measurement input		5	5
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	65.35	64.95
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Price Volatility [Member]
Investments, measurement input	[1]	0.25	0.25
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input	[1]	0.17	0.18
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Estimated Time to Exit [Member]
Investments, measurement input	[1]	3	3
Warrant [Member] | Expected Proceeds [Member] | Measurement Input, Share Price [Member]
Investments, measurement input			0.25
Warrant [Member] | Expected Proceeds [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]		0.25
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member]
Investments, fair value		$ 17,944	$ 6,430
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input			0.25
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0.30	0.30
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input		0.15
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		1	1
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input		1
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Probability Weighting [Member]
Investments, measurement input	[1]	0.86	0.81
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input	[1]	0.36	0.25
Equity Securities [Member] | Last Equity Financing [Member]
Investments, fair value		$ 13,477	$ 7,281
Equity Securities [Member] | Last Equity Financing [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0	0.56
Equity Securities [Member] | Last Equity Financing [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		14,592.6	215.03
Equity Securities [Member] | Last Equity Financing [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	3,532.29	17.15
[1]Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) (1) the fair value of the related investment in the investment type divided by (2) the total fair value of the investment type.

Note 6 - Fair Value - Reconcili

Note 6 - Fair Value - Reconciliation of Level 3 Assets Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Balance	$ 646,232	$ 713,244	$ 706,858	$ 716,319
Purchase of investments	85,827	66,935	121,211	154,488
Warrants and equity received and classified as Level 3	411	1,294	1,628	2,039
Principal payments received on investments	(44,392)	(25,726)	(120,448)	(90,222)
Payment-in-kind interest on investments	377	3,934	2,114	6,088
Proceeds from sale of investments	(69)	(2,557)	(157)	(11,063)
Net realized (loss) gain on investments	(33,894)	(11,552)	(31,213)	(28,198)
Unrealized appreciation (depreciation) included in earnings	28,974	(20,722)	1,906	(26,384)
Transfer out of warrant investments	0	0	0	0
Other	(456)	(715)	1,111	1,179
Balance	683,010	719,135	683,010	719,135
Transfer out of Level 3	0	(5,000)	0	(5,111)
Debt [Member]
Balance	609,068	683,309	670,172	686,458
Purchase of investments	85,782	66,185	119,564	153,728
Warrants and equity received and classified as Level 3	0	0	0	0
Principal payments received on investments	(44,347)	(25,726)	(120,333)	(90,222)
Payment-in-kind interest on investments	377	3,934	2,114	6,088
Proceeds from sale of investments	(69)	(2,528)	(113)	(9,564)
Net realized (loss) gain on investments	(33,385)	(11,440)	(33,344)	(29,105)
Unrealized appreciation (depreciation) included in earnings	37,574	(18,877)	18,564	(21,325)
Transfer out of warrant investments	(21,260)	(9,304)	(24,451)	(12,399)
Other	(456)	(715)	1,111	1,179
Balance	633,284	679,838	633,284	679,838
Transfer out of Level 3		(5,000)		(5,000)
Warrant [Member]
Balance	21,131	24,376	22,975	26,145
Purchase of investments	0	0	0	0
Warrants and equity received and classified as Level 3	411	1,294	1,628	1,950
Principal payments received on investments	0	0	0	0
Payment-in-kind interest on investments	0	0	0	0
Proceeds from sale of investments	0	(23)	(4)	(1,493)
Net realized (loss) gain on investments	(509)	(118)	2,091	1,028
Unrealized appreciation (depreciation) included in earnings	(2,655)	(296)	(5,631)	(2,392)
Transfer out of warrant investments	(73)	0	(2,754)	(5)
Other	0	0	0	0
Balance	18,305	25,233	18,305	25,233
Transfer out of Level 3		0		0
Equity Securities [Member]
Balance	6,850	4,259	7,281	2,416
Purchase of investments	0	750	1,250	760
Warrants and equity received and classified as Level 3	0	0	0	89
Principal payments received on investments	0	0	0	0
Payment-in-kind interest on investments	0	0	0	0
Proceeds from sale of investments	0	(6)	0	(6)
Net realized (loss) gain on investments	0	6	0	(121)
Unrealized appreciation (depreciation) included in earnings	(162)	(1,349)	(4,524)	(2,467)
Transfer out of warrant investments	6,789	3,150	9,470	6,250
Other	0	0	0	0
Balance	13,477	6,810	13,477	6,810
Transfer out of Level 3		0		(111)
Other Investments [Member]
Balance	9,183	1,300	6,430	1,300
Purchase of investments	45	0	397	0
Warrants and equity received and classified as Level 3	0	0	0	0
Principal payments received on investments	(45)	0	(115)	0
Payment-in-kind interest on investments	0	0	0	0
Proceeds from sale of investments	0	0	(40)	0
Net realized (loss) gain on investments	0	0	40	0
Unrealized appreciation (depreciation) included in earnings	(5,783)	(200)	(6,503)	(200)
Transfer out of warrant investments	14,544	6,154	17,735	6,154
Other	0	0	0	0
Balance	$ 17,944	7,254	$ 17,944	7,254
Transfer out of Level 3		$ 0		$ 0

Note 7 - Borrowings (Details Te

Note 7 - Borrowings (Details Textual) - USD ($) $ / shares in Units, $ in Thousands						3 Months Ended		9 Months Ended
	Jun. 21, 2024	Jun. 20, 2024	May 06, 2024	May 24, 2023	Apr. 21, 2020	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jun. 29, 2023	Nov. 09, 2022	Jun. 15, 2022	Mar. 30, 2021	Aug. 13, 2019
Restricted Investments						$ 3,266		$ 3,266		$ 2,642
Long-Term Debt, Gross						436,970		436,970		466,000
Debt Instrument, Face Amount						$ 705,970		$ 705,970		615,000
Key Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity, Accordian Feature											$ 150,000
Line of Credit Facility, Maximum Borrowing Capacity											$ 300,000
Line of Credit Facility, Advance Rate of Eligible Debt Investments											60%
Long-Term Debt, Weighted Average Interest Rate, over Time						8.53%	8.68%	8.67%	8.34%
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage								0.50%
Line of Credit Facility, Current Borrowing Capacity						$ 150,000		$ 150,000		80,000
Line of Credit Facility, Remaining Borrowing Capacity						13,300		13,300		25,000
Long-Term Debt, Gross						0		0		70,000
Debt Instrument, Face Amount						$ 150,000		$ 150,000		$ 150,000
Key Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		0.10%
Debt Instrument, Variable Rate						8%		8%		8.50%
NYL Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 250,000	$ 100,000
Line of Credit Facility, Current Borrowing Capacity						$ 69,000		$ 69,000		$ 69,000
Line of Credit Facility, Remaining Borrowing Capacity						8,200		8,200		17,400
Line of Credit Facility, Maximum Borrowing Capacity, Accordion Feature					$ 200,000
Line of Credit Facility, Advance Rate					67%
Line of Credit Facility, Change in Maximum Borrowing Capacity				$ 50,000
Debt Instrument, Interest Rate, Stated Percentage			4.60%	4.60%
Long-Term Line of Credit						$ 181,000		$ 181,000		181,000
Line of Credit Facility, Interest Rate at Period End						6.43%	5.85%	6.43%	5.85%
Restricted Investments						$ 1,400		$ 1,400		1,400
Long-Term Debt, Gross						181,000		181,000		181,000
Debt Instrument, Face Amount						250,000		250,000		250,000
NYL Facility [Member] | Three Year I Curve [Member]
Debt Instrument, Basis Spread on Variable Rate			3.20%	3.50%
Nuveen Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity, Accordian Feature	$ 200,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 100,000
Line of Credit Facility, Current Borrowing Capacity						50,000		50,000
Line of Credit Facility, Remaining Borrowing Capacity						29,900		29,900
Line of Credit Facility, Advance Rate	67.50%
Long-Term Line of Credit						$ 50,000		$ 50,000		0
Line of Credit Facility, Interest Rate at Period End						7.38%		7.38%
Restricted Investments						$ 900		$ 900
Long-Term Debt, Gross						50,000		50,000		0
Debt Instrument, Face Amount						100,000		100,000		0
Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate	3.15%
Asset-backed Notes 2019 [Member]
Debt Instrument, Interest Rate, Stated Percentage															4.21%
Debt Instrument, Face Amount															$ 160,000
Asset-backed Notes 2022 [Member]
Debt Instrument, Interest Rate, Stated Percentage												7.56%
Restricted Investments						1,000		1,000		1,300
Long-Term Debt, Gross						90,970		90,970		100,000
Debt Instrument, Face Amount						90,970		90,970		100,000		$ 157,800
The 2026 Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage														4.875%
Long-Term Debt, Gross						57,500		57,500		57,500
Debt Instrument, Face Amount						57,500		57,500		57,500				$ 57,500
The 2026 Notes Underwriter Option [Member]
Debt Instrument, Face Amount														$ 7,500
Debt Instrument, Convertible, Conversion Price (in dollars per share)														$ 25
The 2027 Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage													6.25%
Long-Term Debt, Gross						57,500		57,500		57,500
Debt Instrument, Face Amount						$ 57,500		$ 57,500		$ 57,500			$ 50,000
The 2027 Notes Underwriter Option [Member]
Debt Instrument, Face Amount													$ 7,500
Debt Instrument, Convertible, Conversion Price (in dollars per share)													$ 25
Minimum [Member]
Asset Coverage to Borrowings, Ratio, Percent								150%
Minimum [Member] | Key Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		4.10%
Minimum [Member] | NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					3.55%
Minimum [Member] | Nuveen Facility [Member]
Debt Instrument, Interest Rate, Stated Percentage	5%
Minimum [Member] | Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate, Treasury Yield Maturity (Year)	3 years
Maximum [Member]
Asset Coverage to Borrowings, Ratio, Percent								178%
Maximum [Member] | NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					5.15%
Maximum [Member] | Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate, Treasury Yield Maturity (Year)	5 years
Weighted Average [Member] | Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate, Treasury Yield Maturity (Year)	4 years 10 months 17 days

Note 7 - Borrowings - Borrowing

Note 7 - Borrowings - Borrowings (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Nov. 09, 2022	Jun. 15, 2022	Mar. 30, 2021
Total commitment	$ 705,970	$ 615,000
Balance outstanding	436,970	466,000
Unused commitment	269,000	149,000
Unamortized debt issuance costs attributable to term borrowings	(3,001)	(3,765)
Total borrowings outstanding, net	433,969	462,235
Key Facility [Member]
Total commitment	150,000	150,000
Balance outstanding	0	70,000
Unused commitment	150,000	80,000
NYL Facility [Member]
Total commitment	250,000	250,000
Balance outstanding	181,000	181,000
Unused commitment	69,000	69,000
Nuveen Facility [Member]
Total commitment	100,000	0
Balance outstanding	50,000	0
Unused commitment	50,000	0
Asset-backed Notes 2022 [Member]
Total commitment	90,970	100,000	$ 157,800
Balance outstanding	90,970	100,000
Unused commitment	0	0
The 2027 Notes [Member]
Total commitment	57,500	57,500		$ 50,000
Balance outstanding	57,500	57,500
Unused commitment	0	0
The 2026 Notes [Member]
Total commitment	57,500	57,500			$ 57,500
Balance outstanding	57,500	57,500
Unused commitment	$ 0	$ 0

Note 8 - Financial Instrument_3

Note 8 - Financial Instruments With Off-balance-sheet Risk (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability	$ 1,772	$ 2,033
Commitments to Extend Credit [Member]
Other Commitment	189,900	180,500
Unfunded Loan Commitment [Member]
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability	$ 1,800	$ 2,000

Note 8 - Financial Instrument_4

Note 8 - Financial Instruments With Off-balance-sheet Risk - Unfunded Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Unfunded commitments, principal balance	$ 189,875	$ 180,500
Fair value of unfunded commitment liability	1,772	2,033
Better Place Forests Co. [Member]
Unfunded commitments, principal balance	1,000	0
Fair value of unfunded commitment liability	0	0
BrightInsight, Inc. [Member]
Unfunded commitments, principal balance	10,000	15,500
Fair value of unfunded commitment liability	132	241
Britecore Holdings, Inc. [Member]
Unfunded commitments, principal balance	2,500	5,000
Fair value of unfunded commitment liability	36	72
Candesant Biomedical Corporation [Member]
Unfunded commitments, principal balance	10,000	10,000
Fair value of unfunded commitment liability	151	151
Ceribell, Inc. [Member]
Unfunded commitments, principal balance	21,000	0
Fair value of unfunded commitment liability	120	0
Divergent Technologies, Inc. [Member]
Unfunded commitments, principal balance	0	11,250
Fair value of unfunded commitment liability	0	118
Elligo Healthcare Research, Inc. [Member]
Unfunded commitments, principal balance	7,500	15,000
Fair value of unfunded commitment liability	97	194
Fictiv, Inc. [Member]
Unfunded commitments, principal balance	30,000	0
Fair value of unfunded commitment liability	236	0
GT Medical Technologies, Inc. [Member]
Unfunded commitments, principal balance	20,000	0
Fair value of unfunded commitment liability	100	0
Hometeam Technologies, Inc [Member]
Unfunded commitments, principal balance	10,000	0
Fair value of unfunded commitment liability	100	0
MicroTransponder, Inc. [Member]
Unfunded commitments, principal balance	22,500	22,500
Fair value of unfunded commitment liability	0	0
Mirantis, Inc [Member]
Unfunded commitments, principal balance	0	15,000
Fair value of unfunded commitment liability	0	136
Optoro, Inc. [Member]
Unfunded commitments, principal balance	0	6,250
Fair value of unfunded commitment liability	0	0
Parse Biosciences, Inc. [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	252	251
Pivot Bio, Inc. [Member]
Unfunded commitments, principal balance	20,000	0
Fair value of unfunded commitment liability	209	0
SafelyYou, Inc [Member]
Unfunded commitments, principal balance	10,000	20,000
Fair value of unfunded commitment liability	147	270
Sonex Health, Inc. [Member]
Unfunded commitments, principal balance	0	15,000
Fair value of unfunded commitment liability	0	176
Standvast Holdings, LLC [Member]
Unfunded commitments, principal balance	5,000	0
Fair value of unfunded commitment liability	175	0
Supply Network Visibility Holdings, LLC [Member]
Unfunded commitments, principal balance	5,000	10,000
Fair value of unfunded commitment liability	17	35
Swift Health Systems Inc. [Member]
Unfunded commitments, principal balance	375	0
Fair value of unfunded commitment liability	0	0
Tallac Therapeutics, Inc [Member]
Unfunded commitments, principal balance	0	10,000
Fair value of unfunded commitment liability	0	229
Viken Detection Corporation [Member]
Unfunded commitments, principal balance	0	10,000
Fair value of unfunded commitment liability	$ 0	$ 160

Note 9 - Concentrations of Cr_2

Note 9 - Concentrations of Credit Risk (Details Textual) - Debt Investments [Member]	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Investment Concentration Risk [Member] | Reported Value Measurement [Member]
Concentration Risk, Percentage			22%		23%
Investment Concentration Risk [Member] | Estimate of Fair Value Measurement [Member]
Concentration Risk, Percentage			23%		22%
Interest Income [Member] | Reported Value Measurement [Member]
Concentration Risk, Percentage	21%	24%	21%	23%
Interest Income [Member] | Estimate of Fair Value Measurement [Member]
Concentration Risk, Percentage	25%	22%	23%	21%

Note 10 - Distributions (Detail

Note 10 - Distributions (Details Textual) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Common Stock, Dividends, Per Share, Cash Paid (in dollars per share)	$ 0.33
Earnings Per Share, Basic (in dollars per share)	0.32	$ 0.53	$ 1.06	$ 1.54
Earnings Per Share, Basic, Undistributed (in dollars per share)	$ 1.27

Note 10 - Distributions - Distr

Note 10 - Distributions - Distribution Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 25, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Distributions declared per share (in dollars per share)		$ 0.33	$ 0.33	$ 1.04	$ 0.99	$ 1.37
Dividends, cash				$ 27,827		$ 41,881
Dividends, shares (in shares)				126,380		145,743
Dividends, stock				$ 1,451		$ 1,833
O 2025 M2 Dividends [Member] | Forecast [Member]
Record date	Feb. 18, 2025
Payment date	Mar. 14, 2025
Distributions declared per share (in dollars per share)	$ 0.11
O 2025 M1 Dividends [Member] | Forecast [Member]
Record date	Jan. 16, 2025
Payment date	Feb. 14, 2025
Distributions declared per share (in dollars per share)	$ 0.11
O 2024 M7 1 Dividends [Member]
Record date				Nov. 15, 2024
Payment date				Dec. 13, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 0
Dividends, shares (in shares)				0
Dividends, stock				$ 0
O 2024 M12 Dividends [Member] | Forecast [Member]
Record date	Dec. 16, 2024
Payment date	Jan. 15, 2025
Distributions declared per share (in dollars per share)	$ 0.11
O 2024 M7 2 Dividends [Member]
Record date				Oct. 17, 2024
Payment date				Nov. 14, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 0
Dividends, shares (in shares)				0
Dividends, stock				$ 0
O 2024 M7 3 Dividends [Member]
Record date				Sep. 16, 2024
Payment date				Oct. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,914
Dividends, shares (in shares)				18,539
Dividends, stock				$ 195
O 2024 M4 1 Dividends [Member]
Record date				Aug. 16, 2024
Payment date				Sep. 13, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,818
Dividends, shares (in shares)				17,441
Dividends, stock				$ 192
O 2024 M4 2 Dividends [Member]
Record date				Jul. 17, 2024
Payment date				Aug. 15, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,775
Dividends, shares (in shares)				16,852
Dividends, stock				$ 192
O 2024 M4 3 Dividends [Member]
Record date				Jun. 17, 2024
Payment date				Jul. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,766
Dividends, shares (in shares)				15,860
Dividends, stock				$ 199
O 2024 M2 1 Dividends [Member]
Record date				Jun. 17, 2024
Payment date				Jun. 14, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,701
Dividends, shares (in shares)				16,686
Dividends, stock				$ 201
O 2024 M2 2 Dividends [Member]
Record date				Apr. 18, 2024
Payment date				May 15, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,654
Dividends, shares (in shares)				16,687
Dividends, stock				$ 199
O 2024 M2 3 Dividends [Member]
Record date				Mar. 19, 2024
Payment date				Apr. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.05
Dividends, cash				$ 1,625
Dividends, shares (in shares)				7,598
Dividends, stock				$ 85
O 2024 M2 4 Dividends [Member]
Record date				Mar. 19, 2024
Payment date				Apr. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,574
Dividends, shares (in shares)				16,717
Dividends, stock				$ 188
O 2023 M10 1 Dividends [Member]
Record date						Feb. 16, 2024
Payment date						Mar. 15, 2024
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,463
Dividends, shares (in shares)						18,257
Dividends, stock						$ 210
O 2023 M10 2 Dividends [Member]
Record date						Jan. 18, 2024
Payment date						Feb. 14, 2024
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,462
Dividends, shares (in shares)						15,873
Dividends, stock						$ 210
O 2023 M10 3 Dividends [Member]
Record date						Dec. 19, 2023
Payment date						Jan. 16, 2024
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,472
Dividends, shares (in shares)						14,563
Dividends, stock						$ 199
O 2023 M10 4 Dividends [Member]
Record date						Nov. 17, 2023
Payment date						Dec. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.05
Dividends, cash						$ 1,574
Dividends, shares (in shares)						7,137
Dividends, stock						$ 93
O 2023 M7 1 Dividends [Member]
Record date						Nov. 17, 2023
Payment date						Dec. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,463
Dividends, shares (in shares)						15,701
Dividends, stock						$ 206
O 2023 M7 2 Dividends [Member]
Record date						Oct. 18, 2023
Payment date						Nov. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,493
Dividends, shares (in shares)						14,022
Dividends, stock						$ 173
O 2023 M7 3 Dividends [Member]
Record date						Sep. 19, 2023
Payment date						Oct. 16, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,445
Dividends, shares (in shares)						15,067
Dividends, stock						$ 184
O 2023 M4 1 Dividends [Member]
Record date						Aug. 17, 2023
Payment date						Sep. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,458
Dividends, shares (in shares)						8,665
Dividends, stock						$ 106
O 2023 M4 2 Dividends [Member]
Record date						Jul. 18, 2023
Payment date						Aug. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,427
Dividends, shares (in shares)						8,307
Dividends, stock						$ 105
O 2023 M4 3 Dividends [Member]
Record date						Jun. 16, 2023
Payment date						Jul. 14, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,434
Dividends, shares (in shares)						7,424
Dividends, stock						$ 96
O 2023 M2 1 Dividends [Member]
Record date						May 18, 2023
Payment date						Jun. 14, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,087
Dividends, shares (in shares)						7,128
Dividends, stock						$ 86
O 2023 M2 2 Dividends [Member]
Record date						Apr. 18, 2023
Payment date						May 16, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,068
Dividends, shares (in shares)						6,705
Dividends, stock						$ 84
O 2023 M2 3 Dividends [Member]
Record date						Mar. 17, 2023
Payment date						Apr. 14, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,035
Dividends, shares (in shares)						6,894
Dividends, stock						$ 81

Note 11 - Financial Highlight_2

Note 11 - Financial Highlights - Financial Highlights (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Net asset value at beginning of period (in dollars per share)				$ 9.71	$ 11.47
Net investment income (in dollars per share)				1.06	1.54
Realized gain (loss) (in dollars per share)				(0.89)	(0.95)
Unrealized appreciation (depreciation) on investments (in dollars per share)				0.02	(0.81)
Net increase (decrease) in net assets resulting from operations (in dollars per share)		$ 0.2	$ (0.37)	0.19	(0.22)
Distributions declared (in dollars per share)	[1]			(1.04)	(0.99)
From net investment income (in dollars per share)				(1.04)	(0.99)
From net realized gain on investments (in dollars per share)		0	0	0	0
Return of capital (in dollars per share)				0	0
Other (in dollars per share)	[2]			0.2	0.15
Net asset value at end of period (in dollars per share)		9.06	10.41	9.06	10.41
Per share market value, beginning of period (in dollars per share)				13.17	11.6
Per share market value, end of period (in dollars per share)		$ 10.65	$ 11.88	$ 10.65	$ 11.88
Total return based on a market value	[3]			(11.20%)	10.90%
Shares outstanding at end of period (in shares)		37,803,064	33,306,958	37,803,064	33,306,958	33,367,389
Expenses without incentive fee (4)	[4]			15.10%	14%
Incentive fees	[4]			0.10%	1.20%
Net expenses	[4]			15.20%	15.20%
Net investment income with incentive fee (4)	[4]			15%	18.50%
Net assets at the end of the period		$ 342,533	$ 346,575	$ 342,533	$ 346,575	$ 323,981
Average net asset value		$ 331,853	$ 335,531	$ 331,853	$ 335,531
Average debt per share (in dollars per share)				$ 12.7	$ 14.29
Portfolio turnover ratio	[5]			13.40%	10%
[1]Distributions are determined based on taxable income calculated in accordance with income tax regulations, which may differ from amounts determined under GAAP due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given tax year for distribution in the following tax year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.[2]Includes the impact of the different share amounts as a result of calculating per share data based on the weighted average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. The issuance of common stock on a per share basis reflects the incremental net asset value changes as a result of the issuance of common stock in the Company’s continuous public offering and pursuant to the Company’s distribution reinvestment plan. The issuance of common stock at an offering price, net of sales commissions and dealer manager fees, that is greater than the net asset value per share results in an increase in net asset value per share.[3]The total return equals the change in the ending market value over the beginning of period price per share plus distributions paid per share during the period, divided by the beginning price.[4]Annualized.[5]Calculated by dividing (A) the lesser of purchases or sales of portfolio securities for the fiscal year by (B) the monthly average of the value of portfolio securities owned by the Company during the fiscal year, with certain securities excluded from the numerator and denominator pursuant to applicable federal securities laws.

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - USD ($)	Oct. 18, 2025	Oct. 15, 2025	Oct. 23, 2024	Oct. 17, 2024	Oct. 07, 2024	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument, Face Amount						$ 705,970,000	$ 615,000,000
Subsequent Event [Member] | The 2031 Convertible Notes [Member]
Debt Instrument, Face Amount				$ 20,000,000
Debt Instrument, Interest Rate, Stated Percentage				7.125%
Debt Instrument, Convertible, Conversion Price (in dollars per share)				$ 25
Proceeds from Convertible Debt				$ 18,600,000
Debt Instrument, Maturity Date				Oct. 16, 2031
Subsequent Event [Member] | Venture Loan and Security Agreement [Member] | CAMP NYC, Inc [Member]
Proceeds from Sale, Maturity and Collection of Investments			$ 2,000,000
Standvast Holdings, LLC [Member] | Debt Securities [Member] | Subsequent Event [Member]
Payments to Acquire Investments					$ 2,500,000
Swift Health Systems Inc. [Member] | Debt Securities [Member] | Forecast [Member]
Payments to Acquire Investments		$ 600,000
Better Place Forests Co. [Member] | Debt Securities [Member] | Forecast [Member]
Payments to Acquire Investments	$ 500,000